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[BMIM][BF4]  1-Butyl-3-methylimidazolium tetrafluoroborate 
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1 Subject Overview 
 
The Lewis-acid/base reaction between a ligand and a metal fragment to form a complex is one 
of the fundamental chemical processes. In accordance with their role as Lewis-bases, most 
ligands are neutral species or anions. However, cations may also be employed as ligands. The 
use of these species, due to their charged nature, may introduce in the resulting metal 
complexes some interesting properties such as insolubility in organic solvents. That might 
help to solve one of the problems intrinsically associated with catalytic processes – the 
separation and recovery of the catalyst. Therefore, the development of stable and recyclable 
catalysts based on cationic ligands seems to be a promising area of research. 
 
1.1 Cationic Ligands 
 
By definition, all cationic ligands contain moieties in their structure with at least one positive 
charge. Classical examples are ammonium (1, 2, 4) or phosphonium (3) substituents  
(Figure 1).1 Due to their cationic nature, alkylphosphines with positively charged groups such 
as ammonium or phosphonium substituents are generally less strongly donating than their 
neutral alkylphosphine analogues. 
 
 
Figure 1. Various phosphine ligands substituted with cationic groups. 
 
It has been reported that the ammonium-functionalized phosphines 1 (R = Cy or tBu) and 2  
(R = Cy) are lightly less donating (ν (CO) of Ni(CO)3L complexes are 2065, 2064 and  
2061 cm-1 respectively) than their neutral analogues PCy3 and P(tBu)3 (2056 cm -1 in both 
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cases).1 In the same way as alkylammonium groups, alkylphosphonium substituents act as 
electron-withdrawing moieties in ligands of general structure 3.2 An increase in the number of 
methylene spacers in between the PMe3+ moiety and the phosphorus atom reduces this effect.2 
A similar situation takes place by protonation of 4a to form 4b.3 
 
As an example demonstrating the differences in the behavior of neutral and cationic type 
ligands in the Pd-catalyzed cross-coupling reaction, the performance of the hexacationic 
phosphine 7 has been compared with the neutral hexa[(dimethylamino)methyl]-
triphenylphosphine 6 as well as the standard triphenyl-phosphine 8 depicted below.4 
 
 
Scheme 1. Pd-catalyzed Suzuki-Miyaura cross-coupling reaction. 
 
These experiments showed that 7 exhibited a behavior that is dramatically different from that 
of PPh3 (8). For example, when four equivalents of 7 were applied at 1 mol% Pd loading in 
the presence of Na2CO3 in aqueous methanol solution, a quantitative yield of the reaction 
product 11 was reached within ten minutes (R1 = Me, R2 = COOMe), whereas in the case of 
PPh3 (8) the reaction took up to seven hours. The neutral ligand 6 also gave a lower rate  
(130 min) than the hexaionic species 7, but still performed better than PPh3. It has been 
suggested4,5 that the phosphine ligand 7 leads to a preferential formation of coordinatively 
unsaturated and catalytically active Pd(0) species, which may explain the observed high 
catalytic activity. The presence of six permanent cationic charges in the backbone of this 
ligand is proposed to result in a significant interligand Coulombic repulsion avoiding the 
coordination of more than one ligand to the same metal center. This reaction could also be 
performed in good yields (57-100%) with a significant scope of substrates (R1 = H, Me, vinyl, 
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Ac, OH, R2 = COOMe, vinyl, Me, OMe, NH2, NO2, CN, CF3, SMe, X = Br and Cl) using low 
catalyst and ligand loadings (0.1 / 0.4 mol%).4,5 In conclusion, the monodentate, hexacationic 
triarylphosphine ligand 7 in combination with Pd(dba)2 leads to a very efficient catalytic 
system for the Suzuki–Miyaura cross-coupling reaction that surpasses the results obtained 
with the nonionic parent compound as well as the benchmark ligand PPh3. 
 
Finally, Andrieu et al. reported the synthesis of cationic imidazolium-2-phosphines 5. These 
compounds can be described as a phosphine bearing an imidazolium substituent directly 
attached to the phosphorus atom, or a phosphenium cation stabilized by a N-heterocyclic 
carbene.6 In these compounds the lone pair on the phosphorus atom is partially back donated 
into the imidazolium fragment although it still remains available for coordination to a metal 
center. This has been demonstrated by measurement of the CO stretching frequency in the 
corresponding complexes [RhCl(CO)L2] (L = 5, (ν (CO) is 2003 cm-1 for R = Ph).6 These 
values indicate that these ligands have a behavior similar to phosphites. 
 
1.2 Phosphenium Cations 
 
Phosphenium cations have the general formula [R2P:]+ and therefore their reactivity is defined 
by a lone pair that makes them nucleophilic as well as an empty pi-orbital that introduces an 
electrophilic character. Both reactivities have been described. For example, the electrophilic 
character is observed when they react with Lewis-bases7, when they are involved in C–H bond 
insertion,8 or by their reaction with unsaturated organic molecules such as 1,3-dienes9 or 
alkynes.10 Also donative action of the phosphorus lone pair can be shown by their reactivity 
towards azides11 and from the fact that phosphenium ions exhibit rich coordination chemistry. 
 
1.2.1 Types of the phosphenium cations 
 
An obvious procedure to stabilize phosphenium cations consists in the donation of electron 
density to the empty pi-orbital at the phosphorus atom. Depending on how this donation takes 
place, phosphenium cations can be divided into three categories. In type A cations, the 
positive charge is localized exclusively on the substituents (Figure 2). The phosphorus atom is 
neutral or has even a negative pi-charge and is therefore expected to be a mainly nucleophilic 
centre. In contrast, the phosphorus atom in type B cations exhibits a positive charge and may 
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be classified as an ambiphilic center, which exhibits both electrophilic and nucleophilic (lone 
pair) character. Finally, in case C, an external ligand is used to donate electron density to the 
phosphorus atom. In this case the electrophilicity of the phosphorus atom is cancelled and its 
nucleophilic character will strongly depend on the nature of L, as will be shown later. 
 
 
Figure 2. Mesomeric structures of phosphenium cations. 
 
Typical representatives of type A cations are 2-phosphaallylic cations 12,12 type B ions are 
exemplified by aminophosphenium ions 1313 and type C cations – by the Andrieu system 5 
discussed above. 
 
1.2.1.1 Type A phosphenium cations: stabilization by formation of bis(phosphonio)-
isophosphindolides 
 
The first bis(phosphonio)isophosphindolide salt was reported by Schmidtpeter and Thiele.14 
Starting from the o-xylylenebis(phosphonium) ion 14, which is easily prepared from α,α-
dibromo-o-xylene and the corresponding phosphine (PPh2R). Subsequent cyclocondensation 
by reaction with phosphorus trichloride in the presence of triethylamine forms the 
bis(phosphonio)isophosphindole cations 15 (Scheme 2).14,15 
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RPh2P PPh2R
PCl3 (1 eq), Et3N (4 eq), DCM
- 4 [Et3NH]Cl
2 Cl
14 15: R = Ph, C2H3, Py, Me
PRPh2P PPh2R
Cl
 
Scheme 2. Synthesis of bis(phosphonio)isophosphindole cations 15. 
 
Isophosphoindole 15 can be represented by three resonance structures 15a, 15b, and 15c 
(Figure 3). Mesomer 15a presents the cation as a phosphenium ion stabilized by two 
methylenephosphorane groups, 15b as a phosphonio-substituted phosphaalkene, and 15c as a 
phospholide anion modified by two phosphonio substituents. 
 
 
Figure 3. Mesomeric structure of bis(phosphonio)isophosphindole cations 15. 
 
The known bis(phosphonio)isophosphindolide complexes with group 11 metals can be 
divided into mono- and dinuclear complexes. In mononuclear complexes, the cation binds to 
the metal via the phosphorus “lone pair” (D1 and the corresponding example 16, Figure 4), 
while in dinuclear complexes a µ2(P)-bridging coordination of the P-cation to two metals (D2 
and the corresponding example 17) takes place. In these cases the phosphorus is able to 
donate up to 4 electrons as depicted in resonance form 15c (Figure 3).16 
 
 
Figure 4. Schematic representation of bis(phosphonio)isophosphindole complexes D1 and D2 and their 
examples 16 and 17. 
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1.2.1.2 Type B phosphenium cations: stabilization by introduction in electron rich 
heterocycles 
 
P-block elements such as P, C and Si can be stabilized in low oxidation states such as +1 or 
+2 respectively if incorporated in the appropriate organic skeleton. Thus, the first isolated 
carbenes, silylenes and phosphenium cations shared the general structure F (Figure 5). 17 In 
addition, it has been demonstrated that the saturated counterparts with the general structure G 
can also be isolated despite of the lack of aromatic stabilization.18 
 
 
Figure 5. Aromatic 1,3-diazoles (F) and non-aromatic 1,3-diazolidines (G). 
 
Phosphenium cations of this type (E = P) are usually prepared from chlorophosphines 
(R2N)2P–Cl by two different methods: abstraction of the chloride with Lewis-acids such as 
GaCl319 or AlCl3 (Scheme 3, a) or trapping of the chloride anion by silver salts of weakly 
coordinating anions, especially AgPF6 and AgBF4 (Scheme 3, b).15 
 
 
Scheme 3. Formation of phosphenium cations [(R2N)2P]+. 
 
As an example, the 1,3-diazolidene derivatives 22a-c could be prepared starting from glyoxal 
18 which is converted to the corresponding diimine derivative 19 by addition of the 
corresponding amine in ethanol. Subsequent reduction of 19 with LiAlH4 gives the 
corresponding diamine derivative 20 which, in the reaction with phosphorus trichloride, is 
transformed to compound 21. The subsequent anion exchange by the addition of trimethylsilyl 
trifluoromethanesulfonate or silver tetraflouroborate gives the corresponding products 22a-c 
in moderate 43-65% yields (Scheme 4).20 
 
Subject Overview  7 
 
Scheme 4. Synthesis of NHPs derivatives 22a-c. 
 
Additionally, phosphenium cations of this class can be obtained by lithiation of bis-imine 19 
followed by reaction with perchlorosilane yielding the dichlorosilane 24 (Scheme 5). The 
exchange of phosphorus for silicon with PCl3 in refluxing benzene gives the corresponding 
chlorophosphine 25.18 Simple abstraction of Cl- from this compound affords the desired 
phosphenium cation. 
 
 
Scheme 5. Synthesis of chlorophosphine derivative 25. 
 
Interestingly, N-heterocyclic carbenes and N-heterocyclic phosphenium cations (NHPs) are 
isovalent and isostructural, but electronically inverse.21 NHPs are weak σ-donors and good pi-
acceptors due to the formal positive charge and isotropic s- (as opposed to directional sp2-) 
character of the “lone pair” orbital on phosphorus, whereas NHCs are weak pi-acceptors and 
strong σ-donors.22 Several metal complexes of NHP with late transition metals (groups 9 and 
10) have been reported. They are summarized in Figure 6. 
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Figure 6. Some reported group 9 and 10 metal–NHP complexes. 
 
The groups of Baker23 and Richeson24 have both prepared NHP-containing analogues of 
Wilkinson’s catalyst I-III, and Gudat has described a Co complex (IV).25 NHP complexes of 
the group 10 metals include the Ni complex with a zwitterionic phosphenium-containing 
ligand V reported by Niecke,26 a Ni complex VI made by Parry,27 while Baker has shown that 
[NHP]OTf reacts directly with Pt(PPh3)3 or Pd(PPh3)3 affording adducts VII.28 An  
Enders-type NHC can replace one of the PPh3 ligands in this complex to give complex VIII. 
 
1.2.1.3 Type C phosphenium cations: stabilization by formation of complexes with 
Lewis-bases 
 
The bonding interactions in coordination chemistry usually consist in a donation from an 
electron-rich ligand to an electron-deficient species such as a metal center. With this idea on 
mind, the phosphinophosphonium cation 26a can be formally represented as a coordination 
complex 26b involving donation of electron density from a chlorophosphine to a 
phosphenium cation center (Figure 7).29 
 
 
Figure 7. Representative structures of to bonding models for phosphine-stabilized phosphenium cations. 
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It has been calculated that the transfer of Cl+ moieties between the phosphorus atoms in 
compounds with general formula 26 is not kinetically favored.30 Thus, the R2ClP fragment of 
26b (R = Ph), that is not a good σ-donor, is available for ligand exchange, which allows the 
synthesis of some phosphenium cation derivatives, for example – the pentaphenylphosphino-
phosphonium salt 27 (Scheme 6). 
 
 
Scheme 6. Synthesis phosphine-stabilized phosphenium cation 27. 
 
Moreover, the Lewis-base in such donor-stabilized phosphenium complexes can be easily 
substituted by a stronger donor. This approach has been used to synthesize various donor-
phosphenium complexes (Do = DMAP, DBN, DBU, NHCs) (Scheme 7).31 
 
 
Scheme 7. Ligand exchange for the synthesis of new phosphorus–element bonds; replacement of Ph3P by a 
stronger donor (Do). 
 
Another synthetic route able to produce NHC-stabilized phosphenium cations consists in the 
reaction between 1,3-dialkylimidazolium-2-carboxylates 29 and chlorophosphines R2PCl  
(R = phenyl, iso-propyl, cyclohexyl). In that manner, adducts 30a-c were prepared after an 
anion exchange (Scheme 8).32 When the reaction was performed with PhPCl2 and  
1,3-dimethyl-imidazolium-2-carboxylate 29 in a 1:2 ratio, the phosphine 31, which contains 
two imidazolium substituents, was obtained after an anion exchange with KPF6.33 
 
 
Scheme 8. Synthesis carbene-stabilized phosphenium cations [LPR2]+ 30a-c and [L2PPh]2+ 31. 
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Imidazolium substituted phosphines have been applied as ligands. For example, reaction of 32 
with the benzonitrile complexes (PhCN)2MCl2 (M = Pd, Pt) gives the electroneutral 
complexes 33a (M = Pd) and 33b (M = Pt) in 90% and 82% yield, respectively (Scheme 9).34 
In 33, the positive charge of the phosphenium ligand is compensated by the negative charge 
of the MCl3- fragment. 
 
 
Scheme 9. Synthesis of Pd and Pt complexes 33a and 33b. 
 
In addition, these metal complexes have found applications as catalysts. Moreover, these 
types of complexes are interesting because they strongly decrease the metal leaching in 
homogeneous polyphasic catalysis, especially when an ionic liquid phase is used.35 As 
example, cations 30a and 37 were employed as ligands in the palladium-catalyzed 
Sonogashira coupling depicted in Scheme 10. 
 
 
Scheme 10. Palladium-catalyzed aryl alkynylation. 
 
Another example in which these ligands have found application is the platinum-catalyzed 
hydrogenation of halonitrobenzenes to the corresponding haloanilines,36 a process that has 
numerous applications in the manufacture of herbicides, pesticides or chemical fertilizers. The 
challenge of this transformation consists in minimization of the undesired dehalogenation of 
the substrates. Thus, complex 30a was converted to the trans-PtCl2L2 39. Using 39 as 
catalyst, m-chloronitrobenzene 38 was converted into m-chloroaniline 40 in [BMIM][BF4] at 
20 bars of hydrogen at 110 oC (Scheme 11). 
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Scheme 11. Platinum-catalyzed hydrogenation of m-chloronitrobenzene 38. 
 
1.3 Summary I 
 
Cationic ligands have recently received considerable attention because of their intrinsic 
advantages regarding catalyst recycling. In addition, cationic ligands can even increase 
reaction yields and rates.4 
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2 Carbene-Stabilized Phosphorus(III)-Centered Monocations 
 
2.1 General Introduction 
 
As already mentioned, phosphenium cations of the general formula [R2P:]+ are isolobal with 
singlet carbenes and can be stabilized by donation of electron density into their empty 
orbital.37 This goal is often reached either by embedding the phosphorous atom into a 
heterocyclic scaffold38 as in B-type structures, or by reaction with bases of different nature to 
form the corresponding Lewis-adducts C (Scheme 12).39 
 
                           
Scheme 12. Representative structures of N-heterocyclic phosphenium cations B and the conceivable resonance 
extremes of the phosphenium-base adducts C1 and C2. 
 
In both cases, the presence of an unshared pair of electrons at the phosphorous atom makes 
the use of these compounds as ligands plausible; however, their intrinsic positive charge 
renders them poor σ-donors and strong pi-acceptors.40 Specifically, in C-type adducts the 
ground-state structure is dominated by resonance extreme C2 when L is a phosphine, and 
therefore, transition-metal coordination complexes derived from these compounds are 
scarce.41 Even in the cases in which L is an N-heterocyclic carbene (NHC), the coordination 
properties of the resulting adducts are only comparable to those exhibited by the strongly  
pi-accepting phosphites.42 However, we imagined that we could generate phosphenium 
N
P
N
R
R
B
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adducts in which resonance form C1 might have a decisive contribution to the ground state by 
selecting an internal ligand L that is a stronger σ-donor and an even poorer pi-acceptor than 
NHCs. This approach should provide systems with phosphine-like coordination behavior 
while keeping a positive charge that confers them the physicochemical properties of salts. 
Phosphines containing charged functionalities have already been used in several chemical 
processes; the hydroformylation of olefins is one remarkable example.43 Note, however, that 
in such phosphines, the charged groups are invariably appended to the periphery of the 
compound and are not directly attached to the phosphorous atom as in the present case.44  
 
To put our design concept into practice, we considered 1,2-bis(diisopropylamino)-
cyclopropenyl-3-ylidene as the internal ligand that fulfils the necessary electronic 
requirements.45 Their HOMO is higher than that of NHC’s and therefore they are stronger  
σ-donors. Similarly, their LUMO has a slightly higher energetic level, making them even less 
of a pi-accetor than NHC’s (Figure 8).46 
 
 
Figure 8. Frontier orbitals of various singlet carbenes obtained at the RI-BP86/TZVP level of theory. HOMO 
(a1) energies are given in eV and LUMO refers to the lowest-energy b1 orbital. 
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2.2 Results and Discussion 
 
2.2.1 Synthesis 
 
Our starting material, the chlorocyclopropenium salt 42 was prepared from 
tetrachlorocyclopropene 41 and excess of diisopropylamine.47 Condensation of the salt 42 
with a range of secondary aromatic (R = Ph, p-(Me)C6H4, p-(OMe)C6H4, p-(F)C6H4) and 
aliphatic (R = Cy, Ad) phosphines and subsequent anion exchange gave the desired 
phosphanylidenes 43a-f as white, air-stable solids in good to excellent yields (76-96%,  
Scheme 13). 
 
 
Scheme 13. Synthesis of diisopropylaminocyclopropenylidene derivatives 43a-f. 
 
The comparison of the C–P bond lengths in the X-ray structure of 43a (Figure 9) is especially 
informative. The C1–P1 bond (1.814 Å) is only slightly shorter than the two other C–P single 
bonds (1.834 Å and 1.831 Å) connecting the phosphorous atom with the phenyl rings, but is 
significantly longer than typical C–P double bonds. For comparison, the carbon–phosphorous 
distance in an unstabilized ylide such as methylenetriphenylphosphorane (Ph3P=CH2) is 
1.662(8) Å.48 
 
 
Figure 9. Crystal structure of 43a. Hydrogen atoms, solvent molecules and the BF4 anion are omitted for clarity; 
ellipsoids are set at 50% probability.49 
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This data reveals that, in line with our expectations, back donation from the phosphorous 
atom to the cyclopropenyl ring must be marginal. 
 
2.2.2 Electronic properties 
 
Evaluation of the CO stretching frequencies in metal carbonyl complexes provides a useful 
tool to study the electronic properties of the ligands coordinated to a particular metal center. 
The increase of electron density at a metal generated by the coordination of a new ligand is 
compensated by the metallic center by increasing its back-donation to the other surrounding 
ligands. If one of those is CO, the extra back-donation into the pi*-orbital will decrease the CO 
bond order. As a consequence, the CO stretching frequency will be shifted to lower ν, thus 
providing a qualitative measure of the donor ability of the new ligand. 
 
To evaluate the donor ability of the new phosphenium adducts by analysis of the CO 
stretching frequencies, some rhodium complexes 44a-e have been prepared in very good 
yields from phosphanylidenes 43a-e (Scheme 14).  
 
 
Scheme 14. Synthesis of [RhCl(CO)L2](BF4)2 type complexes. 
 
 
Figure 10. Carbonyl stretching frequences in complexes [RhCl(CO)L2](BF4)2 
Rh
Cl
CO
L L
2
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As shown in Figure 10, ligands 43a,b,e,f have a behavior similar to typical phosphines, even 
though they are cationic species. They clearly surpass those complexes containing NHCs as 
internal ligands.50 
 
The same conclusion can be extracted from cyclic voltammetry. Rhodium complexes 45a-d 
were prepared to measure their electrochemical redox potential (Scheme 15). Table 1 shows 
the oxidation potentials from Rh(I) to Rh(II) in [RhCl(cod)L] complexes. As it can be seen, 
the oxidation potential of the complexes containing ligands 43a and 43b are nearly identical 
to those of [RhCl(cod)Ph3P] and [RhCl(cod)Cy3P] respectively. As oxidation potentials are 
directly related to the global electron density of a metal center, it can be concluded that the 
ligand 43a and 43b donate the same amount of electron density as Ph3P and Cy3P, 
respectively.51 
 
 
Scheme 15. Synthesis [RhCl(cod)L](BF4) type complexes. 
 
Table 1: Electrochemical redox potential of complexes [RhCl(cod)L](BF4) (45a-d). The values for commonly 
used phosphines are also included for comparison. 
 
[a] Calibrated versus ferrocene/ferrocenium (E1/2 = 0.46 V), Bu4NPF6 (0.1M) in CH2Cl2. 
 
2.2.3 Coordination properties 
 
Encouraged by the analysis of the electronic properties, we decided to test the potential of 
these compounds in catalysis and prepared a set of gold complexes in which salts 43a-f were 
used as ligands (Scheme 16). 
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Scheme 16. Preparation of different gold(I) complexes 46a-f and 47a,b. 
 
Compounds 46a-f were obtained as air-stable white solids in excellent yields by addition of 
[(Me2S)AuCl] to solutions of 43a-f in dichloromethane. Subsequent exchange of the chloride 
anion for the less coordinating bis(trifluoromethanesulfonyl)imidate anion was performed, 
thus allowing for a convenient way to obtain isolable yet active catalysts 47a,b without the 
necessity of using highly hygroscopic silver salts as cocatalysts.52 Moreover, crystals of 46a 
were obtained, and the structure of the complex was determined, thus confirming the expected 
connectivity (Figure 11). 
 
 
Figure 11. Crystal structure of 46a. Hydrogen atoms, solvent molecules and the BF4 anion are omitted for 
clarity; ellipsoids are set at 50% probability.49 
 
In addition, the reactions of phosphanylidene 43a (R = Ph) or 43e (R = p-(F)C6H4) with 
copper(I) chloride or allylpalladium(II) chloride dimer afforded the corresponding metal 
complexes 48a-c in excellent yields (Scheme 17). 
 
 
Scheme 17. Preparation of some metal complexes 48a-c. 
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The similar reaction between salt 43a and borane-tetrahydrofuran complex gave the 
corresponding adduct 49 in 85% yield (Scheme 18). 
 
 
Scheme 18. Preparation of borane complex 49. 
 
The stability of complex 49 is lower than that of the corresponding metal complexes 48a-d. 
This fact could be explained by the lack of back-donation from boron to phosphorus, an 
energetic contribution that may stabilize complexes 48a-d. Compound 49 slowly decomposes 
in solution, but nevertheless its characterization was possible. 
 
The rhodium(III) complex 50 could also be synthesized by refluxing a solution of salt 43a in 
ethanol with hydrated rhodium trichloride in the presence of tetraethylammonium chloride to 
obtain the desired compound in 96% yield (Scheme 19). 
 
 
Scheme 19. Preparation of rhodium(III) complex 50. 
 
Summarizing, we noted that cyclopropenylidene-stabilized phosphenium cations could be 
successfully used as ligands, producing the corresponding adducts in excellent yields. In order 
to compare the catalytic performance of the newly synthesized gold(I) compounds with 
standard gold(I) phosphine complexes, the new catalysts were tested in a range of already 
reported transformations.53 
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2.2.4 Application in catalysis 
 
2.2.4.1 [2+2] vs [2+3] Cycloaddition of ene-allenes 
 
Gold-based catalysts have appeared in the last years as one of the most powerful methods for 
the electrophilic activation of alkynes toward a variety of nucleophiles under homogeneous 
conditions. These reactions go through three main stages: (1) activation of the alkyne by 
coordination of the gold atom, (2) nucleophilic attack and (3) proto-deauration. Therefore, the 
nature of the ancillary ligand has a tremendous influence on the reaction course and product. 
The gold(I)-catalyzed [2+2]-cycloaddition of ene-allenes first reported by Toste et al.54 is an 
interesting transformation and was chosen to evaluate the behavior of our catalysts. The 
synthesis of the suitable substrate 55 was realized from commercially available starting 
materials as depicted in Scheme 20. 
 
 
Scheme 20. Synthesis of ene-allene 55. 
 
After deprotonation of dimethyl malonate 51 with sodium hydride and reaction with cinnamyl 
bromide 52 in dry THF, the corresponding monoalkylated product 53 was obtained in 75% 
yield.54 The mesylate 54 was obtained in a three-step synthesis starting from the reaction of  
2-methylbut-3-yne-2-ol 56 with 3,4-dihydropyran in presence of pyridinium  
p-toluenesulfonate.55 To this end, the THP-protected compound 57 was obtained in 92% 
yield. Reaction of 57 with n-butyllithium and subsequent addition of paraformaldehyde 
afforded 58 in 89% yield.56 Treatment of 58 with lithium aluminium hydride gave the desired 
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allenol 59 in 67% yield,57 which was later converted into the corresponding mesylate 54 by 
reaction with methanesulfonyl chloride in the presence of triethylamine and catalytic amount 
of 4-dimethyl-aminopyridine (DMAP).58 Deprotonation of cinnamyl malonate 53 with 
sodium hydride and addition of freshly prepared mesylate 54 in the presence of sodium iodide 
afforded the desired ene-allene 55 in 84% yield.54 
 
Scheme 21 shows the proposed mechanism governing the cycloisomerization of 55. Once 
gold coordinates to the substrate, the primarily formed intermediate 60 may evolve following 
two different reaction pathways.59 
 
 
Scheme 21. Control over the cycloaddition of ene-allene 55 by adjusting the pi-acceptor properties of the ligand 
L bound to Au+. 
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Gold(I) catalysts bearing electron rich ligands may stabilize better an adjacent cation, 
therefore, they favor the formal [3+2] cycloaddition pathway via intermediate 63. Conversely, 
electron deficient ligands coordinated to the gold center should promote more effieciently the 
[2+2] cycloaddition pathway to produce intermediate 61, in which a carbenium cation is not 
directly bounded to gold. This route ultimately delivers the known alkylidenecyclobutane 62. 
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Scheme 22. Gold(I)-catalyzed cycloisomerization of ene-allene 55. 
 
Table 2 summarizes the behavior of our catalysts in comparison with Ph3PAuCl and 
(PhO)3PAuCl. 
 
Table 2: Cycloisomerization of ene-allene 55 catalyzed by different gold complexes. 
 
Reaction conditions: 5 mol% of the corresponding gold complex and 5 mol% of appropriate silver salt AgX  
(X = SbF6 or BF4) 
 
The ligand of catalyst 46a behaves as a good pi-acceptor ligand as it gave the [2+2] adduct 62 
as the major product. Introduction of a fluoro-substituent into the aromatic rings of the ligand 
in catalyst 46d did not show any significant influence on the reaction course, as the yields and 
regioisomer ratios were comparable. To put these results into perspective, two control 
experiments with Ph3PAuCl (66) and (PhO)3PAuCl (67) were performed. While 66 delivered 
the mixture of all possible products 62 and 65a,b under the chosen conditions, the 
triphenylphosphite gold(I) complex 67 produced 62 as the only regioisomer due to the 
excellent pi-accepting properties of the ligand. Thus, it can be concluded that our catalyst 
perfectly compares with phosphite-based catalysts. 
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2.2.4.2 [2+4] vs [3+4] Cycloaddition of allene-dienes 
 
As a second model reaction, the cycloisomerization of allene diene 68 was chosen to 
generalize our previous conclusions (Scheme 23). This transformation is also known to be 
dependent on the global electron density at the gold atom, thus providing an additional 
measure for the donor properties of our ligands, based on reactivity parameters.60  
 
 
Scheme 23. Effect of the ligands with different pi-acceptor properties on the gold-catalyzed cyclization of allene-
diene 68. 
 
When pi-acceptor ligands L are used, the carbocationic nature of intermediate 69 is enhanced, 
thus promoting ring contraction by a 1,2-alkyl shift. In contrast, strongly σ-donating ligands at 
the gold center increase the carbene character of 69, thus favoring the 1,2-hydride shift. 
 
The synthesis of allene-diene 68 began with the reaction between dimethyl malonate 51 and 
(E)-5-bromopenta-1,3-diene 72 to give the corresponding monoalkylated dimethyl malonate 
derivative 73 (Scheme 24). The necessary bromide 72 was prepared by the reduction of the 
(E)-1,4-pentadienoic acid 74 using lithium aluminium hydride61 and subsequent reaction of 
the formed alcohol 75 with phosphorus tribromide.62 Further reaction between mesylate 54 
and the dimethyl malonate derivative 73 in the presence of sodium hydride and sodium iodide 
gave the desired allene-diene 68 in 75% yield. 
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Scheme 24. Synthesis of allene-diene 68. 
 
Table 3: Cyclization of ene-allene 68 catalyzed by different gold complexes. 
 
Reaction conditions: 2 mol% of [LAuNTf2] (entries 1-3) or 2 mol% of [LAuCl] and 2 mol% of AgBF4  
(entries 4–6) stirring at room temperature in DCM solution. 
 
The published results concerning this transformation show that complexes of classical 
phosphines such as 77 and 66 give a mixture of products, with 70 predominating.60 The 
phosphite-based catalyst 67 is, as expected, even more selective for the formation of this 
product. In contrast, the very electron rich carbene-based catalyst 76 promotes the selective 
formation of the [3+4] cycloaddion product 71. 
 
In our case, using catalysts 47a and 47b, we obtained again intermediate results, between 
phosphines and phosphites. Interestingly, alkyl groups in 47b increase the electron richness at 
the gold atom giving result similar to phosphines, whereas the phenyl groups in 47a favor the 
back-donation from gold, producing reactivity similar to the one observed in phosphites. 
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2.2.4.3 Other catalytic application examples 
 
In order to validate the applicability of our ligands, two other gold(I)-catalyzed reactions were 
tried. The first one was the cycloisomerization of the ortho-alkynylated phenyl-1H-pyrrole 
derivatives (Scheme 25).63 Addition of an electrophilic metal salt or metal complex to a 
phenylpyrrole which contains an alkyne unit at one of its ortho-positions should result in an 
equilibrium between the substrate 7664 and the intermediate 77. If the latter is trapped by the 
adjacent aromatic ring, a C–C-bond formation with concomitant release of the catalyst will 
result. This reaction offers a flexible entry into pyrrolo[1,2-a]quinolines 78. 
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Scheme 25. Mechanistic studies on the cycloisomerization of ortho-alkynylated phenylpyrrole 76 catalyzed by 
transition metal complexes. 
 
4-Methylpyrrolo[1,2-a]quinoline 78 was obtained exclusively in excellent yields of 98% and 
97% employing only 2 mol% of gold(I) catalyst 47a or 47b respectively (Scheme 26). 
 
 
Scheme 26. Cycloisomerization of ortho-alkynylated phenylpyrrole 76 catalyzed by gold(I) complexes 47a,b. 
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Next, the unprecedented reaction of alcohol 80 in the presence of 46a was studied  
(Scheme 27).65 
 
 
Scheme 27. Transformation of alcohol 80 catalyzed by gold(I) complex 46a. 
 
Two regioisomeric tetrahydroindeno[2,1-b]pyranes 81 and 82 were obtained in 9% and 79% 
yield respectively. Subsequently, it was found that compound 81 isomerizes in the presence of 
catalyst to 82. The mechanism proposed for this conversion includes initial coordination of 
the gold catalyst to the hydroxyl group (83) followed by an elimination that affords 
carbocation 84 that is stabilized by the conjugation with the aromatic systems (Scheme 28). 
This carbocation 84 undergoes a Nazarov-type cyclization followed by proton elimination to 
form product 81. 
 
 
Scheme 28. Proposed mechanism of the formation of tetrahydroindeno[2,1-b]pyranes 81 and 82. 
 
The mechanism of the double bond isomerization in compound 81 forming compound 82 in 
the presence of gold(I) catalyst has not been studied. We can assume that the isomerization 
could take place through coordination of the catalyst to the double bond of 81 (Scheme 29) 
that results in the formation of the carbocation 86. Protodemetalation from resonance form 
86b produces the final regioisomer 82 and regenerates the gold catalyst. 
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Scheme 29. Feasible mechanism of the compound 81 double bond isomerization forming compound 82. 
 
The introduction of an extra substituent at the double bond of the pyran ring should lead to the 
formation of only one reaction product because the isomerization described is no longer 
possible. In order to prove this hypothesis, we introduced methyl and phenyl substituents in 
that position. 
 
The corresponding methyl substituted dihydropyran 90a was prepared from δ-valerolactone 
87 (Scheme 30). Alkylation with methyl iodide in the presence of LDA and HMPA in THF 
solution gave the α-methylated derivative 88 in 81%.66 Next, reduction with DIBAL in 
dichloromethane solution gave the corresponding alcohol 8966 in excellent yield, which, after 
dehydratation in the presence of phosphorous pentoxide, gave the expected product 90a in 
moderate 52% yield.67  
 
 
Scheme 30. Synthesis fo 5-methyl-3,4-dihydro-2H-pyran 90a. 
 
The phenyl substituted dihydropyran 90b was prepared in a different way (Sheme 31) starting 
by the alkylation of phenylacetic acid 91 with bromochloropropane 92. After the cyclization 
of 93 in the presence of DBU,68 reduction with DIBAL and dehydration afforded the 
corresponding product 90b in 72% yield. 
 
 
Scheme 31. Synthesis of 5-phenyl-3,4-dihydro-2H-pyran 90b. 
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The deprotonation of dihydropyrans 90a,b with t-BuLi and addition of benzophenone gave 
the desired substrates 96a and 96b in low but reproducible yields (26% and 24% respectively, 
Scheme 32). 
 
 
Scheme 32. Synthesis of alcohols 96a,b. 
 
When substrate 96a was treated with catalyst 47a,b, only product 97 was obtained  
(Scheme 33). Its structure was confirmed by X-ray (Figure 12).  
 
 
Scheme 33. Transformation of alcohol 96a catalyzed by gold(I) complex 47a,b. 
 
Figure 12. Crystal structure of 97. Thermal ellipsoids at 50% probability; hydrogen atoms and solvent molecules 
have been omitted for clarity. 
 
Surprisingly, when alcohol 96b, which contained a phenyl substituent, was submitted to the 
same reaction conditions, a mixture of two regioisomeric products 98 and 99 in 1:2 ratio was 
observed in 82% overall yield (Scheme 34). 
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Scheme 34. Transformation of alcohol 96b catalyzed by gold(I) complex 46a. 
 
The formation of the two compounds could be explained by the mechanism proposed in 
Scheme 35. After abstraction of the OH- moiety by the gold catalyst, the attack of the 
generated carbocation 100 to the extra phenyl ring takes place via intermediate 102 forming 
the compound 99 after the release of a proton. The cyclization, which occurs through the 
earlier described mechanism (page 26, Scheme 28) via intermediate 101, leads to the 
formation of compound 98. 
 
 
Scheme 35. Proposed mechanism of the formation of tetrahydroindeno[2,1-b]pyranes 98 and 99. 
 
2.2.5. Gold recycling 
 
Once it has been proved that complexes 47a,b are good catalysts for gold promoted 
transformations, we decided to make use of the extra positive charge that our ligands bear. 
Thus, the cycloisomerization of 10369 to 104 (Scheme 36) was chosen as a model reaction due 
to the high solubility of 104 in apolar solvents such as diethyl ether. In contrast, 47a,b are 
practically insoluble in this solvent due to the fact that they are salts. Therefore, after full 
conversion, the DCM used as solvent was removed in vacuo, and diethyl ether was added. 
The catalyst precipitated and could be separated from the product by simple filtration and 
reused for the next cycle (Figure 13). 
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Scheme 36. Cycloisomerization of enyne 103 catalyzed by gold(I) complexes 47a,b. 
 
 
Figure 13. Schematic representation of the recycling process of gold catalyst 47a. 
 
As shown in Figure 13, the test reaction could be performed up to four times with consistently 
excellent yields (runs 1–3 yield of isolated product, runs 4, 5 yield determined by gas 
chromatography). 
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2.3 Summary II 
 
In conclusion, the synthesis of cyclopropenylidene-stabilized phosphenium adducts has been 
achieved and their coordination behavior studied. In contrast to other phosphenium-carbene 
adducts, these compounds exhibit electronic properties that can be ranked in between classical 
triaryl and trialkyl phosphines and phosphites, even though they carry a global positive 
charge. Moreover, gold complexes containing these ligands have been synthesized and their 
practical utility in catalysis was demonstrated in several mechanistically different 
transformations. Finally, taking advantage of the saline nature of our ligands, the recycling 
possibilities of the catalysts derived thereof were also explored. 
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3 Carbene-Stabilized Phosphorus(III)-Centered Dications 
 
3.1  General Introduction 
 
Highly charged cations centered at main group elements are promising reagents for the 
activation of small molecules.70 Moreover, their geometries and unusual electronic 
environments make them interesting targets for theoretical studies as they often have intricate 
bonding situations not always free of controversy.71 Therefore, the next challenge of our 
research after the preparation of monocationic phosphorus(III)-centered compounds was the 
desing of their dicationic analogues. 
 
The synthesis of few NHC-stabilized dicationic phosphorus(III) species has been achieved by 
Andrieu.72 Thus, compound 106 could be obtained from the reaction between imidazolium-2-
carboxylate 105 and dichlorophenylphosphine (Scheme 37). 
 
 
Scheme 37. Preparation of dicationic P(III) species 106. 
 
It was also found that dicationic adducts of type 112 were not formed in the reaction of free 
N-heterocyclic carbenes 108 (R = Mes, iPr, Et, dipp) with electrophilic phosphorus sources 
such as PCl3. Instead, bulky carbenes afford hypervalent (NHC→PCl3) complexes 107 that do 
not react further,73 while less sterically demanding NHCs promote a reductive process which 
is probably initiated by preferential nucleophilic attack of the carbene at the highly activated 
Cl-atom, instead of the central P-atom, in intermediates of the general formula [(NHC)2PCl]2+ 
112.74 Thus, [(NHC)2P]+ derivatives 109 and 110 are the ultimate result of this transformation 
(Scheme 38a). 
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Scheme 38. (a) Reaction of PCl3 with free carbenes; (b) preparation of dicationic P(III) species via “onio-
substituent transfer” methodology. 
 
Compound 112 has been synthesized by Weigand employing masked carbene 111.75 This 
strategy avoids the undesired reductive pathway (Scheme 38b). 
 
3.2 Results and Discussion 
 
3.2.1 Synthesis  
 
With this idea in mind, we envisaged that the mono-alkyl or aryl substituted 
phosphanylidenes 113a,b, prepared by the reaction between chlorocyclopropenium salt 42 
and the corresponding monoalkyl- or monoarylphosphine, could serve as convenient starting 
materials for the preparation of the [L2P]2+ type cations (Scheme 39). 
 
 
Scheme 39. Synthesis of diisopropylaminocyclopropenylylidene derivatives 113a,b. 
 
Deprotonation of 113a and 113b with KHMDS afforded the very electron rich 
phosphaalkenes 114a and 114b, that were only stable at low temperature (Scheme 40). The 
most significant changes after this deprotonation were observed in the 31P NMR. While the 
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resonances of the starting materials 113a or 113b appear at -44.8 and -70.9 ppm respectively, 
they were shifted in the case of 114a and 114b to +5.3 and -36.9 ppm respectively. 
 
 
Scheme 40. Deprotonation of 113a,b with KHMDS. 
 
Further treatment of 114b with chlorocyclopropenium salt 42 afforded the desired dicationic 
compound 115 in 69% yield (Scheme 41).  
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Scheme 41. Synthesis of [L2PPh]2+ type compound 115. 
 
The same compound 115 could be obtained by the reaction of bis(trimethylsilyl)-
phenylphosphine 116 and chlorocyclopropenium salt 42 although in only 52 % yield.76 
 
3.2.2 Electronic properties 
 
The formation of dicationic species 115 was indicated by the 31P NMR resonance  
(δ = -47.9 ppm). This value is comparable to the reported data for imidazolylylidene 
substituted sister compounds 106 (δ = −50.8 ppm).77 Moreover, the proposed structure, 
[L2PPh]2+, has also been confirmed by single X-ray diffraction analysis of 115 (Figure 14). 
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Figure 14. Molecular structure of compound 115 in the solid state. Thermal ellipsoids at 50% probability; 
tetrafluoroborate counter anions, solvent molecules, and hydrogen atoms have been omitted for clarity. 
 
Two structural parameters are crucial for understanding the electron environment around the 
phosphorus atom in 115. The P−C(carbene) bond lengths (both 1.805 Å) are only slightly 
shorter than those observed in neutral aromatic phosphines but significantly longer than 
typical P−C double bonds.78 In addition, the degree of pyramidalization at phosphorus 
(67.5%) is even higher than that observed for neutral aromatic phosphines (56.7% for PPh3).79 
Both parameters reveal that back-donation from the phosphorus to the cyclopropenyl rings 
must be marginal, if any, and suggest retention of a nonbonding electron pair on this atom. 
 
In an attempt to gain insight into the electronic structure of these compounds, density 
functional calculations at the B3LYP/6-31G* level were performed in cooperation with the 
theoretical department of the Max Planck Institute for Coal Research under the leadership of 
Prof. Thiel. The optimized structures closely match the experimental crystallographic data 
(Table 4). In addition, the comparison with classical pi-acceptor ligand such as P(OMe)3 and 
P(C6F5)3 is shown. 
 
Table 4: B3LYP/6-31G* results for representative bond lengths (Å) and natural bond orders. 
 
aP–O(OMe) distance and bond order. 
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According to natural population analysis, the phosphorus atom in 115 bears a positive charge 
of +0.88e. This indicates that the real nature of 115 is intermediate between Lewis-structures I 
and II, (page 35, Scheme 40).  
 
Table 5: Natural population analysis (B3LYP/6-311+G**//6-31G*). 
 
aSum of natural charges of –OMe group; bSum of natural charges of –C6F5 group. 
 
Moreover, in line with our analysis of the crystal structure, the Wiberg bond index values 
(0.909 for each C−P bond) support the absence of back-donation from phosphorus to the 
carbene moieties.  
 
Analysis of the frontier orbitals shows that the HOMO has considerable electron density on 
the phosphorus and an orbital occupancy of 1.87e (Figure 15). This should provide some 
Lewis-base reactivity to this cation despite the global +2 positive charge that it bears. 
 
(a) (b)
 
Figure 15. Representation of the calculated HOMO (left) and LUMO (right) for 115. 
 
In addition, very strong pi-acceptor properties must be conferred by the low-lying LUMO if 
we compare with P(OMe)3 and P(C6F5)3 (Table 6). 
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Table 6: Molecular orbital energies (B3LYP/6-311+G**//6-31G*). 
 
 
3.2.3 Coordination properties 
 
Based on the conclusions from the theoretical analysis of 115 we were expecting that the 
dication could successfully serve as a strong pi-acceptor ligand. Thus, 115 was submitted to 
reaction with chloro(dimethylsulfide)gold(I), potassium tetrachloroplatinate(II) or 
tetrachloropalladate(II) (Scheme 42). 
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Scheme 42. Synthesis of gold, platinum and palladium complexes 117-119. 
 
Compound 115 reacted with all three metallic salts affording complexes 117, 118 and 119 as 
white or slightly orange solids in excellent yield (98%) in each case. Importantly, the 
coordination of phosphorus to the platinum centre in complex 118 was confirmed by a new 
resonance in the 31P NMR (δ = -21.2 ppm, 1JP-Pt = 1994.8 Hz) and ultimately by X-ray 
diffraction (Figure 16). 
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Figure 16. Molecular structure of compound 118 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, tetrafluoroborate counter anion and solvent molecules have been omitted for clarity. 
 
In order to generate the required vacant coordination site on Au for the application of complex 
117 in catalysis, it is necessary the abstraction the chloride and replacement by a non-
coordinating anion. The use of the bis(trifluoromethanesulfonyl)imidate moiety has been 
suggested as a convenient way to get active and at the same time stable catalysts. 
 
 
Scheme 43. Synthesis of the compex 120. 
 
Making the same manipulation with 117, the corresponding complex 120 was obtained in 
90% yield (Scheme 43). Unfortunately, the stability of the 120 was low and it underwent slow 
decomposition in DCM solution at room temperature. 
 
Despite the reactivity of 115 towards gold, platinum and palladium, the rhodium complexes 
(using [Rh(cod)Cl]2 and [Rh(CO)2Cl]2) were never obtained. This created some difficulties in 
the evaluation of the donor ability of [L2PPh]2+ type ligands by measuring IR-stretching 
frequencies of the carbonyl group. However, a qualitative idea of their donor properties can 
be obtained by screening reactions that dramatically depend on the ligand electronic 
properties. 
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3.2.4 Application in catalysis 
 
3.2.4.1 [2+4] vs [3+4] Cycloaddition of allene-dienes 
 
The gold(I)-catalyzed cyclization of allene-diene 68 discussed in the second chapter (see  
page 23 and Scheme 44) was used again as a practical tool to estimate the donor ability of 
115, because the evolution of intermediate 69 depends on the global electron density at the 
gold atom. 
 
 
Scheme 44. Effect of the ligands with different pi acceptor properties on the gold-catalyzed cyclization of allene-
diene 68. 
 
The cyclization of 68 catalyzed by 2 mol% of catalyst 117 and 2 mol% of AgBF4 gave a 
mixture of 70 and 71 in 86% overall yield with a 70:71 ratio of 97:3 (determined by  
1H NMR). This result confirms our predictions about the strong pi-acceptor behavior of this 
ligand. By comparison, the 70:71 ratio in the case of phosphites (L = (PhO)3P, see page 24) 
was also 97:3. Moreover, this reaction is a successful example for the catalytic application of 
the double charged compounds as ligands. The stronger pi-acidity of [L2PPh]2+ compared to 
[LPR2]+ is now clear and might allow to find new specific applications for this ligand in 
catalysis.53 
 
3.2.4.2 Cycloisomerization of 1,6-enynes 
 
Enynes are the most-widely studied substrate class in the field of Au- and Pt-catalyzed 
cycloisomerization. Especially in the cycloisomerization of 1,6-enynes platinum catalysts 
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have been successfully employed. The mechanistic considerations of the possible pathways of 
that transformation are shown in Scheme 45.80 Specifically, when arylated enynes (R = Ph) 
are used as substrates, the cycloizomerization leads to the formation of cyclobutenes because 
of the extra stabilization of carbocation B due to the aromatic group. Interestingly, this 
reaction allows the formation of highly strained cyclobutene derivatives in a single operation 
that are difficult to prepare otherwise. Conversely, in the case of non-substituted alkynes, 
evolution through intermediate A predominates and the formation of 1,3-diene products is 
observed. 
 
 
Scheme 45. Mechanistic considerations of the platinum-catalyzed cycloisomerization of 1,6-enynes. 
 
It is known that this and many other Pt(II)-catalyzed reactions are accelerated in presence of 
CO.81 Thus, enhancing Lewis-acidity of the platinum catalyst by coordination of pi-acceptor 
ligands provides a good strategy to facilitate this reaction. Therefore, this transformation 
seems appropriate to test our pi-acceptor [L2PPh]2+ ligand. 
 
  
Scheme 46. Platinum-catalyzed cycloisomerization of enyne 121. 
 
The necessary substrate 121 was prepared by palladium-catalyzed Sonogashira coupling from 
the enyne 10382 and iodobenzene in presence of PdCl2(Ph3P)2, CuI and Et3N in 70% yield 
(Scheme 47).81 
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Scheme 47. Sonogashira reaction of enyne 103. 
 
As depicted in Scheme 46 we have pursued this cycloisomerization reaction using 10 mol% 
of PtCl2 and 10 mol% of ligand 115 in DCE at 80 oC. Although this reaction was described in 
toluene, we have replaced toluene by dichloroethane in order to improve the solubility of our 
cationic ligands while still being able to heat to the same temperature. Under the indicated 
conditions, we obtained complete conversion after 3 hours and an excellent isolated yield of 
95%. 
 
The conversion of 121 in 122 was screened by GC-MS, and the results are summarized in 
Figure 17. In the absence of any ligand a slow reaction was observed that did not reach full 
conversion even after 24 h. The use of the carbon monoxide (1 atm), clearly improved the 
reaction rate. The same behavior was observed for Ph3P and (C6F5)3P. Triphenylphosphite, 
another typical pi-acceptor ligand, performed even better reaching a conversion of 97% after  
6 h. Interestingly, our cationic ligands 43a and 115 showed excellent behavior due to their  
pi-acceptor properties, giving 88% and 95% yield, respectively, in only 3 hours (Figure 17). 
 
 
Figure 17. Comparison of [LPPh2]+ and [L2PPh]2+ type ligands properties with a commonly used classical 
ligands. 
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Under the previously described conditions, the related substrate 12383 containing a 
cyclohexenyl instead of the cycloheptenyl of 121, also showed good reactivity, affording 124 
in excellent yield (Scheme 48). 
 
EtOOC COOEt
Ph
Ph
H
H
H
COOEt
EtOOC
DCE, 80 oC
PtCl2 / Ligand 115
(10 mol% / 10 mol%)
123 124: 94%
 
Scheme 48. Platinum-catalyzed cycloisomerization of enyne 123. 
 
3.3 Trapping Intermediate 114a 
 
During the synthesis of compound 115, the formation of phosphaalkenes 114a and 114b was 
proposed. Unfortunately, we were not able to isolate them; therefore we tried to trap them by 
reaction with different electrophiles. The presence of two non-shared electron pairs on the 
phosphorus atom of 114 can be postulated and therefore it might react with up to two Lewis-
acids. To check this hypothesis, adamantyl phosphanylidene 113a was deprotonated with 
potassium hexamethyldisilazane and treated with two equivalents of chloro(dimethylsulfide)-
gold(I) or borane-tetrahydrofuran complex. Thus, we were able to obtain the corresponding 
adducts 125 and 126 in 99% and 39% yields respectively (Scheme 49). These results support 
our assumption about the existence of two lone electron pairs on phosphorus. 
 
 
Scheme 49. Synthesis of gold and boron adducts 125 and 126. 
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Additionally, the structure of the compound 126 was confirmed by X-ray diffraction analysis 
(see page 189, Appendix 7.2.16). 
 
3.4 Summary III 
 
In summary, an efficient synthesis of the carbene stabilized [L2PPh]2+ cations has been 
introduced by the deprotonation of monophenyl-substituted phosphanylidene 113b and further 
reaction with the corresponding chlorocyclopropenium salt 42. Despite the presence of two 
positive charges, the coordination ability of 115 to gold, platinum and palladium has been 
demonstrated. In these complexes [L2PPh]2+ ligands showed strong pi-acceptor character that 
we used in Pt(II) and Au(I)-catalyzed reactions, improving the already reported catalytic 
systems in terms of reactivity. 
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4 Carbene-Stabilized Phosphorus(III)-Centered Trications 
 
4.1 General Introduction 
 
The synthesis of carbene-stabilized phosphorus(III)-centered trications was defined as our 
next task. As previously discussed, many compounds based on p-block elements can promote 
transformations that traditionally were reserved to transition metals (see page 33). In addition, 
their sometimes unusual electronic properties and geometry make them interesting targets for 
investigation. Herein we present our results associated with the synthesis and applications of 
[L3P]3+ trications. 
 
There are only three reported examples of [L3P]3+ trications stabilized by N-based ligands. For 
example, 4-dimethyl-aminopyridine is able to form the tris-pyridino-substituted 
phosphorus(III) compounds of type 129 containing three positive charges.84 Scheme 50 
resumes it synthesis and the quinuclidine analogue.85 
 
 
Scheme 50. Synthesis of N-based [L3P]3+ cations 129a,b. 
 
Attempts to carry out the same reaction with a stronger neutral base such as 1,5-diaza-
bicyclo[4.3.0]non-5-ene (DBN) 130 surprisingly led to a complicated mixture.86 In order to 
overcome this problem, compound 130 was converted into the cationic silyl protected salt 131 
by treatment with trimethylsilyl triflate (Scheme 51). It was proposed that the intrinsic 
reactivity of trimethylsilyl groups towards halogens should improve the reaction rate and 
purity of the products. This methodology to obtain highly charged base-stabilized cations has 
been named the “onio-substituent transfer” reaction. Thus, trionio-substituted phosphine 132 
was obtained in 40 % yield by treating PCl3 with three equivalents of the silyl derivative 131. 
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Scheme 51. Synthesis of N-based [L3P]3+ cation 132. 
 
It is worth noting that, up to now, no solid-state structural analysis of such a species has been 
reported. Their connectivities were thus determined only on the basis of spectroscopic and 
chemical data. In addition, all obtained compounds were stabilized by N-based ligands. 
 
The outstanding donor properties exhibited by N-heterocyclic carbenes (NHCs) have rendered 
them privileged ligands for the stabilization of metal complexes and highly electrophilic 
species.87 The synthesis of mono- and dicationic P(III) species has been accomplished already 
using these ligands. However, in the case of P3+ centers no success has been achieved.  
 
It is our objective in this section to find a synthesis for these elusive [L3P]3+ type cations. Our 
strategy consists in the use of an alternative synthetic approach, based on the use of an 
unprecedented “reverse electron demand” onio-substituent transfer strategy where an 
umpolung of reagents has been achieved by introduction of trimethylsilyl groups as 
substituents on the phosphorus atom and a chloride as the substituent on the carbene 
precursor. 
 
4.2 Results and Discussion 
 
4.2.1 Synthesis 
 
To put this concept into practice, 1-chlorocyclopropenium cations were deliberately chosen as 
carbene precursors instead of the more common chloroimidazolium salts due to the 
simultaneous convergence of three beneficial factors: (a) an enhanced tendency to undergo 
nucleophilic attack at the chlorinated carbon;88 (b) the smaller steric demand derived from a 
carbene embedded in a three membered ring that facilitates the coordination of several of 
these ligands to the same central atom,89 and (c) the stronger σ-donor and weaker pi-acceptor 
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properties of cyclopropenylidenes as compared with NHCs. Note that the net donation from 
the carbene ligand must compensate for the continuous increase of formal positive charge on 
the phosphorus atom in order to allow the consecutive nucleophilic substitution process to 
take place.90 
 
Thus, by gentle heating of a mixture of the 1-chloro-2,3-bis(diisopropylamino)cyclo-
propenium salt 42 or 133 with P(SiMe3)3 in THF, the desired P(III)-centered trications 134a 
and 134b were isolated for the first time as white solids in moderate yields (Scheme 52).91 
 
 
Scheme 52. Synthesis of [L3P]+3 сations 134a,b. 
 
Surprisingly, the use of “umpoled” reaction partners, the corresponding TMS-substituted 
compound 13692 and PCl3, gave no reaction under the same conditions (Scheme 53). 
 
 
Scheme 53. Synthesis of [L3P]+3 сation 134b. 
 
An alternative method to synthesize [L3P]3+ type compounds was also attempted. After Li/Cl 
exchange with BuLi in 133, the lithiated species was reacted with phosphorus trichloride to 
afford the corresponding compound 134b (Scheme 54).93 This strategy allowed us to increase 
the yield of this reaction from 32% to 45%. 
 
 
Scheme 54. Alternative synthesis of the compound 134b. 
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One explanation for the low yields in the preparation of [L3P]3+ type cations could be steric 
hindrance. Therefore, the reduction of steric demand of the carbenes moieties was carried out 
by exchanging the iso-propyl groups for methyl groups on the nitrogen atoms. Thus, the 
chlorocyclopropenium cation 140 was prepared following reported procedures (Scheme 55).94 
 
 
Scheme 55. Synthesis of the chlorocyclopropenium salt 140. 
 
Reaction of this salt with tris(trimethylsilyl)phosphine afforded the desired product 141 in 
68% yield. This improved yield confirms our hypothesis about the influence of the steric 
factors on this reaction (Scheme 56). 
 
 
Scheme 56. Synthesis of the compound 141. 
 
The tricationic character of 134a, 134b and 141 was suggested by the increased shielding of 
the P center (31P NMR resonances at δ = −76.5, −76.4, and −93.5 ppm, respectively) when 
compared with the data reported for dicationic bis-imidazolylidene substituted sister 
compounds 106 (δ = −50.8 ppm).95 Subsequently, single crystal X-ray diffraction analysis 
unambiguously confirmed the proposed connectivity for the cationic part of 134a (Figure 18). 
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Figure 18. Molecular structure of compound 134a in the solid state. Thermal ellipsoids at 50% probability; 
tetrafluoroborate counterions, solvent molecules, and hydrogen atoms have been omitted for clarity. 
 
As in the case of [L2PPh]2+ 115, the P−C(carbene) bond distances in 134a are only slightly 
shorter (1.787, 1.790 and 1.796 Å) than those observed in neutral aromatic phosphines but 
significantly longer than typical P−C double bonds.78 The pyramidalization degree at 
phosphorus (55.4%) is perfectly comparable to those observed for neutral aromatic 
phosphines (56.7% for PPh3).79 
 
Some interesting conclusions could also be made by exploring the NMR spectra of 115 and 
134a. In the 1H NMR spectrum of 115 the methyl groups signals appear as four doublets 
(1.21, 1.25, 1.38 and 1.44 ppm, J = 6.9 Hz for each case, 4 × 12H), indicating their 
nonequivalence (Figure 19). In the 13C NMR spectrum we observed six signals corresponding 
to the methyl groups (21.2, 21.5, 21.5, 21.6, 21.6 and 21.7 ppm) (Figure 20).  
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Figure 19. 1H NMR of 115 in CD2Cl2. 
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Figure 20. 13C NMR of 115 in CD2Cl2. 
 
However, in the 1H NMR spectrum of 134a (Figure 21) the methyl groups signals appear only 
as two doublets (1.40 and 1.46 ppm, J = 6.9 Hz in both cases, 2 × 36H). The total number of 
methyl group signals was also reduced by half in the 13C NMR spectrum (21.4, 21.9 and  
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22.0 ppm, Figure 22). An increase of the number of nonequivalent methyl groups in 115 may 
be indicative of a higher phosphorus inversion barrier than in the triple charged salt 134a. 
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Figure 21. 1H NMR of 134a in CD2Cl2. 
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Figure 22: 13C NMR of 134a in CD2Cl2. 
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4.2.2 Electronic properties 
 
The calculated bond order between phosphorus and carbon in these structures is 0.919. 
According to natural population analysis, the phosphorus atom in 134a bears a positive charge 
of (+0.88e). The optimized DTF structures closely match the experimental ones: the 
calculated bond length between phosphorus atom and carbon atom of cyclopropenyl moiety in 
the compound 134a (1.82 Å) are in agreement with the results obtained from X-ray diffraction 
analysis (1.787, 1.7901 and 1.7964 Å for each C-P bond respectively). 
 
 
Figure 23. Representation of the calculated HOMO (left) and LUMO (right) for 134a. 
 
Inspection of the frontier orbitals shows that the HOMO has substantial lone pair character at 
phosphorus, with a natural orbital occupancy of 1.84e (Figure 23). This might provide some 
Lewis-base reactivity to this cation in spite of the global +3 charge that it formally bears. 
More importantly, the very low-lying LUMO is expected to confer remarkably strong  
pi-acceptor properties (Figure 24). 
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Figure 24. Molecular orbital energies (B3LYP/6-311+G**//6-31G*). 
 
4.2.3 Coordination properties 
 
Encouraged by the distinctive electronic properties, electron-rich metal-containing moieties 
able to engage in gentle back-donation were chosen in an attempt to ascertain whether these 
trications could actually be employed as ligands. Thus, when 141 was reacted with K2PdCl4 
and K2PtCl4 in acetonitrile, complexes 142 and 143 were efficiently obtained in 92% and 87% 
yields respectively (Scheme 57). The triple charged compound 134a reacted neither with the 
Pd nor Pt metallic sources. This lack of reactivity might be attributable to steric factors, 
because the smaller compound 141, also with three positive charges, reacted efficiently under 
the same conditions. 
 
 
Scheme 57. Formation of Pd and Pt complexes 142 and 143. 
 
The coordination of phosphorus to Pd and Pt in 142 and 143 was primarily suggested by the 
appearance of new resonances in the 31P NMR spectra (δ = −46.1 and −62.4 ppm, 
respectively). Especially informative are the satellite signals in 143 (1JP−Pt= 2033 Hz) that are 
indicative of Pt−P bond formation. Ultimately, the structure of 143 was confirmed by X-ray 
diffraction analysis (Figure 25). 
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Figure 25. Molecular structure of compound 143 in the solid state. Thermal ellipsoids at 50% probability; 
perchlorate counterions, solvent molecules, and hydrogen atoms have been omitted for clarity. 
 
The nature of this metal−ligand bond has been further examined by quantum chemical 
calculations. Charge decomposition analysis reveals that the total L→M σ-donation (0.31e) is 
lower than the M→L pi-back-donation (0.43e) which should hence be regarded as the main 
interaction in 143 and thus as the principal source of its stability. Generally, ligands are 
anionic or neutral species and monocationic ligands are rare.96 Compounds of this type, 
formally constituted by a tricationic ligand with no spacer between the donor atom and the 
positive charged groups, seem to be unknown.1 
 
It was found that the coordination of 141 to the gold(I) moiety was also possible  
(Scheme 58). The adduct 144 was isolated in 94% yield, but the stability of this complex is 
lower than the corresponding Pd and Pt complexes. Although it could be stored at -40 oC, it 
decomposes at room temperature. The low stability of 144 may be due to the weakening of 
metal back-donation to the phosphorus atom. 
 
 
Scheme 58. Formation of Au(I) complexe 144. 
 
Next, we assumed that if an electron pair remains on the phosphorus, compound 141 might be 
able to be protonated with the concomitant formation of an adduct which is able to carry four 
positive charges (Scheme 59). 
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Scheme 59. Protonation of the compound 141. 
 
However, compound 141 gave no reaction with an excess of tetrafluoroboric acid. This failure 
can be considered as an evidence of the electron poorness of the phosphorus atom in this 
compound. 
 
4.3 Summary IV 
 
In summary, we have synthesized for the first time a tricationic P(III)-carbene stabilized 
center. Unexpectedly, despite the presence of three positive charges, coordination of 134a to 
electron-rich transition metals such as Pt and Pd has been possible and their stability 
demonstrated in both the solid state and in solution. The coordination to less electron-rich 
metals such gold, was also possible. Additionally, the nature of the metal−ligand interaction 
has been analyzed by DFT calculations. Whether this and related compounds could have 
applications in catalysis is under investigation. 
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5 Carbene-Stabilized Chalcogenoid Dications 
 
5.1 General Introduction 
 
Due to the recent development of p-block-centered polycation chemistry, an interesting 
addition to this work could be the synthesis of cyclopropenylidene-stabilized chalcogenium 
polycations. 
 
It is known that cationic chalcogenium-centered compounds are usually very reactive species 
if they are not stabilized by donating heteroatoms.97 For example, sulfenium cations can be 
generated by electrochemical oxidation of various disulfides and are applied for some 
reactions such as the α-thiolation of alkyl ketones or the preparation of electron rich 
methylsulfanyl aromatic compounds (Scheme 60). 
 
 
Scheme 60. Reaction of MeS+ cation with ketone and phenol derivatives. 
 
Similar to the already described phosphenium cations, the stabilization of chalcogenium 
cationic species can be achieved by incorporation of the chalcogen into electron rich 
heterocycles (structure 148, Scheme 61) or by formation of complexes with Lewis-bases 
(structures 149 and 150). 
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Scheme 61. Examples of Ch2+ dications, stabilized by imines, amines and carbenes. 
 
5.1.1. Stabilization by incorporation in electron rich heterocycles 
 
Bidentate ligands such 1,2-diimines can stabilize chalcogenium dications. For example, 1,2,5-
chalcogenadiazolium  compounds 148 were synthesized by the reaction of chalcogen 
dichloride (Ch = S, Se) with the 1,2-diimine 151 (R = Cy, dipp, dmp, pMeOPh, R1 = H, Me, 
Ph, BIAN) followed by treatment with TMSOTf (Scheme 62).98 
 
 
Scheme 62. Synthesis of 1,2,5-chalcogenadazolium compounds 148. 
 
Tellurium dichloride has a “transient nature”, therefore, tellurium containing analogues of 
type 148 (Ch = Te) could not be obtained using the methodology just described. Thus, the 
tellurenium dication 156 was prepared by the alternative way using ligand exchange from 153 
to 155 and halide abstraction with an excess of AgOTf (Scheme 63).99 
 
 
Scheme 63. Synthesis of the dicationic tellurium compound 156. 
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5.1.2 Stabilization by formation of complexes with Lewis-bases 
 
The most common way for the preparation of stabilized chalcogenium monocations is the 
abstraction of a Cl- group of the corresponding sulfenyl, selenyl or telluryl chlorides with non-
coordinating anions.100 For example, selenyl chloride, formed by the oxidation of methyl 
selenide 157 with t-BuOCl, is dechlorinated by treatment with KPF6 to give compound 158 
(Scheme 64). 
 
 
Scheme 64. Synthesis of N-stabilized selenenium monocation 158. 
 
Similar methods were used for the generation of chalcogen-centered dications. For example, 
pyridine-stabilized sulfenium(II) dications 162 were prepared by treatment of sulfur 
dichloride with TMSOTf and subsequent treatment with pyridines (Scheme 65).70 
 
 
Scheme 65. Synthesis of pyridine-stabilized S2+ dications 162. 
 
Recently, bis-imines were identified as appropriate ligands for the transfer of Ch2+ to other 
neutral two-electron donor ligands. For example, the addition of two equivalents of 1,3-
diisopropylimidazol-2-ylidene 164 to 163 gives the dication 150 (Scheme 66).101 
 
 
Scheme 66. Synthesis of NHC-stabilized dications 150. 
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Cyclopropenylidenes, that have already been successfully used for the stabilization of 
polycharged phosphorus-centered cations, might also be used for the synthesis of other p-
block element analogues applying the same “reverse electron demand” onio-substituent 
transfer methodology. Therefore, we decided to investigate its scope by reaction with 
bis(trimethylsilyl)-chalcogenides. 
 
5.2 Results and Discussion 
 
5.2.1 Synthesis of carbene-stabilized sulfenium, selenenium and tellurenium 
cations 
 
The reaction of silylated chalcogenides 165 (Y = S, Se and Te) and chlorocyclopropenium 
salts 42 or 133 afforded the desired carbene-stabilized sulfenium and selenenium dications 
166a,b and 167a,b in moderate to good yields (66-85%), proving the generality of our 
strategy (Scheme 67 and 68). 
 
 
Scheme 67. Synthesis of the sulfenium and selenenium cations 166a,b and 167a,b. 
 
The synthesis of the corresponding tellurium compound 169 using this methodology was not 
as efficient as in the sulfur and selenium case, probably because bis(trimethyl-silyl)telluride 
168 partially decomposes in the reaction conditions releasing metallic tellurium. The use of 
chlorocyclopropenium salt 42 with a tetrafluoroborate counteranion led to the formation of 
considerable amounts of byproduct 170 (Scheme 68). Compound 170 was isolated in 55-83% 
yields and its structure has been confirmed by X-ray diffraction analysis (see page 199, 
Appendix 7.2.21). 
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Scheme 68. Synthesis of the tellurenium cations 169a,b. 
 
The formation of byproduct 170 could be explained by the reaction of the already formed 
product 169a with BF3 that may be present in the reaction medium due to the following 
equilibrium (Scheme 69). 
 
BF4 BF3 F
 
Scheme 69. An equilibrium between tetrafluoroborate anion, boron trifluoride and fluoride anion. 
 
This side reaction could be explained by the weaker tellurium-carbon bond in comparison 
with the sulfur-carbon and selenium-carbon bonds, which is probably due to an inefficient 
(C)sp2-(Te)5p orbital overlap. This also explains the absence of the side reaction in the case of 
sulfur and selenium where (C)sp2-(S)3p and (C)sp2-(Se)4p overlaps are more efficient. The 
increase in the yield of the reaction in the sequence S>Se>Te (85%, 66% and 32%, Schemes 
67 and 68) speaks in favor of this explanation. 
 
Due to the bad results obtained with (TMS)2Te 168, we investigated an alternative approach 
to synthesis of tellurenium compounds 169a,b. An alternative could be the use a different 
source of tellurium such as sodium telluride 172.102 Thus, treatment of tellurium powder with 
sodium naphthalide yielded TeNa2 172 (Scheme 70), which was reacted with 
chlorocyclopropenium triflate 133 to yield the desired product 169b in 53% yield. However, 
the reaction of sodium telluride 172 with chlorocyclopropenium tetrafluoroborate 42 did not 
afford any identicable product, probably because of the instability of BF4- under these highly 
reducing conditions. 
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Scheme 70. Alternative synthesis of the tellurenium compound 169b. 
 
The structures of all produced chalcogenenium cations 166a, 167a and 169b have been 
confirmed by X-ray diffraction (Figure 26, 27 and 28). 
 
Figure 26. Molecular structure of compound 166a in the solid state. Hydrogen atoms, tetraflouroborate counter 
anions and solvent molecules have been omitted for clarity. Thermal ellipsoids at 50% probability. 
 
 
Figure 27. Molecular structure of compound 167a in the solid state. Hydrogen atoms, tetraflouroborate counter 
anions and solvent molecules have been omitted for clarity. Thermal ellipsoids at 50% probability. 
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Figure 28. Molecular structure of compound 169b in the solid state. Hydrogen atoms, triflate counter anions and 
solvent molecules have been omitted for clarity. Thermal ellipsoids at 50% probability. 
 
The bond lengths between the chalcogen atom and the adjacent carbon atoms as well as bond 
angles (C-Ch-C) in compounds 166a, 167a and 169b were compared. Compounds 166a and 
167a have the same counter anion (BF4-); in the case of 169b the counter anion is different 
(TfO-) and in the X-ray structure we can see the Te-OTf interaction. The observed bond 
lengths (C–Ch) for 166a are 1.7297(13) Å and 1.7394(13) Å, for 167a are 1.8847(16) Å and 
1.8773(16) Å, for 169b are 2.085(3) Å and 2.087(3) Å. The bond angles are 100.14(6)o, 
97.30(7)o and 95.44(10)o for 166a, 167a and 169b respectively. This comparison clearly 
shows that the increasing of the sizes S<Se<Te correlates with an increase in the  
carbon–chalcogen bond length and a decreased angle between these two bonds. This might be 
explained by less efficient hybridization between the s- and p-orbitals. Therefore, the bond 
angle changes from 120o, which is characteristic for the sp2 hybridization, to close to 90o 
which is typical for the orthogonal p-orbitals. 
 
5.3 Summary V 
 
In summary, a new synthetic approach for preparation of cyclopropenylidene-stabilized 
chalcogenoid-centered dications have been developed. The compounds were isolated in 
moderate to good yields and their molecular structures were confirmed by X-ray diffraction. 
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6 Experimental Part 
 
6.1 General Experimental Conditions 
 
6.1.1 Working techniques 
 
All moisture- and oxidation-sensitive reactions were performed in carefully dried glassware 
under an argon atmosphere. The saturated aqueous solutions of sodium chloride, sodium 
bicarbonate, sodium carbonate and ammonium chloride, were saturated over sediment, unless 
indicated otherwise. 
 
Solvents and reagents 
 
All solvents were purified by distillation before use following standard procedures. Dry 
solvents were obtained by distillation over the appropriate drying agent (vide infra) and then 
kept under an atmosphere of argon: diethyl ether, tetrahydrofuran, toluene, benzene, pentane 
and n-hexane (sodium, benzophenone as indicator); N,N'-dimethylformamide (Desmodur®, 
dibutyltin dilaurate); dichloromethane, acetone, acetonitrile, triethylamine (calcium hydride); 
fluorobenzene (phosphorus pentoxide), methanol and ethanol (magnesium). 1,2-Dichloro-
ethane was purchased from Sigma-Aldrich and used as received. Other commercial reagents 
were obtained from various sources and used without further purification. 
 
Inert gas atmosphere 
 
Air and moisture-sensitive reactions were conducted under an argon atmosphere. Argon was 
obtained from Air Liquide with higher than 99.5% purity. 
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Chromatographic methods 
 
Reactions were mostly monitored by thin layer chromatography (TLC) using silica gel  
pre-coated polyester sheets (40 × 80 mm, Polygram® SIL G/UV254 from Macherey-Nagel). 
The spots were visualized with UV-light (λ = 254 nm) and/or by staining with 
phosphomolybdic acid or potassium permanganate stains.  
 
Flash column chromatography was performed using silica gel 60 (Merck, 60 Å, 230-400 
mesh 0.040-0.063 mm) and separations were conducted at slightly elevated pressure in a glass 
column. 
 
6.1.2 Analytical methods 
 
Nuclear magnetic resonance spectroscopy (NMR) 
 
Spectra were recorded on Bruker DPX 300 (1H: 300 MHz, 13C: 75 MHz, 31P: 121 MHz), 
Bruker AV 400 (1H : 400 MHz, 13C: 100 MHz, 31P: 161 MHz), and Bruker AV 500 (1H: 500 
MHz, 13C: 125 MHz, 31P: 202 MHz) spectrometers at room temperature (298 K). Chemical 
shifts (δ) are given in parts per million (ppm) relative to tetramethylsilane (1H and 13C, 
internal standard) and H3PO4 (31P, external standard) and coupling constants (J) in Hertz (Hz). 
The corresponding solvent signals were used as a references: CDCl3: δC 77.0 ppm, δH 7.26 
ppm; CD2Cl2: δC 54.0 ppm, δH 5.32 ppm; CD3CN: δC 1.32 ppm, δC 118.26 ppm δH 1.94 
ppm; [D8]-toluene δC 20.4 ppm, δC 125.5 ppm, δC 128.3 ppm, δC 129.2 ppm, δC 137.9 
ppm, δH 2.08 ppm, δH 6.97 ppm, δH 7.01 ppm and δH 7.09 ppm. The 1H NMR multiplicities 
are assigned as follows: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), sextet 
(sext), septet (sept), multiplet (m), broad (br.). The signals have been assigned using 1D and 
2D experiments. 
 
Infrared spectroscopy 
 
IR spectra were recorded using ATR (attenuated total reflection) on a Spectrum One (Perkin-
Elmer) spectrometer at room temperature. The characteristic absorption bands are given in 
wavenumbers [cm-1]. 
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Analytical gas chromatography 
 
GC-MS couplings were performed on an Agilent Technology GC 6890 Series and MSD 5973 
(carrier gas: helium) with HP6890 Series Injector, employing an MN Optima®5 column (30 m 
× 0.25 mm × 0.25 mm). The mass spectra were recorded with an Agilent Technology 5973 
Network MSD spectrometer. Quantitative evaluation of the integration was based on the 
substance peaks without considering response factors, unless stated otherwise. 
 
Mass spectrometry (MS) 
 
Mass spectra were measured on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) 
spectrometer by electron ionization, chemical ionization, or fast atom/ion bombardment 
techniques. High resolution masses were determined on a Bruker APEX III FT-MS 
spectrometer (7 T magnet). All masses are given in atomic units per elementary charge (m/z) 
and reported in percentage relative to the basic peak. The mechanistic studies (cf. Chapter 
4.5.2) were performed by ESI-MS with a Finnigan Ultra Mass TSQ 7000. 
 
X-ray crystal structure analysis 
 
The crystal structures were measured in the X-ray department of the Max Planck Institute for 
Coal Research in Mülheim an der Ruhr, led by Dr. C. W. Lehmann. The measurements were 
made using a Bruker-AXS Kappa CCD diffractometer. 
 
6.1.3 Starting materials as well as in working group-made chemicals 
 
Commercially available chemicals were used without further purification unless otherwise 
stated. Working group's internal chemicals: diethyl 2-(cyclohept-2-enyl)-2-(prop-2-
ynyl)malonate 103 and diethyl 2-(cyclohex-2-enyl)-2-(3-phenylprop-2-ynyl)malonate 123,69 
1-(2-(prop-1-ynyl)phenyl)-1H-pyrrole 76.64 
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6.2 Synthesis 
 
Compound 43a 
 
 
 
Diphenylphosphine (2.9 mL, 16.7 mmol) was added to a mixture of chlorocyclopropenium 
salt 42 (2.0 g, 5.58 mmol) in THF (20 mL) and the resulting mixture was heated at 60 oC for 
24 hours. After cooling to room temperature, the solvent was removed in vacuo, the residue 
dissolved in DCM (30 mL) and washed with a saturated solution of NaBF4 (3 × 25 mL). Once 
dried over Na2SO4, the organic phase was concentrated and the residue washed with Et2O  
(3 × 10 mL) affording the desired compound as a white solid (2.55 g, 90%). 1H NMR  
(300 MHz, CD2Cl2) δ = 0.98 (d, J = 6.8 Hz, 12H), 1.29 (d, J = 6.8 Hz, 12H), 3.34 (sept,  
J = 6.8 Hz, 2H), 3.99 (sept, J = 6.8 Hz, 2H), 7.32-7.47 ppm (m, 10H). 31P NMR (121 MHz, 
CD2Cl2) δ = -23.61 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 21.6, 22.0, 53.6, 107.1 (d,  
J = 66.8 Hz), 130.5 (d, J = 8.1 Hz), 131.4 (d, J = 8.1 Hz), 131.7, 134.7 (d, J = 21.2 Hz), 139.7 
ppm. IR (neat) ν = 695, 752, 1047, 1547, 1867, 2974 cm-1. HRMS calcd. for C27H38N2P+: 
421.276711; found 421.276467. 
 
Compound 43b 
 
 
 
Dicyclohexylphosphine (0.84 mL, 4.17 mmol) was added to a mixture of 
chlorocyclopropenium salt 42 (500 mg, 1.39 mmol) in THF (5 mL) and the resulting mixture 
was heated at 60 oC for 24 hours. After cooling to room temperature, the solvent was removed 
in vacuo, the residue dissolved in DCM (20 mL) and washed with a saturated solution of 
NaBF4 (3 × 15 mL). Once dried over Na2SO4, the organic phase was concentrated and the 
residue washed with Et2O (3 × 5 mL) affording the desired compound as a white solid  
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(620 mg, 86%). 1H NMR (300 MHz, CD2Cl2) δ = 0.96-1.24 (m, 8H), 1.31 (d, J = 6.6 Hz, 
12H), 1.33 (d, J = 6.8 Hz, 12H), 1.35-1.51 (m, 6H), 1.55-1.95 (m, 8H), 3.94 (sept, J = 7.2 Hz, 
2H), 4.08 (sept, J = 7.2 Hz, 2H). 31P NMR (121 MHz, CD2Cl2) δ = -16.77 ppm. 13C NMR 
(100 MHz, CD2Cl2) δ = 21.1, 21.2, 22.0 (br.s), 26.5, 27.3, 27.4, 27.6, 27.7, 31.5, 31.6, 31.9, 
32.1, 36.2 (d, J = 13.7 Hz), 53.2 (br.s), 107.1 (d, J = 78.8 Hz), 142.2 ppm. IR (neat) ν = 680, 
1035, 1050, 1548, 1862, 2847, 2919 cm-1. (ESI) MS calcd. for C27H50N2P+: 433.4; found 
433.5. 
 
Compound 43c 
 
 
 
Diadamantylphosphine (1.26 g, 4.17 mmol) was added to a mixture of chlorocyclopropenium 
salt 42 (500 mg, 1.39 mmol) in THF (5 mL) and the resulting mixture was heated at 60 oC for 
72 hours. After cooling to room temperature, the solvent was removed in vacuo, the residue 
dissolved in DCM (20 mL) and washed with a saturated solution of NaBF4 (3 × 15 mL). Once 
dried over Na2SO4, the organic phase was concentrated and the residue washed with Et2O  
(3 × 10 mL) affording the desired compound as a white solid (680 mg, 79%). 1H NMR  
(300 MHz, CD2Cl2) δ = 1.30 (d, J = 6.9 Hz, 6H), 1.38 (d, J = 6.9 Hz, 12H), 1.45 (d,  
J = 6.9 Hz, 6H), 1.56-1.77 (m, 12H), 1.84 (br.s, 12H), 2.04 (br.s, 6H), 3.76-3.83 (m, 1H), 3.92 
(sept, J = 7.2 Hz, 1H), 4.36 (sept, J = 6.9 Hz, 1H), 4.57 (sept, J = 6.9 Hz, 1H); 31P NMR  
(121 MHz, CD2Cl2) δ = 15.63 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 20.9, 21.4, 21.5, 21.6, 
23.3, 29.5 (d, J = 8.5 Hz), 37.0, 39.5 (d, J = 25.2 Hz), 42.9 (d, J = 11.5 Hz), 49.9, 57.5, 57.6, 
105.0 (d, J = 90.5 Hz), 145.2 ppm (d, J = 22.4 Hz). IR (neat) ν = 1033, 1048, 1089, 1375, 
1452, 1539, 1851, 2848, 2901 cm-1. HRMS calcd. for C35H58N2P+: 537.433212; found 
537.433029. 
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Compound 43d 
 
 
 
Di(p-tolyl)phosphine (1.80 g, 8.40 mmol) was added to a mixture of chlorocyclopropenium 
salt 42 (1.00 g, 2.80 mmol) in THF (20 mL) and the resulting mixture was heated at 60 oC for 
24 hours. After cooling to room temperature, the solvent was removed in vacuo, the residue 
dissolved in DCM (20 mL) and washed with a saturated solution of NaBF4 (3 × 15 mL). Once 
dried over Na2SO4, the organic phase was concentrated and the residue washed with Et2O  
(3 × 20 mL) affording the desired compound as a white solid (1.44 g, 96%). 1H NMR  
(400 MHz, CD2Cl2) δ = 0.97 (d, J = 6.6 Hz, 12H), 1.27 (d, J = 6.8 Hz, 12H), 2.31 (s, 6H), 
3.32 (sept, J = 6.6 Hz, 2H), 3.98 (sept, J = 6.8 Hz, 2H), 7.20-7.21 ppm (m, 8H). 31P NMR 
(161 MHz, CD2Cl2) δ = -24.12 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 21.5, 21.6, 21.9, 22.0 
(br.s), 53.4 (br.s), 108.1 (d, J = 67,8 Hz), 127.9 (d, J = 6.1 Hz), 131.2 (d, J = 8.1 Hz), 134.6 
(d, J = 22.3 Hz), 139.4, 142.4 ppm. IR (neat) ν = 686, 811, 1048, 1547, 1863, 2976 cm-1. 
HRMS calcd. for C29H42N2P+: 449.308012; found 449.308455. 
 
Compound 43e 
 
 
 
Di(p-fluorophenyl)phosphine (2.67 g, 12.0 mmol) was added to a mixture of 
chlorocyclopropenium salt 42 (1.44 g, 4.00 mmol) in THF (20 mL) and the resulting mixture 
was heated at 60 oC for 24 hours. After cooling to room temperature, the solvent was removed 
in vacuo, the residue dissolved in DCM (20 mL) and washed with a saturated solution of 
NaBF4 (3 × 15 mL). Once dried over Na2SO4, the organic phase was concentrated and the 
residue washed with Et2O (3 × 20 mL) affording the desired compound as a white solid  
(1.65 g, 76%). 1H NMR (400 MHz, CD2Cl2) δ = 0.99 (d, J = 6.8 Hz, 12H), 1.29 (d,  
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J = 6.9 Hz, 12H), 3.35 (sept, J = 6.8 Hz, 2H), 4.00 (sept, J = 6.9 Hz, 2H), 7.15 (m, 4H), 7.41 
ppm (m, 4H). 31P NMR (161 MHz, CD2Cl2) δ = -24.57 ppm. 13C NMR (100 MHz, CD2Cl2)  
δ = 21.5, 21.6, 21.9, 54.0 (br.s), 108.8 (d, J = 58.5 Hz), 117.8 (dd, J = 21.2 Hz, J = 9.2 Hz), 
127.0 (dd, J = 7.1 Hz, J = 4.0 Hz), 137.1 (dd, J = 23.2 Hz, J = 9.1 Hz), 139.6, 165.4 ppm (d,  
J = 252.6 Hz). IR (neat) ν = 691, 836, 1049, 1552, 1869, 2987 cm-1. (ESI) MS calcd. for 
C27H36F2N2P+ 457.26, found 457.29. HRMS calcd. for C27H36N2F2P+: 457.257868; found 
457.257700. 
 
Compound 43f 
 
 
 
Di(p-methoxyphenyl)phosphine (0.875 g, 3.6 mmol) was added to a mixture of 
chlorocyclopropenium salt 42 (430 mg, 1.2 mmol) in THF (5 mL) and the resulting mixture 
was heated at 60 oC for 12 hours. After cooling to room temperature, the solvent was removed 
in vacuo, the residue dissolved in DCM (20 mL) and washed with a saturated solution of 
NaBF4 (3 × 15 mL). Once dried over Na2SO4, the organic phase was concentrated and the 
residue purified by silica gel flash chromatography (9:1 DCM : Acetone) affording the desired 
compound as a white solid (0.55 g, 80%).1H NMR (300 MHz, CD2Cl2) δ = 0.97 (d,  
J = 6.8 Hz, 12H), 1.27 (d, J = 6.9 Hz, 12H), 3.34 (sept, J = 6.8 Hz, 2H), 3.76 (s, 6H), 3.97 
(sept, J = 6.9 Hz, 2H), 6.94 (m, 4H), 7.31 ppm (m, 4H). 31P NMR (121 MHz, CD2Cl2)  
δ = -23.83 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 21.6, 21.7, 22.0, 56.3, 108.1 (d,  
J = 67.4 Hz), 116.0 (d, J = 9.1 Hz), 122.0 (d, J = 3.3 Hz), 136.6 (d, J = 23.4 Hz), 139.2 (d,  
J = 1.3 Hz), 162.8 ppm. IR (neat) ν = 684, 834, 1024, 1247, 1553, 1866, 2982 cm-1; (ESI) MS 
calcd. for C29H42N2O2P+: 481.30 found 481.37. HRMS calcd. for C29H42N2O2P+: 481.297843; 
found 481.297370. 
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Compound 44a 
 
 
 
Dry THF (2 mL) was added to a cooled (- 20 oC) solid mixture of [RhCl(CO)2]2 (10 mg, 
0.025 mmol) and chlorophosphenium salt 43a (50 mg, 0.1 mmol). The reaction mixture was 
allowed to warm to room temperature and then stirred additionally for 30 min. After removal 
of the solvents in vacuo, the solid residue was washed with pentane (3 × 1 mL) and dried, 
affording the desired product as a yellow solid (56 mg, 93%).1H NMR (400 MHz, CD2Cl2)  
δ = 0.89 (d, J = 6.9 Hz, 24H), 1.27 (d, J = 6.9 Hz, 24H), 3.39 (m, 4H), 4.04 (m, 4H),  
7.52-7.62 (m, 12H), 8.08-8.16 ppm (m, 8H). 31P NMR (161 MHz, CD2Cl2) δ = 30.15 ppm (d, 
J = 133.1 Hz). 13C NMR (100 MHz, CD2Cl2) δ = 21.2, 21.6, 55.0 (br.s), 101.4 (t,  
J = 13.4 Hz), 128.5 (t, J = 25.8 Hz), 130.1 (t, J = 5.8 Hz), 133.5, 134,3 (d, J = 21.6 Hz), 136.1 
(t, J = 7.8 Hz),139.2 ppm (t, J = 4.3 Hz). IR (neat) ν = 700, 800, 1036, 1053, 1552, 1865, 
1970, 2975 cm-1. HRMS calcd. for C53H76BClF4N4OP2Rh+: 1095.427971; found 
1095.427645. 
 
Compound 44c 
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Dry THF (2 mL) was added to a cooled (-20 oC) solid mixture of [RhCl(CO)2]2 (12 mg,  
0.030 mmol) and phosphenium salt 43e (65 mg, 0.12 mmol). The reaction mixture was 
allowed to warm to room temperature and then stirred additionally for 30 min. After removal 
of the solvents in vacuo, the solid residue was washed with pentane (3 × 1 mL) and dried, 
affording the desired product as a yellow solid (74 mg, 99%).1H NMR (300 MHz, CD2Cl2)  
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δ = 1.02 (d, J = 7.0 Hz, 24H), 1.36 (d, J = 7.0 Hz, 24H), 3.45 (sept, J = 7.0 Hz, 4H), 4.13 
(sept, J = 7.0 Hz, 4H), 7.34 (m, 8H), 8.28 ppm (m, 8H). 31P NMR (121 MHz, CD2Cl2)  
δ = 26.12 ppm (d, J = 131.3 Hz). 13C NMR (75 MHz, CD2Cl2) δ = 21.3, 21.6, 54.0, 100.6 (t,  
J = 15.1 Hz), 117.5 (dd, J = 21.5, 6.3 Hz), 124.4 (t, J = 4.7 Hz), 138.8 (dt, J = 9.7 Hz,  
J = 8.5 Hz), 139.3 (dd, J = 7.0 Hz, J = 3.7 Hz), 166.0 ppm (d, J = 256.0 Hz). IR (neat)  
ν = 687, 814, 1035, 1239, 1556, 1865, 1976, 2972 cm-1. HRMS calcd. for 
C55H72B3ClF16N4OP2Rh-: 1341.399085; found 1341.398831. 
 
Compound 44d 
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Dry THF (2 mL) was added to a cooled (-20 oC) solid mixture of [RhCl(CO)2]2 (13 mg,  
0.031 mmol) and phosphenium salt 43d (67 mg, 0.12 mmol). The reaction mixture was 
allowed to warm to room temperature and then stirred additionally for 30 min. After removal 
of the solvents in vacuo, the solid residue was washed with pentane (1 × 15 mL) and dried, 
affording the desired product as a yellow solid (76 mg, 99%).1H NMR (300 MHz, CD2Cl2)  
δ = 0.89 (d, J = 6.8 Hz, 24H), 1.26 (d, J = 6.8 Hz, 24H), 2.37 (s, 12H), 3.39 (sept, J = 7.0 Hz, 
4H), 4.03 (sept, J = 7.0 Hz, 4H), 7.35 (d, J = 7.9 Hz, 8H), 7.93-8.00 ppm (m, 8H). 31P NMR 
(121 MHz, CD2Cl2) δ = 28.82 ppm (d, J = 131.2 Hz). 13C NMR (75 MHz, CD2Cl2) δ = 21.5, 
21.9, 22.0, 53.4 (br.s) 55.1 (br.s), 100.2 (d, J = 12.6 Hz), 125.5 (dd, J = 27.8 Hz, J = 26.5 Hz), 
131.1 (t, J = 6.4 Hz), 136.4 (t, J = 7.9 Hz), 139.3 (d, J = 3.3 Hz), 145.0 (t, J = 1.3 Hz), 163.4 
ppm. IR (neat) ν = 664, 807, 1031, 1357, 1554, 1866, 1969, 2969 cm-1. HRMS calcd. for 
C59H84BClF4N4OP2Rh+: 1151.488064; found 1151.491726. 
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Compound 44e 
 
 
 
Dry THF (2 mL) was added to a cooled (-20 oC) solid mixture of [RhCl(CO)2]2 (9.0 mg, 
0.023 mmol) and phosphenium salt 43f (52 mg, 0.091 mmol). The reaction mixture was 
allowed to warm to room temperature and then stirred additionally for 30 min. After removal 
of the solvents in vacuo, the solid residue was washed with pentane (3 × 1 mL) and dried, 
affording the desired product as a yellow solid (61 mg, 99%). 1H-NMR (300 MHz, CD2Cl2)  
δ = 0.91 (d, J = 6.9 Hz, 24H), 1.25 (d, J = 6.9 Hz, 24H), 3.42 (sept, J = 6.9 Hz, 4H), 3.81 (s, 
12H), 4.02 (sept, J = 6.9 Hz, 4H), 7.04 (m, 8H), 8.02 ppm (m, 8H). 31P NMR (121 MHz, 
CD2Cl2) δ = 27.12 ppm (d, J = 130.3 Hz). 13C NMR (100 MHz, CD2Cl2) δ = 21.5, 21.9, 24.0, 
56.6, 103.2 (t, J = 13.0 Hz), 115.8 (t, J = 6.7 Hz), 119.8 (t, J = 29.0 Hz), 138.3 (t, J = 8.5 Hz), 
139.3, (t, J = 4.5 Hz), 164.2 ppm. IR (neat) ν = 685, 800, 1053, 1257, 1551, 1864, 1977, 2979 
cm-1. HRMS calcd. for C59H84B3ClF12N4O5P2Rh-: 1389.479175; found: 1389.478116. 
 
Compound 45a 
 
 
 
[RhCl(cod)]2 (24.6 mg, 0.05 mmol) was added to a solution of 43a (50.9 mg, 0.10 mmol) in 
DCM (2 mL) and the resulting mixture stirred for 1 h at room temperature. Then the solvent 
was evaporated and the resulting yellow residue washed with pentane (2 mL) and dried to 
afford 45a as a yellow solid (72.4 mg, 96%). 1H NMR (400 MHz, CD2Cl2) δ = 1.09 (d,  
J = 6.4 Hz, 12H), 1.33 (d, J = 6.8 Hz, 12H), 1.98 (m, 2H), 2.08 (m, 2H), 2.29 (m, 4H), 3.54 
(br.s, 2H), 3.94 (br.m, 2H), 4.10 (br.m, 2H), 5.58 (br.s, 2H), 7.39-7.70 ppm (m, 10H).  
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31P NMR (161 MHz, CD2Cl2) δ = 25.30 ppm (d, J = 150.6 Hz). 13C NMR (100 MHz, CD2Cl2) 
δ = 21.9, 22.4, 29.5 (bs), 33.7 (d, J = 2.0 Hz), 53.3(br.s), 59.1(br.s), 72.9 (d, J = 12.9 Hz), 
102.9 (d, J = 12.9 Hz), 108.6 (dd, J = 7.0, 12.6 Hz), 128.0 (d, J = 43.9 Hz), 130.3 (d,  
J = 10.7 Hz), 133.3 (d, J = 1.9 Hz), 135.1 (d, J = 12.0 Hz), 139.2 ppm (d, J = 7.9 Hz). IR 
(neat) ν = 696, 752, 996, 1032, 1049, 1091, 1376, 1552, 1868, 2938, 2975 cm-1; HRMS calcd. 
for C35H50ClN2PRh+: 667.244969; found: 667.245253. 
 
Compound 45b 
 
 
 
[RhCl(cod)]2 (24.6 mg, 0.05 mmol) was added to a solution of 43b (52.0 mg, 0.10 mmol) in 
DCM (2 mL) and the resulting mixture stirred for 1 h at room temperature. Then the solvent 
was evaporated and the resulting yellow residue washed with pentane (2 mL) and dried to 
afford 45b as a yellow solid (67.4 mg, 88%). 1H NMR (400 MHz, CD2Cl2) δ = 1.23-1.45 (m, 
8H), 1.50 (br.s, 12H), 1.57 br.s, 12H), 1.84 (br.s, 4H), 1.96 (br.s, 8H), 2.11-2.27 (m, 4H), 
2.31-2.42 (m, 2H), 2.42-2.57 (m, 2H), 3.78 (br.s, 2H), 4.22 (br.s, 2H), 4.83 (br.s, 2H) 5.51 
ppm (br.s, 2H). 31P NMR (161 MHz, CD2Cl2) δ = 28.3 ppm (d, J = 150.5 Hz). 13C NMR  
(100 MHz, CD2Cl2) δ = 22.2 (br.s), 23.0 (br.s), 26.2 (d, J = 1.3 Hz), 27.2, 27.3, 27.4, 27.5, 
28.8 (d, J = 1.2 Hz), 30.5 (br.s), 31.3, 31.6 (d, J = 2.6 Hz), 33.6 (d, J = 2.5 Hz), 34.6 (br.s). 
34.9 (br.s), 58.8 (br.s), 71.4 (d, J = 13.0 Hz), 102.2, 107.8 (dd, J = 12.0 Hz, J = 6.9 Hz), 141.4 
ppm (br.s). IR (neat) ν = 727, 1004, 1050, 1093, 1535, 1860, 2852, 2933 cm-1. HRMS calcd. 
for C35H62ClN2PRh+: 679.338870; found: 679.338987. 
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Compound 45c 
 
 
 
[RhCl(cod)]2 (25.0 mg, 0.05 mmol) was added to a solution of 43e (54.0 mg, 0.10 mmol) in 
DCM (2 mL) and the resulting mixture stirred for 1 h at room temperature. Then the solvent 
was evaporated and the resulting yellow residue washed with pentane (2 mL) and dried to 
afford 45c as a yellow solid (77.0 mg, 97%). 1H NMR (300 MHz, CD2Cl2) δ = 1.22 (d,  
J = 6.7 Hz, 12H), 1.45 (d, J = 6.5 Hz, 12H), 2.05-2.28 (m, 4H), 2.30-2.56 (m, 4H), 3.65 (m, 
2H), 4.03 (m, 2H), 4.21 (m, 2H), 5.70 (m, 2H), 7.26-7.37 (m, 4H), 7.73-7.86 ppm (m, 4H). 
31P NMR (121 MHz, CD2Cl2) δ = 22.65 ppm (d, J = 153.0 Hz). 13C NMR (100 MHz, CD2Cl2) 
δ = 21.6, 21.9, 29.1 (br.s), 33.3 (d, J = 2.4 Hz), 55.5 (br.s), 57.6, 72.4 (d, J = 13.0 Hz), 101.6 
(d, J = 19.3 Hz), 108.5 (dd, J = 12.4 Hz, J = 7.2 Hz), 117.3 (dd, J = 21.5 Hz, J = 11.5 Hz), 
123.5 (dd, J = 45.9 Hz, J = 2.5 Hz), 137.4 (dd, J = 14.4 Hz, J = 8.9 Hz), 138.9 (dd, J = 7.2 Hz, 
J = 1.4 Hz), 165.6 ppm (dd, J = 256.0 Hz, J = 2.4 Hz). IR (neat) ν = 681, 815, 1053, 1548, 
1865, 2976 cm-1. HRMS calcd. for C35H48ClF2N2PRh+: 703.226126; found 703.225916. 
 
Compound 45d 
 
BF4
N
N
P
iPr
iPr
iPr
iPr
Rh
Cl
Me
Me
 
 
[RhCl(cod)]2 (25.0 mg, 0.05 mmol) was added to a solution of 43d (54.0 mg, 0.10 mmol) in 
DCM (2 mL) and the resulting mixture stirred for 1 h at room temperature. Then the solvent 
was evaporated and the resulting yellow residue washed with pentane (2 mL) and dried to 
afford 45d as a yellow solid (77.0 mg, 99%). 1H NMR (400 MHz, CD2Cl2) δ = 1.08 (d,  
J = 6.5 Hz, 12H), 1.32 (d, J = 6.7 Hz, 12H), 1.92-2.11 (m, 4H), 2.18-2.33 (m, 4H), 2.35 (s, 
6H), 3.51 (m, 2H), 3.95 (m, 2H), 4.08 (m, 2H), 5.54 (m, 2H), 7.23-7.29 (m, 4H), 7.43-7.50 
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ppm (m, 4H). 31P NMR (161 MHz, CD2Cl2) δ = 24.66 ppm (d, J = 151.0 Hz). 13C NMR  
(100 MHz, CD2Cl2) δ = 21.9, 22.0, 22.4, 29.5, 33.7 (d, J = 2.9 Hz), 53.2 (br.s), 56.0 (br.s), 
72.7 (d, J = 12.9 Hz), 103.5 (d, J = 15.7 Hz), 108.3 (dd, J = 12.7 Hz, J = 6.9 Hz), 124.5 (d,  
J = 46.0 Hz), 130.9 (d, J = 10.1 Hz), 135.0 (d, J = 12.2 Hz), 139.1 (d, J = 8.4 Hz), 142.2 ppm 
(d, J = 2.0 Hz). IR (neat) ν = 677, 808, 1053, 1552, 1863, 2969 cm-1. HRMS calcd. for 
C37H54ClN2PRh+: 695.276269; found 695.276236. 
 
Compound 46a 
 
 
 
[AuCl(Me2S)] (63.0 mg, 0.20 mmol) was added to a cooled (-20 oC) suspension of salt 43a 
(109.0 mg, 0.20 mmol) in dry THF (3 mL) and the solution stirred at this temperature for 1 h. 
The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (154 mg, 97%).1H NMR (400 MHz, CD2Cl2) δ = 0.96 (d, J = 6.9 Hz, 12H), 1.33 (d,  
J = 6.9 Hz, 12H), 3.35 (sept, J = 6.9 Hz, 2H), 4.07 (sept, J = 6.9 Hz, 2H), 7.54-7.64 (m, 6H), 
7.86-7.93 ppm (m, 4H). 31P NMR (161 MHz, CD2Cl2) δ = 17.86 ppm. 13C NMR (75 MHz, 
CD2Cl2) δ = 21.9, 22.0, 68.5, 96.8 (d, J = 45.3 Hz), 125.5 (d, J = 67.5 Hz), 131.1 (d,  
J = 13.6 Hz), 134.7 (d, J = 2.6 Hz), 135.9 (d, J = 16.2 Hz), 138.7 ppm. IR (neat) ν = 692, 751, 
1057, 1568, 1866, 2979 cm-1. HRMS calcd. For C27H38AuClN2P+: 653.212121; found 
653.213006. 
 
Compound 46b 
 
 
 
[AuCl(Me2S)] (29.5 mg, 0.10 mmol) was added to a cooled (-20 oC) suspension of salt 43b 
(52.0 mg, 0.10 mmol) in dry DCM (3 mL) and the solution stirred at this temperature for 1 h. 
The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (70.8 mg, 94%).1H NMR (300 MHz, CD2Cl2) δ = 1.23-1.45 (m, 10H), 1.51 (d, J =  
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5.7 Hz, 12H), 1.63 (d, J = 6.9 Hz, 12H), 1.65-1.82 (m, 4H), 1.94 (br.s, 4H), 2.10-2.16 (m, 
2H), 2.36-2.50 (m, 2H), 4.16 (sept, J = 6.9 Hz, 2H), 4.27 ppm (sept, J = 6.9 Hz, 2H).  
31P NMR (121 MHz, CD2Cl2) δ = 33.31 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 22.0, 22.1, 
25.8 (br.s), 26.8 (d, J = 15.5 Hz), 27.1 (d, J = 13.4 Hz), 30.8, 30.9, 32.1, 32.2, 38.0 (d,  
J = 32.1 Hz), 54.5 (br.s), 68.5, 95.1 (br.s), 141.1 ppm. IR (neat) ν = 682, 1029, 1051, 1558, 
1863, 2851, 2928 cm-1. HRMS calcd. for C27H50AuClN2P+: 665.306018; found 665.306796. 
 
Compound 46c 
 
 
 
[AuCl(Me2S)] (29.5 mg, 0.10 mmol) was added to a cooled (-20 oC) suspension of salt 43c 
(62.5 mg, 0.10 mmol) in dry DCM (3 mL) and the solution stirred at this temperature for 1 h. 
The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (81.4 mg, 95%).1H NMR (400 MHz, CD2Cl2) δ = 1.28 (d, J = 6.4 Hz, 8H), 1.39 (d,  
J = 6.8 Hz, 12H), 1.62 (br.s, 6H), 1.71 (s, 10H), 2.00-2.14 (m, 18H), 4.12 (br.s, 1H), 4.36 
(br.s, 1H), 4.43 ppm (sept, J = 6.8 Hz, 2H). 31P NMR (161 MHz, CD2Cl2) δ = 33.31 ppm 
(br.s). 13C NMR (100 MHz, CD2Cl2) δ = 21.7 (br.s), 22.7 (br.s), 23.0, 28.9, 29.1, 36.0, 36.1, 
42.3, 42.4, 44.7 (br.s), 54.0, 54.2, 54.3, 58.2, 93.7 (br.s), the two C-N from the 
cyclopropenium cations were not detected after prolonged measurement. IR (neat) ν = 672, 
734, 1055, 1551, 1842, 2899 cm-1. HRMS calcd. for C35H58AuClN2P+: 769.368616; found 
769.368204. 
 
Compound 46d 
 
 
 
[AuCl(Me2S)] (29.0 mg, 0.098 mmol) was added to a cooled (-20 oC) suspension of salt 43e 
(54.0 mg, 0.098 mmol) in dry THF (2 mL) and the solution stirred at this temperature for 1 h. 
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The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (75 mg, 99%). 1H NMR (300 MHz, CD2Cl2) δ = 1.00 (d, J = 6.8 Hz, 12H), 1.33 (d,  
J = 6.8 Hz, 12H), 3.38 (sept, J = 6.8 Hz, 2H), 4.08 (sept, J = 6.8 Hz, 2H), 7.29 (dt, J = 8.6 Hz, 
J = 2.0 Hz, 4H), 7.89-8.02 ppm (m, 4H). 31P NMR (121 MHz, CD2Cl2) δ = 15.73 ppm.  
13C NMR (75 MHz, CD2Cl2) δ = 21.9, 22.0, 50.0, 58.1, 96.0 (d, J = 47.9 Hz), 118.5 (dd,  
J = 22.1 Hz, J = 14.9 Hz), 121.6 (dd, J = 70.5 Hz, J = 3.5 Hz), 138.6 (dd, J = 9.7 Hz,  
J = 2.0 Hz), 138.8 (dd, J = 7.7 Hz, J = 2.6 Hz), 167.0 ppm (dd, J = 257.6 Hz, J = 2.6 Hz).  
IR (neat) ν = 829, 1052, 1236, 1496, 1566, 1864, 2978 cm-1. HRMS calcd. for 
C27H36AuClF2N2P+: 689.193278; found 689.192744. 
 
Compound 46e 
 
 
 
[AuCl(Me2S)] (25.0 mg, 0.085 mmol) was added to a cooled (-20 oC) suspension of salt 43d 
(46.0 mg, 0.085 mmol) in dry THF (2 mL) and the solution stirred at this temperature for 1 h. 
The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (64 mg, 98%). 1H NMR (300 MHz, CD2Cl2) δ = 0.97 (d, J = 7.0 Hz, 12H), 1.32 (d,  
J = 7.0 Hz, 12H), 2.36 (s, 6H), 3.36 (sept, J = 7.0 Hz, 2H), 4.06 (sept, J = 7.0 Hz, 2H), 7.36 
(dd, J = 7.8 Hz, J = 2.6 Hz, 4H), 7.73 ppm (dd, J = 14.5 Hz, J = 7.8 Hz, 4H). 31P NMR  
(121 MHz, CD2Cl2) δ = 16.13 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 21.9, 22.0, 22.1, 22.2, 
87.5 (d, J = 13.6 Hz), 122.2 (d, J = 69.2 Hz), 131.7 (d, J = 13.6 Hz), 135.8 (d, J = 16.2 Hz), 
138.6 (d, J = 7.6 Hz), 146.0 ppm (d, J = 2.6 Hz). IR (neat) ν = 658, 814, 1051, 1375, 1567, 
1866, 2972 cm-1. HRMS calcd. for C29H42AuClN2P+: 681.243414; found 681.243078. 
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Compound 46f 
 
 
 
[AuCl(Me2S)] (30.0 mg, 0.10 mmol) was added to a cooled (-20 oC) suspension of salt 43f 
(57.0 mg, 0.10 mmol) in dry THF (4 mL) and the solution stirred at this temperature for 1 h. 
The solvent was then removed in vacuo at 0 oC, affording the desired product as an off white 
solid (79 mg, 99%). 1H NMR (300 MHz, CD2Cl2) δ = 0.98 (d, J = 6.7 Hz, 12H), 1.32 (d,  
J = 6.7 Hz, 12H), 3.39 (sept, J = 6.7 Hz, 2H), 3.79 (s, 6H), 4.05 (sept, J = 6.7 Hz, 2H), 7.05 
(dd, J = 13.9 Hz, J = 8.8 Hz,  4H), 7.80 ppm (dd, J = 8.8 Hz, J = 2.2 Hz, 4H). 31P NMR  
(121 MHz, CD2Cl2) δ = 14.37 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 20.4, 20.5, 55.0, 97.2 (d, 
J = 42.0 Hz), 114.8 (d, J = 73.3 Hz), 115.0 (d, J = 14.8 Hz), 136.2 (d, J = 18.1 Hz), 136.9 (d, 
J = 7.1 Hz), 163.3 ppm (d, J = 2.6 Hz). IR (neat) ν = 688, 800, 1052, 1260, 1567, 1867, 2973 
cm-1. HRMS calcd. for C29H42AuClO2N2P+: 713.233248; found 713.233797. 
 
Compound 47a 
 
BF4
N
N
P
iPr
iPr
iPr
iPr
Au
Ph
Ph
N
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Tf
 
 
AgNTf2 (77.6 mg, 0.20 mmol) was added to a cooled (0 oC) suspension of complex 46a 
(148.2 mg, 0.20 mmol) in dry DCM (3 mL) and the solution stirred at this temperature for 1 h. 
The reaction mixture was then filtered through a Celite plug. After evaporation of the filtrate 
in vacuo the desired product was obtained as an off white solid (196 mg, 96%). 1H NMR  
(400 MHz, CD2Cl2) δ = 0.95 (d, J = 7.2 Hz, 12H), 1.32 (d, J = 7.2 Hz, 12H), 3.27 (sept,  
J = 6.8 Hz, 2H), 4.08 (sept, J = 6.8 Hz, 2H), 7.52-7.66 (m, 6H), 7.81-7.95 ppm (m, 4H).  
31P NMR (161 MHz, CD2Cl2) δ = 14.47 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 21.9, 22.0, 
55.4 (br.s), 94.6 (d, J = 54.8 Hz), 120.2 (q, J = 320.2 Hz), 124.3 (d, J = 71.6 Hz), 131.4 (d,  
J = 13.5 Hz), 135.2 (d, J = 2.5 Hz), 135.9 (d, J = 16.8 Hz), 139.0 ppm (d, J = 7.6 Hz).  
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IR (neat) ν = 691, 956, 1052, 1130, 1182, 1351, 1401, 1439, 1567, 1866, 2986 cm-1. HRMS 
calcd. for C29H38AuClN3O4F6PS2 +: 898.160568; found 898.160583. 
 
Compound 48a 
 
 
 
To a cooled (-20 oC) solid mixture of CuCl (26 mg, 0.26 mmol) and compound 43a (67 mg, 
0.13 mmol) a dry THF (2 mL) was added and the solution stirred at this temperature for 5 h. 
The solvent was removed in vacuo, the precipitate was dissolved in DCM (2 mL) and the 
resulting solution was filtered under argon and the filtrate concentrated in vacuo to give the 
desired product as a white solid (79 mg, 99%). 1H NMR (300 MHz, CD2Cl2) δ = 0.93 (d,  
J = 6.9 Hz, 12H), 1.29 (d, J = 6.9 Hz, 12H), 3.31 (sept, J = 6.9 Hz, 2H), 4.02 (sept,  
J = 6.9 Hz, 2H), 7.41-7.56 (m, 6H), 7.67-7.77 ppm (m, 4H). 31P NMR (121 MHz, CD2Cl2)  
δ = -15.24 ppm. 13C NMR (75 MHz, CD2Cl2) δ = 23.4, 23.5, 55.5, 103.0 (d, J = 53.0 Hz), 
129.3 (d, J = 38.2 Hz), 132.2 (d, J = 11.0 Hz), 134.8 (d, J = 1.9 Hz), 136.7 (d, J = 17.4 Hz), 
140.1 ppm (d, J = 5.5 Hz). IR. (neat) ν = 694, 750, 1032, 1547, 1864, 2979 cm-1. (ESI) MS 
calcd. for C27H38ClCuN2P+: 519.2; found 519.0. 
 
Compound 48b 
 
 
 
To a cooled (-20 oC) solid mixture of allyl palladium chloride dimer (24 mg, 0.06 mmol) and 
compound 43a (66 mg, 0.13 mmol) a dry THF (6 mL) was added and the solution stirred at 
this temperature for 30 min. The solvent was removed in vacuo, affording the desired product 
as a white solid (89 mg, 99%). 1H NMR (300 MHz, CDCl3) δ = 0.94-1.00 (m, 12H), 1.42 (d,  
J = 7.0 Hz, 12H), 3.07 (d, J = 12.3 Hz, 1H), 3.38 (sept, J = 7.0 Hz, 2H), 3.82-3.93 (m, 1H), 
4.07-4.22 (m, 3H), 4.97-5.06 (m, 1H), 5.64-5.80 (m, 1H), 7.52-7.68 (m, 6H), 7.85-7.99 (m, 
2H), 7.99-8.12 ppm (m, 2H). 31P NMR (121 MHz, CDCl3) δ = 26.94 ppm. 13C NMR  
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(100 MHz, CDCl3) δ = 21.1, 21.2, 21.4, 53.6 (d, J = 122.0 Hz), 58.9, 77.2, 81.2 (d,  
J = 31.6 Hz), 100.3 (d, J = 23.1 Hz), 118.0 (d, J = 5.4 Hz), 127.9 (dd, J = 45.9 Hz,  
J = 24.6 Hz), 129.8 (t, J = 11.3 Hz), 132.5 (dd, J = 6.2 Hz, J = 2.2 Hz), 135.2 (d, J = 15.9 Hz), 
138.9 ppm (d, J = 8.0 Hz). IR. (neat) ν =  699, 756, 1036, 1372, 1435, 1552, 1864, 2977 cm-1. 
HRMS calcd. for C30H43N2ClPPd+: 603.189045; found 603.189620. 
 
Compound 48c 
 
 
 
To a cooled (-20 oC) solid mixture of allyl palladium chloride dimer (17.6 mg, 0.05 mmol) 
and compound 43e (52.0 mg, 0.10 mmol) a dry THF (4 mL) was added and the solution 
stirred at this temperature for 30 min. The solvent was removed in vacuo, affording the 
desired product as a pale yellow solid (69 mg, 99%). 1H NMR (400 MHz, CD2Cl2) δ =  
0.85-0.93 (m, 12H), 1.30 (d, J = 7.0 Hz, 12H), 3.00 (d, J = 12.0 Hz, 1H), 3.34 (sept,  
J = 7.0 Hz, 2H), 3.72-3.81 (m, 1H), 3.98-4.10 (m, 3H), 4.84-4.92 (m, 1H), 5.60-5.73 (m, 1H), 
7.17-7.28 (m, 4H), 7.73-7.82 (m, 2H), 7.86-7.95 ppm (m, 2H). 31P NMR (161 MHz, CD2Cl2) 
δ = 25.49 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 21.6, 21.6, 22.0, 55.1 (br.s), 60.6, 81.9 (d,  
J = 32.3 Hz), 101.1 (d, J = 21.3 Hz), 118.0 (ddd, J = 21.3 Hz, J = 13.1 Hz, J = 7.5 Hz), 119.4 
(d, J = 5.2 Hz), 124.5 (dd, J = 48.7 Hz, J = 22.8 Hz), 138.4 (m), 139.3 (d, J = 7.7 Hz), 166.2 
ppm (dd, J = 255.6 Hz, J = 5.3 Hz). IR. (neat) ν =  674, 844, 1031, 1230, 1359, 1548, 1854, 
2987 cm-1. HRMS calcd. for C30H41N2ClF2PPd+: 639.170431; found 639.170937. 
 
Compound 49 
 
 
 
To a suspension of phosphenium salt 43a (51 mg, 0.1 mmol) in dry THF a BH3·THF solution 
(1M, 0.2 mL, 0.2 mmol) was added and the reaction mixture was stirred at room temperature 
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for 3h. The solvent was removed in vacuo, the residue washed with Et2O (3 × 8 mL) and dried 
in vacuo. The product was obtained as a white solid (45 mg, 85%). 1H NMR (400 MHz, 
CD2Cl2) δ = 0.88 (d, J = 6.9 Hz, 12H), 1.29-1.45(m, 15H), 3.42 (sept, J = 6.9 Hz, 2H), 4.04 
(sept, J = 6.9 Hz, 2H), 7.49-7.61 (m, 6H), 7.82-7.90 ppm (m, 4H). 31P NMR (161 MHz, 
CD2Cl2) δ = 14.97 ppm. 11B (128 MHz, CD2Cl2) δ = -1.16, -37.80 (br.s). 13C NMR (75 MHz, 
CD2Cl2) δ = 20.9, 22.1, 53.3 (br.s), 99.3 (d, J = 38.3 Hz), 125.6 (d, J = 60.7 Hz), 130.6 (d,  
J = 11.0 Hz), 134.2 (d, J = 2.5 Hz), 134.5 (d, J = 11.0 Hz), 138.8 ppm (d, J = 8.1 Hz). IR 
(neat) ν = 701, 741, 1048, 1558, 1866, 2378, 2973 cm-1. 
 
Compound 50 
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The mixture of phosphenium salt 43a (60 mg, 0.118 mmol), RhCl3(H2O)3 (12.3 mg, 0.059 
mmol) and Et4NCl (10.0 mg, 0.059 mmol) in ethanol (2.5 mL) was refluxed for 3 h. The 
solvent was removed in vacuo and the residue was purified by column chromatography (4:1 
DCM : Acetone). The product was isolated from the first fraction as a dark-yellow solid  
(66.0 mg, 96%). 1H NMR (300 MHz, CD2Cl2) δ = 1.03 (d, J = 6.6 Hz, 24H), 1.37 (d,  
J = 6.6 Hz, 24H), 3.83 (sept, J = 6.6 Hz, 4H), 4.00-4.18 (m, 4H), 7.26-7.39 (m, 12H),  
8.27-8.37 ppm (m, 8H). 31P NMR (121 MHz, CD2Cl2) δ = 16.67 ppm (d, J = 94.7 Hz).  
13C NMR (100 MHz, CD2Cl2) δ = 21.2, 21.6, 58.1, 100.5 (t, J = 13.4 Hz), 127.4 (t,  
J = 5.4 Hz), 129.0 (t, J = 26.3 Hz), 130.2, 134,2 (t, J = 5.5 Hz), 140.1 ppm (t, J = 3.5 Hz).  
IR (neat) ν = 697, 1055, 1435, 1538, 1873, 2980 cm-1. HRMS calcd. for C54H76Cl4N4P2Rh+: 
1085.334184; found 1085.334199. 
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Compound 53 
 
 
 
To a cooled (0 ºC) suspension of NaH (260 mg, 10.8 mmol) in dry THF (75 mL) dimethyl 
malonate 51 (1.4 mL, 11.9 mmol) was added dropwise and the mixture stirred for 30 min. 
Cinnamyl bromide 52 (1.6 mL, 10.8 mmol) was added dropwise and the solution was stirred 
overnight at room temperature. The reaction was quenched with sat. aq. NH4Cl (75 mL). The 
aqueous layer was extracted with MTBE (3 × 75 mL) and the combined organic layers were 
washed with brine (2 × 25 mL) and dried over Na2SO4, filtered and concentrated in vacuo. 
The crude oil was purified by flash column chromatography (1:9 MTBE : hexane) to give the 
monoallylmalonate as transparent oil from the second fraction (2.02 g, 75%). 1H NMR  
(400 MHz, CDCl3) δ = 2.81 (dt, J = 7.4 Hz, J = 1.2 Hz, 2H), 3.54 (t, J = 7.6 Hz, 1H), 3.74 (s, 
6H), 6.14 (dt, J = 15.7 Hz, J = 7.2 Hz, 1H), 6.48 (d, J = 15.7 Hz, 1H), 7.19-7.35 ppm (m, 5H). 
13C NMR (100 MHz, CDCl3) δ = 32.2, 51.7, 52.5, 125.3, 126.2, 127.4, 128.4, 132.9, 136.9, 
169.2 ppm; The spectroscopic data were consistent with the previously published values.54 
 
Compound 54 
 
 
 
Methanesulfonyl chloride (0.95 mL, 12.1 mmol) was added dropwise via syringe to a cooled 
(0 °C) solution of 4-methyl-2,3-pentadien-1-ol 59 (0.99 g, 10.1 mmol), 4-(dimethylamino)-
pyridine (124 mg, 1.01 mmol) and triethylamine (2.1 mL, 15.1 mmol) in dry DCM (50 mL), 
and the resulting mixture was stirred for 1 h at 0 °C. After that water (20 mL) was added to 
the reaction mixture and the aqueous layer was extracted with DCM (3 × 25 mL). The 
combined organic layers with ca. 10g crushed ice were washed with aq. HCl (1M,  
1 × 50 mL), sat. aq. NaHCO3 (2 × 50) mL and brine (2 × 50 mL), dried over anhydrous 
Na2SO4 and filtered. Removal of the volatile material in vacuo gave 4-methyl-2,3-pentadienyl 
methanesulfonate 54 as orange oil (1.58 g, 89%). The crude mesylate was used in the next 
step without further purification. 1H NMR (400 MHz, CDCl3) δ = 1.72 (d, J = 2.8 Hz, 6H), 
3.02 (s, 3H), 4.68 (d, J = 7.3 Hz, 2H), 5.13-5.21 ppm (m, 1H). 13C NMR (100 MHz, CDCl3)  
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δ = 20.0, 31.5, 38.3, 69.5, 83.7, 98.2, 204.6 ppm; The spectroscopic data were consistent with 
the previously published values.58 
 
Compound 55 
 
 
 
Dimethyl-2-cinnamylmalonate 53 (900 mg, 3.6 mmol) was added dropwise to a cooled (0 ºC) 
suspension of NaH (96 mg, 4.0 mmol) in dry THF (50 mL). After 30 min, a solution of 
allenyl mesylate 54 (828 mg, 4.7 mmol) in dry THF (15 mL) was added dropwise, followed 
by the addition of NaI (706 mg, 4.7 mmol) in one portion. The formed yellow suspension was 
stirred overnight at room temperature. The reaction mixture was quenched with sat. aq. 
NH4Cl (50 mL). The aqueous layer was extracted with Et2O (3 × 25 mL) and the combined 
organic layers were washed with brine (3 × 50 mL), dried over Na2SO4, filtered and 
evaporated. The crude oil was purified by column chromatography (1:9 MTBE : hexane) to 
give the desired product (1.0 g, 84%). 1H NMR (400 MHz, CDCl3) δ = 1.67 (s, 3H), 1.68 (s, 
3H), 2.60 (d, J = 7.6 Hz, 2H), 2.85 (dd, J = 7.6 Hz, J = 1.3 Hz, 2H), 3.73 (s, 6H), 4.78-4.85 
(m, 1H), 6.03 (dt, J = 15.5 Hz, J = 7.7 Hz, 1H), 6.44 (d, J = 15.5 Hz, 1H), 7.18-7.33 ppm (m, 
5H). 13C NMR (100 MHz, CDCl3) δ = 20.5, 32.9, 36.0, 52.4, 58.2, 82.7, 95.2, 124.0, 126.2, 
127.4, 128.5, 133.9, 137.1, 171.2, 203.8 ppm. The spectroscopic data were consistent with the 
previously published values.54 
 
Compound 57 
 
 
 
2-Methylbut-3-yne-2-ol (6.0 mL, 60 mmol) and 3,4-dihydro-2H-pyran (22.6 mL, 240 mmol) 
were added to a stirred solution of PPTS (0.77 g, 3.0 mmol) in DCM (30 mL). The reaction 
mixture was stirred at room temperature for 16 h and then concentrated under reduced 
pressure. The residue was dissolved in Et2O (50 mL) and washed with water (25 mL). The 
organic phase was dried over Na2SO4, filtered and concentrated in vacuo. After vacuum 
distillation (85 °C, 13.4 mbar) the desired product was obtained as transparent liquid (9.31 g, 
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92%). 1H NMR (400 MHz, CDCl3) δ = 1.44-1.60 (m, 10H), 1.66-1.76 (m, 1H), 2.43 (s, 1H), 
1.78-1.89 (m, 1H), 3.54-3.47 (m, 1H), 3.95 (ddd, J = 10.3 Hz, J = 5.9 Hz, J = 4.3 Hz, 1H), 
5.06 ppm (dd, J = 5.4, 3.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ = 20.4, 25.3, 29.8, 30.6, 
31.9, 63.3, 70.8, 71.8, 86.4, 96.1 ppm. The spectroscopic data were consistent with the 
previously published values.55 
 
Compound 58 
 
 
 
n-BuLi (1.6 M in hexane, 45.0 mL, 71.9 mmol) was added dropwise over 30 min to a cooled 
(-78 °C) solution of 2-(2-methylbut-3-yne-2-yloxy)tetrahydro-2H-pyran 57 (9.31 g, 55.3 
mmol) in dry THF (150 mL). The mixture was allowed to warm to 0 oC and HMPA  
(12.0 mL, 65.6 mmol) and paraformaldehyde (3.32 g, 110.6 mmol) were added. The reaction 
mixture was stirred at room temperature for 2 h, and then quenched by a phosphate buffer 
solution (pH 6.9, 25 mL). The mixture was extracted with Et2O (3 × 70 mL). The combined 
organic layer was washed with water (1M, 2 × 60 mL), dried over anhydrous Na2SO4 and 
filtered. After concentration and vacuum distillation (100 oC, 2.4 mbar) the desired product 
was obtained as transparent liquid (9.76 g, 89%). 1H NMR (400 MHz, CDCl3) δ = 1.47-1.54 
(m, 9H), 1.64-1.95 (m, 4H), 3.45-3.56 (m, 1H), 3.90-3.98 (m, 1H), 4.26-4.31 (m, 2H),  
5.02-5.08 ppm (m, 1H). 13C NMR (100 MHz, CDCl3) δ = 20.2, 25.4, 29.9, 30.5, 31.9, 51.1, 
63.1, 70.9, 82.2, 88.1, 95.8 ppm. The spectroscopic data were consistent with the previously 
published values.56 
 
Compound 59 
 
 
 
A solution of 4-methyl-4-(tetrahydropyran-2-yloxy)pent-2-yn-1-ol (9.76 g, 49.2 mmol) in dry 
Et2O (30 mL) was added dropwise over 30 min to a cooled (0 °C) suspension of LiAlH4  
(4.67 g, 123 mmol) in dry Et2O (120 mL). After being stirred at room temperature for 3 h, the 
reaction was quenched by addition of a mixture of Celite and sodium sulfate decahydrate  
(v/v = 1/1), and the mixture was filtered. The solvent was removed and the residue was 
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distilled under reduced pressure (35 oC, 2.4 mbar) to give pure methylpenta-2,3-dien-1-ol 59 
as transparent oil (3.27 g, 67%). 1H NMR (400 MHz, CDCl3) δ = 1.65-1.75 (br.s, 1H), 1.70 
(d, J = 3.2 Hz, 6H), 4.07 (d, J = 5.6 Hz, 2H), 5.16-5.22 ppm (m, 1H). 13C NMR (100 MHz, 
CDCl3) δ = 15.2, 20.6, 60.9, 65.8, 89.9, 200.5 ppm. The spectroscopic data were consistent 
with the previously published values.57 
 
Compounds 62 and 65a 
 
 
 
A mixture of gold catalyst 46a (4.3 mg, 5.8 µmol) and AgBF4 (1.1 mg, 5.8 µmol) in dry DCM 
(0.5 mL) was stirred at room temperature for 10 min. Then a solution of ene-allene 55 (38 mg, 
116 µmol) in dry DCM (1.0 mL) was added to the reaction mixture. The reaction was stirred 
at room temperature and monitored by TLC analysis and GC-MS. Upon completion (2 h), the 
mixture was filtered through a short silica plug and eluted with DCM. Evaporation of the 
filtrate afforded the mixture of isomeric cycloadducts 62 and 65a as transparent oil (30 mg, 
78%). The ratio of the isomers was determined by 1H NMR spectroscopy as 62:65a = 97:3. 
The isomers were separated by flash column chromatography (2:1 DCM : Hexane). 
Compound 62 was isolated as major product. 1H NMR (400 MHz, CDCl3)  
δ = 1.29 (s, 3H), 1.60 (s, 3H), 2.22 (dd, J = 13.7 Hz, J = 8.8 Hz, 1H), 2.34 (dd, J = 13.3 Hz,  
J = 7.7 Hz, 1H), 2.57-2.63 (m, 1H), 2.71 (d, J = 13.4 Hz, 1H), 2.77 (dd, J = 13.8 Hz,  
J = 1.6 Hz, 1H), 3.71 (s, 3H), 3.55-3.62 (m, 1H), 3.67-3.70 (m, 1H), 3.72 (s, 3H), 7.14-7.20 
(m, 3H), 7.25-7.32 ppm (m, 2H). 13C NMR (100 MHz, CDCl3) δ = 18.8, 18.8, 39.0, 40.1, 
44.4, 44.6, 51.8, 52.4, 52.8, 62.6, 125.7, 127.0, 128.4, 129.2, 134.0, 144.9, 172.0, 172.8 ppm. 
 
Compound 65a was isolated as minor product. 1H NMR (400 MHz, CDCl3) δ = 1.37 (s, 3H), 
1.64 (s, 3H), 2.11 (dd, J = 13.2 Hz, J = 4.8 Hz, 1H), 2.19 (dd, J = 12.8 Hz, J = 6.3 Hz, 1H), 
2.49 (ddd, J = 12.5 Hz, J = 8.8 Hz, J = 1.0 Hz, 1H), 2.46 (ddd, J = 12.8, J = 8.4 Hz,  
J = 1.0 Hz, 1H), 2.54 (tdd, J = 8.3 Hz, J = 7.2 Hz, 2.0 Hz, 1H), 3.29-3.37 (m, 2H), 3.69 (s, 
3H), 3.69 (s, 3H), 7.05 (d, J = 7.0 Hz, 2H), 7.17 (tt, J = 7.8 Hz, J = 1.4 Hz, 1H), 7.26 ppm (t,  
J = 7.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ = 12.3, 12.6, 38.7, 41.8, 49.0, 52.4, 52.7, 
53.7, 61.2, 63.5, 126.0, 127.3, 128.4, 133.6, 134.0, 146.1, 171.9, 172.6 ppm. The 
spectroscopic data were consistent with the previously published values.54 
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Compound 68 
 
 
 
(E)-dimethyl-2-(penta-2,4-dienyl)malonate 73 (308 mg, 1.6 mmol) solution in dry THF  
(5 mL) was added dropwise to a cooled (0 ºC) suspension of NaH (41 mg, 1.7 mmol) in dry 
THF (10 mL). After 30 min, a solution of allenyl mesylate 54 (336 mg, 2.0 mmol) in dry THF  
(5 mL) was added dropwise, followed by the addition of NaI (303 mg, 2.0 mmol) in one 
portion. The formed suspension was stirred overnight at room temperature. The reaction 
mixture was quenched with sat. aq. NaHCO3 (30 mL). The aqueous layer was extracted with 
EtOAc (3 × 20 mL), the organic phases dried over Na2SO4, filtered and evaporated. The crude 
oil was purified by column chromatography (1:15 EtOAc : hexane) to give the desired 
product (324 mg, 75%). 1H NMR (400 MHz, CDCl3) δ = 1.65 (s, 3H), 1.66 (s, 3H), 2.54 (d,  
J = 7.6 Hz, 2H), 2.72 (d, J = 7.6 Hz, 2H), 3.71 (s, 6H), 4.72-4.80 (m, 1H), 5.00 (d,  
J = 10.0 Hz, 1H), 5.51 (dt, J = 15.2 Hz, J = 7.6 Hz, 1H), 5.11 (d, J = 16.8 Hz, 1H), 6.09 (dd,  
J = 15.0 Hz, J = 10.4 Hz, 1H), 6.27 ppm (dt, J = 16.9 Hz, J = 10.3 Hz, 1H). 13C NMR  
(100 MHz, CDCl3) δ = 20.5, 32.8, 35.5, 52.4, 58.1, 82.6, 95.2, 116.4, 128.0, 135.0, 136.7, 
171.2, 203.8 ppm. The spectroscopic data were consistent with the previously published 
values.103 
 
Compounds 70 and 71 
 
 
 
A mixture of gold catalyst 133 (2.1 mg, 2 µmol) and AgBF4 (0.4 mg, 2 µmol) in dry DCM 
(0.5 mL) was stirred at room temperature for 10 min. Then, the solution was filtered and 
added to a stirred solution of (E)-dimethyl 2-(4-methylpenta-2,3-dienyl)-2-(penta-2,4-
dienyl)malonate 68 (29 mg, 104 µmol) in dry DCM (1.0 mL). The reaction was stirred at 
room temperature and monitored by GC-MS analysis. Upon completion (after 1.5 h), the 
mixture was filtered through a short silica plug and eluted with DCM (2 × 2 mL). The filtrate 
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was evaporated and the obtained residue was subjected to column chromatography (1:10 
EtOAc:hexane) to afford the mixture of desired isomers 70 and 71 as transparent oils (25 mg, 
86%). The ratio of the isomers was determined by 1H NMR spectroscopy as 70:71 = 97:3.  
Compound 70:1H NMR (400 MHz, CDCl3) δ = 1.64 (s, 3H), 1.78 (s, 3H), 2.13-2.26 (m, 3H), 
2.65 (dd, J = 12.8 Hz, J = 6.4 Hz, 1H), 2.74 (d, J = 20.1 Hz, 1H), 2.85 (d, J = 19.7 Hz, 1H), 
2.99 (d, J = 7.6 Hz, 1H), 3.69-3.72 (m, 1H), 3.72 (s, 3H), 3.73 (s, 3H), 5.69-5.76 (m, 1H), 
5.83 ppm (d, J = 9.2 Hz, 1H).13C NMR (100 MHz, CDCl3) δ = 21.8, 21.9, 31.4, 37.4, 39.8, 
44.2, 48.2, 52.7, 52.7, 58.4, 123.9, 127.9, 127.9, 129.1, 173.2, 173.3 ppm. 
 
Compound 71: 1H NMR (400 MHz, CDCl3) δ = 0.95 (s, 3H), 1.00 (s, 3H), 1.83-1.89 (m, 1H), 
2.07 (dd, J = 12.6 Hz, J = 11.1 Hz, 1H), 2.48 (dd, J = 14.9 Hz, J = 4.0 Hz, 1H), 2.60 (dddd,  
J = 12.6 Hz, J = 8.3 Hz, J = 1.3 Hz, J = 0.3 Hz, 1H), 2.88 (dt, J = 16.5 Hz, J = 2.3 Hz, 1H), 
2.99 (dq, J = 16.4 Hz, J = 1.6 Hz, 1H), 3.49-3.57 (m, 1H), 3.71 (s, 3H), 3.74 (s, 3H),  
5.15-5.19 (m, 1H), 5.67-5.76 (m, 2H). 13C NMR (100 MHz, CDCl3) δ = 28.6, 31.5, 34.3, 39.0, 
39.1, 41.0, 41.9, 52.7, 52.8, 58.2, 129.1, 132.5, 135.0, 136.5, 172.0, 172.2. The spectroscopic 
data were consistent with the previously published values.104 
 
Compound 72 
 
 
 
Phosphorus tribromide (1.03 mL, 10.9 mmol) was added to a cooled (0 °C) solution of  
(E)-penta-2,4-dien-1-ol (0.91 g, 10.9 mmol) in dry Et2O (20 mL). After stirring at 0 °C for  
1 h, water (10 mL) was carefully added. The layers were separated, the aqueous layer 
extracted with Et2O (3 × 20 mL). The combined organic layers were washed with water  
(1 × 20 mL), NaHCO3 (1 × 20 mL) and brine (1 × 20 mL), dried over Na2SO4, filtered and 
carefully concentrated under reduced pressure, using an ice bath, to afford bromide 72 as a 
pale yellow liquid (1.48 g, 93%). 1H NMR (300 MHz, CDCl3) δ = 4.04 (d, J = 7.9 Hz, 2H), 
5.15 (d, J = 10.2 Hz, 1H), 5.26 (d, J = 16.2 Hz, 1H), 5.83 (dt, J = 13.9 Hz, J = 7.9 Hz, 1H),  
6.23-6.39 ppm (m, 2H). 13C NMR (75 MHz, CDCl3) δ = 32.8, 119.4, 129.1, 135.2, 135.5 
ppm. The spectroscopic data were consistent with the previously published values.62 
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Compound 73 
 
 
 
Dimethyl malonate 51 (0.53 mL, 4.5 mmol) was added dropwise to a cooled (0 ºC) 
suspension of NaH (98 mg, 4.1 mmol) in dry THF (30 mL) and the mixture stirred for 30 min. 
The solution of dienyl bromide 72 (60 mg, 4.1 mmol) was added dropwise. The obtained 
mixture was stirred overnight at room temperature and then quenched with sat. aq. NH4Cl (30 
mL). Aqueous layer was extracted with MTBE (3 × 30 mL) and combined organic layers 
were washed with brine (2 × 20 mL) and dried over Na2SO4, filtered and concentrated in 
vacuo. The crude oil was purified by flash column chromatography (1:9 MTBE : hexane) to 
give the monoallylmalonate as transparent oil from the second fraction (372 mg, 46%).  
1H NMR (400 MHz, CDCl3) δ = 2.68 (t, J = 7.3 Hz, 2H), 3.45 (t, J = 7.6 Hz, 1H), 3.74 (s, 
3H), 3.74 (s, 3H), 5.02 (d, J = 10.1 Hz, 1H), 5.14 (d, J = 16.9 Hz, 1H), 5.62 (dt, J = 15.7 Hz,  
J = 7.4 Hz, 1H), 6.12 (dd, J = 14.9 Hz, J = 10.6 Hz, 1H), 6.27 ppm (dd, J = 17.0 Hz,  
J = 10.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ = 31.8, 51.6, 52.6, 116.6, 129.3, 133.8, 
136.5, 169.2 ppm. The spectroscopic data were consistent with the previously published 
values.61 
 
Compound 75 
 
 
 
(E)-1,4-pentadienoic acid 74 (2.94 g, 30 mmol) was added to a cooled (-78 °C) suspension of 
LiAlH4 (2.28 g, 60 mmol) in dry Et2O (200 mL). The reaction mixture was stirred at -78 °C 
for 30 min, then allowed to warm to 0 °C and stirred for 2 h at that temperature, then allowed 
to warm to room temperature and stirred overnight. The reaction was quenched with water  
(10 mL), the precipitate was filtered, the filtrate was dried over Na2SO4 and concentrated 
under reduced pressure obtaining the product as transparent liquid (2.48 g, 98%). 1H NMR 
(400 MHz, CDCl3) δ = 4.16 (d, J = 5.7 Hz, 2H), 5.07 (dd, J = 10.1 Hz, J = 1.7 Hz, 1H), 5.19 
(dd, J = 17.0 Hz, J = 1.7 Hz, 1H), 5.88 (dt, J = 15.2 Hz, J = 5.7 Hz, 1H), 6.22-6.38 ppm (m, 
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2H). 13C NMR (100 MHz, CDCl3) δ = 62.9, 117.3, 131.6, 132.7, 136.3 ppm. The 
spectroscopic data were consistent with the previously published values.61 
 
Compound 78 
 
 
 
Catalyst 47a (6.3 mg, 0.006 mmol) was added to a stirred solution of alkynylated 
phenylpyrrole 76 (58 mg, 0.32 mmol) in dry DCM (2.0 mL). The reaction mixture was stirred 
at room temperature for 5 h. Solvent was removed in vacuo and after column chromatography 
(1:20 EtOAc : hexane) the desired pyrrolo[1,2-a]quinoline 78 was isolated (57 mg, 98%).  
1H NMR (400 MHz, CDCl3) δ = 2.47 (s, 3H), 6.57 (dd, J = 3.8 Hz, J = 1.4 Hz, 1H), 6.82 (dd,  
J = 3.7 Hz, J = 3 Hz, 1H), 6.87 (s, 1H), 7.35 (dt, J = 7.9 Hz, J = 1 Hz, 1H), 7.50 (dt,  
J = 7.3 Hz, J = 1.4 Hz, 1H), 7.65 (dd, J = 7.8 Hz, J = 1.3 Hz, 1H), 7.91 ppm (m, 2H). 
13CNMR (100 MHz, CDCl3) δ = 18.7, 101.9, 113.0, 113.1, 114.7, 118.0, 124.2, 125.1, 127.5, 
128.5, 132.7 ppm. The spectroscopic data were consistent with the previously published 
values.63 
 
Compound 80 
 
 
 
tert-Butyllithium (1.7 M in pentane, 8.4 mL, 14.2 mmol) was added dropwise to a cooled  
(-78 ºC) solution of 3,4-dihydro-2H-pyran (1.84 g, 21.6 mmol) in Et2O (15 mL) and the 
mixture was stirred for 1 h, then was allowed to warm to 0 ºC and stirred for 3 h. The mixture 
was cooled to -78 ºC and benzophenone (2.59 g, 14.2 mmol) was added. The reaction mixture 
was allowed to warm to room temperature and stirred overnight. Saturated aqueous NH4Cl 
(20 mL) was added to the reaction mixture followed by extraction with Et2O  
(4 × 30 mL). The combined organic extracts were washed with brine (4 × 30 mL) and dried 
over Na2SO4 and concentrated in vacuo. The product was isolated after column 
chromatography (1:9 MTBE : hexane) as white solid (2.88 g, 76%). 1H NMR (CD2Cl2,  
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300 MHz) δ = 1.71-1.81 (m, 2H), 1.93-2.01 (m, 2H), 3.34 (s, 1H), 3.94-4.00 (m, 2H), 4.29 (t, 
J = 3.8 Hz, 1H), 7.12-7.26 (m, 6H), 7.27-7.33 ppm (m, 4H). 13C NMR (CD2Cl2, 75 MHz)  
δ = 21.0, 22.9, 67.5, 81.3, 102.2, 127.9, 128.4, 128.5, 145.4, 156.4 ppm. IR (neat) ν = 746, 
890, 1019, 1061, 1153, 1446, 1665, 3446 cm-1. HRMS calcd. for C18H18O2Na+: 289.119897; 
found: 289.119790. 
 
Compounds 81 and 82 
 
 
 
A mixture of the gold compound 46a (5.0 mg, 0.007 mmol) and AgBF4 (1.3 mg,  
0.007 mmol) in dry DCM (1.0 mL) was stirred at room temperature for 10 min and then the 
precipitate was filtered off. The filtrate was added to a stirred solution of alcohol 80 (36.0 mg, 
0.140 mmol) in dry DCM (1 mL) and stirred at room temperature overnight. After 
evaporation of the solvent the two isomeric products were separated by column 
chromatography (9:1 Hex : MTBE). The isomer 82 was isolated from the first fraction  
(27 mg, 79% yield). 1H NMR (400 MHz, CDCl3) δ = 1.98-2.07 (m, 2H), 2.41-2.55 (m, 2H), 
4.12-4.24 (m, 2H), 4.41-4.45 (m, 1H), 6.95-7.00 (m, 1H), 7.04-7.09 (m, 2H), 7.11-7.15 (m, 
2H), 7.18-7.25 (m, 2H), 7.26-7.31 ppm (m, 2H). 13C NMR (100 MHz, CDCl3) δ = 18.4, 22.2, 
53.4, 68.2, 111.2, 116.4, 123.0, 123.4, 126.9, 127.0, 128.1, 128.7, 138.7, 141.4, 144.4, 161.8 
ppm. IR (neat) ν = 697, 947, 1050, 1281, 1454, 1639, 2925 cm-1. HRMS calcd. for C18H16O: 
248.120116; found: 248.120154. 
 
The minor isomer 81 was isolated from the second fraction (3.0 mg, 9%) 1H NMR  
(400 MHz, CD2Cl2) δ = 1.32-1.43 (m, 1H), 1.74-1.83 (m, 1H), 1.98-2.11 (m, 1H), 2.49-2.59 
(m, 1H), 3.25 (dd, J = 12.4 Hz, J = 6.6 Hz, 1H), 3.81 (dt, J = 10.7 Hz, J = 3.4 Hz, 1H),  
4.23-4.31 (m, 1H), 7.03 (dt, J = 7.3 Hz, J = 1.0 Hz, 1H), 7.13-7.18 (m, 1H), 7.19-7.24 (m, 
1H), 7.25-7.28 (m, 1H), 7.32-7.38 (m, 3H), 7.51-7.54 ppm (m, 2H). 13C NMR (100 MHz, 
CD2Cl2) δ = 25.2, 26.7, 44.1, 71.3, 94.7, 119.5, 123.0, 123.9, 127.3, 127.5, 129.0, 129.3, 
134.2, 141.9, 144.3, 162.3 ppm. 
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Compound 88 
 
O
O
Me
 
 
A solution of n-BuLi in hexane (1.6 M, 82.2 mL, 131.5 mmol) was added dropwise over  
10 min to a cooled (0 ºC) solution of diisopropylamine (18.6 mL, 131.5 mmol) in dry THF 
(200 mL). The resulting solution was cooled to -78 ºC and stirred for 30 min. Then a solution 
of δ-valerolactone (10.0 mL, 107.8 mmol) and HMPA (23.1 mL, 131.5 mmol) in dry THF 
(100 mL) was added dropwise over 10 min and the reaction mixture was stirred at this 
temperature for 1 h. Methyl iodide (7.1 mL, 113.2 mmol) was added dropwise over 5 min and 
the resulting mixture was stirred for 2 h at -78 ºC. The reaction was quenched with sat. aq. 
NH4Cl solution (200 mL) and heated to room temperature. The organic layer was separated; 
the water layer was extracted with Et2O (3 × 200 mL) and the combined organic layers were 
dried over Na2SO4. After evaporation of the solvent, the residue was purified by column 
chromatography (1:1 Et2O : pentane) to give the desired product (9.96 g, 81%). 1H NMR  
(300 MHz, CDCl3) δ = 1.28 (d, J = 6.9 Hz, 3H), 1.49-1.64 (m, 1H), 1.85-1.98 (m, 2H),  
2.04-2.19 (m, 1H), 2.52-2.68 (m, 1H), 4.30-4.37 ppm (m, 2H). The spectroscopic data were 
consistent with the previously published values.66 
 
Compound 89 
 
O
OH
Me
 
 
A solution of diisobutylaluminium hydride in hexane (1.0 M, 7.7 mL, 7.7 mmol) was added 
dropwise over 7 min to a cooled (-78 ºC) stirred solution of α-methyl-δ-valerolactone 88  
(0.80 g, 7.0 mmol) in dry DCM (20 mL). The mixture was stirred for 30 min and then 
quenched with EtOAc (3 mL). The mixture was warmed to room temperature and then poured 
into a solution of sat. aq. Na-K tartrate (250 mL). The resulting mixture was vigorously stirred 
until both (aqueous and organic) layers were clear (2 h). The layers were separated, and the 
aqueous layer was extracted with DCM (4 × 100 mL). The combined organic layers were 
dried over Na2SO4, filtered, concentrated and purified by flash column chromatography (1:1 
Et2O : pentane) affording the desired product as mixture of diastereomers in ratio 0.3:0.7 
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(0.80 g, 99%). 1H NMR (300 MHz, CDCl3) δ = 0.95 (d, J = 6.9 Hz, 0.9H), 1.00 (d,  
J = 6.7 Hz, 2.1H), 1.19-1.28 (m, 2H), 1.42-1.66 (m, 2H), 1.79-1.90 (m, 1H), 2.39-2.62 (m, 
0.3H), 2.76-2.99 (m, 0.7H), 3.45-3.57 (m, 1H), 3.89-4.06 (m, 1H), 4.35 (d, J = 7.7 Hz, 0.7H) 
5.00 ppm (d, J = 3.0 Hz, 0.3H). The spectroscopic data were consistent with the previously 
published values.66 
 
Compound 90a 
 
 
 
Heating a mixture of δ-lactol 89 (2.06 g, 17.8 mmol) and phosphorus pentoxide (0.02 g) in a 
short-path distillation apparatus afforded a distillate that was dried (K2CO3) and redistilled 
(100 oC, 200 mbar), yielding 2-methyl-3,4-dihydro-2H-pyran 90a (0.91 g, 52%). 1H NMR 
(300 MHz, CDCl3) δ = 1.55-1.57 (m, 3H), 1.82-1.98 (m, 4H), 3.86-3.92 (m, 2H), 6.21-6.24 
ppm (m, 1H). 13C NMR (75 MHz, CDCl3) δ = 19.1, 23.0, 25.5, 65.4, 109.1, 138.9 ppm. The 
spectroscopic data were consistent with the previously published values.67 
 
Compound 90b 
 
 
 
The mixture of δ-lactol 95 (0.68 g, 3.8 mmol) and phosphorus pentoxide (7.0 mg) in toluene 
(30 mL) was heated at 105 oC for 30 min. The sat. aq. NaHCO3 (30 mL) was added, the 
organic layer was separated, the water layer was extracted with EtOAc (3 × 30 mL), the 
combined organic layers were dried over Na2SO4 and evaporated. The product was purified 
by column chromatography (5:1 hexane : EtOAc), yielding 2-phenyl-3,4-dihydro-2H-pyran 
90b (0.44 g, 72%). 1H NMR (300 MHz, CDCl3) δ = 1.98-2.08 (m, 2H), 2.41-2.48 (m, 2H), 
4.05 (t, J = 5.2 Hz, 2H), 6.96 (s, 1H), 7.15-7.40 ppm (m, 5H). 13C NMR (100 MHz, CDCl3)  
δ = 23.1, 23.2, 66.4, 113.7, 124.7, 126.5, 129.1, 140.5, 142.8 ppm. IR (neat) ν = 698, 755, 
1067, 1448, 1722, 2930 cm-1. 
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Compound 94 
 
 
 
A solution of n-HexLi in hexane (2.47 M, 20.8 mL, 51.4 mmol) was added dropwise over  
15 min to a cooled (-60 ºC) solution of phenylacetic acid (3.5 g, 25.7 mmol) in dry THF  
(100 mL). The reaction mixture was warmed to 0 ºC and stirred for 2 h. 1-Bromo-3-
chloropropane (2.8 mL, 28.3 mmol) was added to a reaction mixture, the mixture was allowed 
to warm to room temperature and stirred for 18 h. The reaction was quenched with NaOH 
(1N, 50 mL). The aqueous layer was separated; the organic layer was extracted with NaOH 
(1N, 50 mL). The combined aqueous cuts were re-acidified with HCl (1N, 130 mL) and 
extracted with EtOAc (2 × 60 mL). The organic phase was washed with water (50 mL) and 
concentrated in vacuo to give oil that contains intermediate 93. The oil was redissolved in 
THF (50 mL), treated with DBU (3.9 mL, 25.7 mmol) and heated at 60 oC for 18 h. The 
resultant slurry was cooled to room temperature, diluted with EtOAc (50 mL), filtered, the 
residue was washed with EtOAc (2 × 25 mL). The combined filtrates were concentrated in 
vacuo (at or below 25 oC). The product was purified by flash column chromatography (1:3 
hexane : EtOAc) yielding the desired lactone 94 (4.00 g, 88%). 1H NMR (300 MHz, CDCl3)  
δ = 1.95-2.19 (m, 3H), 2.26-2.39 (m, 1H), 3.76-3.85 (m, 1H), 4.41-4.55 (m, 2H), 7.23-7.42 
ppm (m, 5H). 13C NMR (75 MHz, CDCl3) δ = 22.4, 28.6, 47.5, 69.6, 127.7, 128.6, 129.1, 
139.3, 172.8 ppm. The spectroscopic data were consistent with the previously published 
values.68 
 
Compound 95 
 
 
 
A solution of diisobutylaluminium hydride in hexane (1.0 M, 25.0 mL, 25.0 mmol) was added 
dropwise over 10 min to a cooled (-78 ºC) stirred solution of α-phenyl-δ-valerolactone 94  
(4.0 g, 22.7 mmol) in dry DCM (50 mL). The mixture was stirred for 30 min and then 
quenched with EtOAc (6 mL). The mixture was warmed to room temperature and then poured 
into a solution of sat. aq. Na-K tartrate (1000 mL). The resulting mixture was vigorously 
stirred until both the aqueous and organic layers were clear (2 h). The layers were separated, 
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and the aqueous layer was extracted with DCM (4 × 300 mL). The combined organic layers 
were dried over Na2SO4, filtered, concentrated and purified by flash column chromatography 
(1:1 Et2O : pentane), affording the desired product as mixture of diastereomers in ratio 0.4:0.6 
(1.62 g, 40%). 1H NMR for the diastereomer mixture (300 MHz, CDCl3) δ = 1.43-1.98 (m, 
4H), 1.99-2.40 (m, 1H), 2.56-3.10 (m, 1H), 3.44-3.81 (m, 1H), 3.99-4.19 (m, 1H), 4.81-4.88 
(m, 0.6H), 5.25-5.35 (m, 0.4H), 7.19-7.44 ppm (m, 5H). 13C NMR for the major diastereomer  
(300 MHz, CDCl3) δ = 25.6, 30.7, 49.9, 66.7, 99.5, 127.2, 128.3, 128.6, 128.9 ppm. 13C NMR 
for the minor diastereomer (300 MHz, CDCl3) δ = 23.3, 26.1, 47.1, 60.0, 94.8, 127.1, 127.8, 
128.3, 128.7 ppm. 
 
Compound 96a 
 
O
Me
Ph
Ph
OH
 
 
tert-Butyllithium (1.7 M in pentane, 1.2 mL, 2.1 mmol) was added dropwise to a cooled  
(-78 ºC) stirred solution of 5-methyl-3,4-dihydro-2H-pyran 90a (0.30 g, 3.1 mmol) in dry 
Et2O (3 mL) and the mixture was stirred for 1 h. The mixture was allowed to warm to 0 ºC 
and stirred for 3 h. After cooling down to -78 ºC a benzophenone (0.37 g, 2.1 mmol) was 
added. The reaction mixture was allowed to warm to room temperature and stirred overnight. 
Saturated aqueous NH4Cl (20 mL) was added to the reaction mixture, and the mixture was 
extracted with Et2O (4 × 15 mL). The combined organic extracts were washed with brine  
(2 × 15 mL) and dried over Na2SO4 and concentrated in vacuo. The residue was isolated after 
column chromatography (1:9 MTBE : hexane) as white solid (0.15 g, 26%). 1H NMR 
(CD2Cl2, 300 MHz) δ = 0.93-0.95 (m, 3H), 1.74-1.84 (m, 2H), 1.96 (t, J = 6.6 Hz, 2H), 3.83 
(t, J = 5.1 Hz, 2H), 3.88 (s, 1H), 7.14-7.29 ppm (m, 10H). 13C NMR (CD2Cl2, 75 MHz)  
δ = 19.1, 24.0, 29.4, 66.9, 81.6, 108.1, 128.0, 128.5, 128.8, 146.5, 149.6 ppm. IR (neat)  
ν = 695, 761, 891, 1010, 1126, 1236, 1445, 1666, 3527 cm-1. HRMS calcd. for C19H20O2Na+: 
303.135551; found: 303.135833. 
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Compound 96b 
 
O
Ph
Ph
Ph
OH
 
 
tert-Butyllithium (1.7 M in pentane, 0.7 mL, 1.2 mmol) was added dropwise to a cooled  
(-78 ºC) stirred solution of 5-phenyl-3,4-dihydro-2H-pyran 90b (0.28 g, 1.8 mmol) in dry 
Et2O (3 mL) and the mixture was stirred for 1 h. The mixture was allowed to warm to 0 ºC 
and stirred for 3 h. After cooling down to -78 ºC a benzophenone (0.21 g, 1.2 mmol) was 
added. The reaction mixture was allowed to warm to room temperature and stirred overnight. 
Saturated aqueous NH4Cl (15 mL) was added to the reaction mixture, and the mixture was 
extracted with Et2O (4 × 15 mL). The combined organic extracts were washed with brine  
(2 × 15 mL) and dried over Na2SO4 and concentrated in vacuo. The residue was isolated after 
column chromatography (1:9 MTBE : hexane) as white solid (0.10 g, 24%). 1H NMR (CDCl3, 
400 MHz) δ = 1.83-1.91 (m, 2H), 2.23 (t, J = 6.6 Hz, 2H), 2.79 (s, 1H), 3.94 (t, J = 5.1 Hz, 
2H), 6.80-6.85 (m, 2H), 6.95-7.00 (m, 3H), 7.07-7.17 (m, 6H), 7.18-7.24 ppm (m, 4H).  
13C NMR (CDCl3, 100 MHz) δ = 22.7, 30.4, 65.4, 81.4, 112.8, 126.7, 127.1, 127.1, 127.9, 
128.8, 141.1, 145.6, 151.2 ppm. IR (neat) ν = 695, 748, 1052, 1446, 1492, 1718, 2929 cm-1. 
HRMS calcd. for C24H22O2Na+: 365.151195; found: 365.151081. 
 
Compound 97 
 
 
 
Catalyst 47a (1.0 mg, 0.001 mmol) was added to a stirred solution of alcohol 96a (0.1 mmol) 
in dry DCM (2 mL) and the reaction mixture stirred at room temperature for 30 min. The 
reaction mixture was then filtered through a silica plug. After evaporation of the filtrate the 
title compound was obtained (27 mg, 96% yield). 1H NMR (300 MHz, CD2Cl2) δ = 1.30 (s, 
3H), 1.45-1.61 (m, 2H), 2.13-2.31 (m, 2H), 3.54-3.64 (m, 1H), 4.28-4.36 (m, 1H), 7.06 (dt,  
J = 7.3, 1.3 Hz, 1H), 7.14 (dt, J = 7.4, 1.4 Hz, 1H), 7.18-7.26 (m, 2H), 7.31-7.38 (m, 3H), 
7.47-7.52 ppm (m, 2H). 13C NMR (75 MHz, CD2Cl2) δ = 22.9, 23.0, 33.8, 45.2, 73.3, 118.2, 
120.3, 121.8, 124.6, 127.3, 127.5, 129.0, 129.4, 133.9, 142.3, 149.7, 166.2 ppm. IR (neat)  
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ν = 757, 1002, 1069, 1140, 1305, 1445, 1619, 2874, 2931 cm-1. HRMS calcd. for C19H18O: 
262.135762; found: 262.135495. 
 
Compounds 98 and 99 
 
 
 
The mixture of the gold compound 46a (5.1 mg, 0.0067 mmol) and AgBF4 (1.3 mg,  
0.0067 mmol) in dry DCM (1.0 mL) was stirred at room temperature for 10 min and then the 
precipitate was filtered off. The filtrate was added to a stirred solution of alcohol 96b  
(47.0 mg, 0.140 mmol) in dry DCM (2 mL) and stirred at room temperature for 30 min. After 
evaporation of the solvent the two isomeric products were separated by preparative HPLC 
(150 mm YMC Pack ODS-A, 5 µm, 20 mm, Acetonitrile/Water 80:20). The compound 98 
was isolated as a white solid (12 mg, 26% yield). 1H NMR (400 MHz, CD2Cl2) δ = 1.55-1.63 
(m, 1H), 1.71 (dt, J = 12.3 Hz, J = 4.0 Hz, 1H), 1.77-1.90 (m, 1H), 3.00-3.08 (m, 1H), 3.74 
(dt, J = 11.0 Hz, J = 3.5 Hz, 1H),  4.13-4.21 (m, 1H), 6.96 (dt, J = 7.6 Hz, J = 1.3 Hz, 1H), 
7.08 (dt, J = 7.6 Hz, J = 1.2 Hz, 1H), 7.12-7.17 (m, 2H), 7.20-7.35 (m, 4H), 7.37-7.43 (m, 
4H), 7.58-7.64 ppm (m, 2H). 13C NMR (100 MHz, CD2Cl2) δ = 23.0, 32.6, 72.7, 120.4, 121.0, 
121.4, 123.0, 124.9, 127.1, 127.4, 127.5, 127.8, 129.1, 129.5, 129.7, 133.7, 142.2, 142.5, 
148.5, 163.8 ppm. IR (neat) ν = 698, 747, 1051, 1631, 2924, 3356 cm-1. HRMS calcd. for 
C24H20O: 324.151418; found: 324.151288. 
 
The compound 99 was isolated as a white solid (25 mg, 56% yield). 1H NMR (400 MHz, 
CD2Cl2) δ = 1.91-1.98 (m, 2H), 2.40 (t, J = 6.3 Hz, 2H), 4.13 (t, J = 5.2 Hz, 2H), 6.93 (dt,  
J = 7.5 Hz, J = 1.3 Hz, 1H), 7.00-7.03 (m, 1H), 7.05-7.08 (m, 1H), 7.09-7.19 ppm (m, 11H). 
13C NMR (100 MHz, CD2Cl2) δ = 19.1, 22.8, 64.5, 69.2, 111.8, 117.9, 123.9, 125.1, 127.5, 
127.9, 128.8, 129.0, 143.8, 144.3, 145.6, 163.6 ppm. IR (neat) ν = 700, 740, 1050, 1645, 2923 
cm-1. HRMS calcd. for C24H20O: 324.151414; found: 324.151238. 
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Compound 113a 
 
 
 
Adamantylphosphine (2.401 g, 14.3 mmol) was added to a mixture of chlorocyclopropenium 
salt 42 (2.559 g, 7.1 mmol) in THF (15 mL) and the resulting mixture was heated at 60 oC 
overnight. After cooling to room temperature, the solvent was removed in vacuo, the residue 
dissolved in DCM (40 mL) and the solution was washed with a saturated solution of NaBF4  
(6 × 35 mL). Once dried over Na2SO4, the organic phase was concentrated and the residue 
was purified by column chromatography (9:1 DCM : Acetone), getting the product from the 
first fraction as a white solid (3.030 g, 87%). 1H NMR (400 MHz, CDCl3) δ = 1.35 (d,  
J = 6.8 Hz, 18H), 1.41 (d, J = 6.8 Hz, 6H), 1.66-1.70 (m, 6H), 1.80-1.85 (m, 6H), 1.95-2.00 
(m, 3H), 3.96 (sept, J = 6.8 Hz, 2H), 3.99 (d, J = 221.3 Hz, 1H), 4.13 ppm (sept, J = 6.8 Hz, 
2H). 31P NMR (161 MHz, CDCl3) δ = -44.48 ppm. 13C NMR (100 MHz, CDCl3) δ = 20.6, 
20.9, 21.0, 21.4, 28.4 (d, J = 8.6 Hz), 35.5, 36.7 (d, J = 11.2 Hz), 42.7 (d, J = 9.5 Hz), 51.4, 
53.6, 101.9 (d, J = 67.7 Hz), 140.3 ppm. IR (neat) ν = 607, 1045, 1153, 1376, 1543, 1863, 
2903 cm-1. HRMS calcd. for C25H44N2P+: 403.323658; found 403.323727. 
 
Compound 113b 
 
 
 
A solution of phenylphosphine in hexane (7.4 mL, 5.3 mmol, 10 %) was added to a mixture of 
chlorocyclopropenium salt 42 (630.0 mg, 1.8 mmol) in THF (6.0 mL) and the resulting 
mixture was heated at 60 oC overnight. After cooling to room temperature, the solvent was 
removed in vacuo, the residue dissolved in DCM (15 mL) and the solution was washed with a 
saturated solution of NaBF4 (3 × 25 mL). Once dried over Na2SO4, the organic phase was 
concentrated and the residue washed with pentane (3 × 10 mL), affording the desired 
compound as a white solid (575 mg, 76%). 1H NMR (300 MHz, CDCl3) δ = 1.12 (d,  
J = 6.9 Hz, 6H), 1.31-1.46 (m, 18H), 3.64-3.80 (m, 2H), 4.14 (sept, J = 6.9 Hz, 2H), 5.63 (d,  
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J = 233.6 Hz, 1H) 7.44-7.51 (m, 3H), 7.64-7.72 ppm (m, 2H). 31P NMR (161 MHz, CDCl3)  
δ = -70.88 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 21.6, 21.8, 22.9, 50.8, 56.7, 105.5 (d,  
J = 58.7 Hz), 126.0, 130.4 (d, J = 8.1 Hz), 132.3, 137.1 (d, J = 20.2 Hz), 138.7 ppm (d,  
J = 4.1 Hz). IR (neat) ν = 729, 1032, 1349, 1558, 1872, 2984 cm-1. HRMS calcd. for 
C21H34N2P+: 345.245415; found 345.245568. 
 
Compound 114a 
 
 
 
KHMDS (88.0 mg, 0.44 mmol) was added to a cooled (-40 oC) suspension of 
adamantylphosphanylidene 113a (216.0 mg, 0.44 mmol) in dry THF (5 mL) and the resulting 
mixture was stirred for 1.5 h. The solvent was removed in vacuo, the yellowish residue was 
dissolved in dry DCM (3.0 mL) and the mixture was filtered under argon atmosphere. The 
filtrate was concentrated in vacuo and the residue was washed with Et2O (6 × 5 mL). The 
corresponding product is stable at -20 oC (176 mg, 99%). 1H NMR (300 MHz, toluene-d8,  
-40 oC) δ = 0.95 (d, J = 6.7 Hz, 12H), 1.20 (d, J = 6.7 Hz, 12H), 1.83-1.89 (m, 6H), 2.10-2.15 
(m, 3H), 2.38-2.44 (m, 6H), 3.39-3.56 (m, 2H), 3.99 ppm (sept, J = 6.7 Hz, 2H). 31P NMR 
(121 MHz, toluene-d8, -40 oC) δ = 2.28 ppm. 13C NMR (75 MHz, toluene-d8, -40 oC) δ = 21.4, 
23.7 (br.s), 29.8, 29.9, 31.9, 32.4, 37.5, 45.4 (d, J = 13.2 Hz), 48.6, 49.3 (br.s), 123.3 (d,  
J = 30.3 Hz), 126.5 ppm (d, J = 16.1 Hz). 
 
Compound 114b 
 
 
 
KHMDS (20.0 mg, 0.095 mmol) was added to a cooled (-40 oC) suspension of 
phenylphosphanylidene 113b (41.0 mg, 0.095 mmol) in dry toluene-d8 (1.5 mL) and the 
resulting mixture was stirred for 30 min. The suspension was filtered under argon atmosphere. 
After NMR experiments, the solution was concentrated in vacuo. The corresponding product 
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is stable at -20 oC (32 mg, 97%). 1H NMR (300 MHz, toluene-d8) δ = 0.95 (br.s, 24H), 3.31 
(br.s, 4H), 7.12-7.17 (m, 3H), 8.03-8.10 ppm (m, 2H). 31P NMR (121 MHz, toluene-d8)  
δ = -36.86 ppm. 13C NMR (75 MHz, toluene-d8) δ = 22.5 (br.s), 49.3 (br.s), 82.4 (d,  
J = 239.9 Hz), 125.0 (d, J = 1.5 Hz), 125.6 (d, J = 4.9 Hz), 127.4 (d, J = 3.6 Hz), 137.0 ppm 
(d, J = 14.1 Hz). 
 
Compound 115 
 
 
 
Dry THF (6 mL) was added to a cooled (- 40 oC) solid mixture of KHMDS (215.7 mg,  
1.08 mmol) and phosphenium salt 113b (425.0 mg, 0.98 mmol) and the solution stirred at this 
temperature for 2 h. Then chlorocyclopropenium salt 42 (353.0 mg, 0.98 mmol) was added, 
the reaction mixture was allowed to warm to room temperature and stirred overnight. The 
solvent was removed in vacuo, the residue was dissolved in DCM (15 mL) and the solution 
washed with a saturated solution of NaBF4 (3 × 15 mL). Once dried over Na2SO4, the organic 
phase was concentrated and the residue washed with THF (3 × 10 mL) affording the desired 
compound as a white solid (516 mg, 69%). 1H NMR (400 MHz, CD2Cl2) δ = 1.21 (d,  
J = 6.9 Hz, 12H), 1.25 (d, J = 6.9 Hz, 12H), 1.38 (d, J = 6.9 Hz, 12H), 1.44 (d, J = 6.9 Hz, 
12H), 3.64 (sept, J = 6.9 Hz, 4H), 4.17 (sept, J = 6.9 Hz, 4H), 7.62-7.68 (m, 3H), 7.73-7.80 
ppm (m, 2H). 31P NMR (161 MHz, CD2Cl2) δ = -48.31 ppm. 13C NMR (100 MHz, CD2Cl2)  
δ = 21.2, 21.5, 21.5, 21.6, 21.6, 21.7, 53.4, 54.8, 98.2 (d, J = 59.5 Hz), 125.0 (d, J = 4.6 Hz), 
131.1 (d, J = 8.9 Hz), 133.0, 134.8 (d, J = 22.9 Hz), 140.0 ppm. IR (neat) ν = 694, 1029, 
1151, 1357, 1555, 1858, 2974 cm-1. HRMS calcd. for C36H61BF4N4P+: 667.467509; found 
667.467401. 
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Compound 117 
 
 
 
[AuCl(Me2S)] (39.0 mg, 0.13 mmol) was added to a cooled (-20 oC) suspension of salt 115 
(100.0 mg, 0.13 mmol) in dry THF (4 mL). The reaction mixture was allowed to warm to 
room temperature and stirred at this temperature for 2 h. The solvent was then removed in 
vacuo affording the desired product as a white solid (129 mg, 98%). 1H NMR (400 MHz, 
CD2Cl2) δ = 1.25 (d, J = 7.0 Hz, 12H), 1.34 (d, J = 7.0 Hz, 12H), 1.45 (d, J = 7.0 Hz, 24H), 
3.86 (sept, J = 7.0 Hz, 4H), 4.24 (sept, J = 7.0 Hz, 4H), 7.72-7.78 (m, 3H), 8.08-8.17 ppm (m, 
2H). 31P NMR (161 MHz, CD2Cl2) δ = -9.96 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 21.5, 
21.7, 21.9, 55.5, 56.0, 90.9 (d, J = 53.2 Hz), 121.9 (d, J = 69.4 Hz), 131.5 (d, J = 14.2 Hz), 
135.4, 135.4 (d, J =17.9 Hz), 138.9 ppm (d, J = 6.3 Hz). IR (neat) ν = 694, 1030, 1151, 1358, 
1556, 1858, 2973 cm-1. HRMS calcd. for C36H61AuBClF4N4P+: 899.401161; found 
899.401924. 
 
Compound 118 
 
 
 
K2PtCl4 (48.4 mg, 0.117 mmol) was added to a solution of salt 115 (88.0 mg, 0.117 mmol) in 
dry DCM (3.0 mL). The reaction mixture was allowed to warm to room temperature and 
stirred overnight. The solvent was then removed in vacuo affording the desired product as a 
pale yellow solid (111 mg, 98%). 1H NMR (400 MHz, CD2Cl2) δ = 1.10 (d, J = 6.4 Hz, 12H), 
1.14 (d, J = 6.4 Hz, 12H), 1.33 (d, J = 7.0 Hz, 12H), 1.36 (d, J = 7.0 Hz, 12H),  4.05-4.18 (m, 
4H), 4.29-4.43 (m, 4H), 7.58-7.67 (m, 3H), 8.37-8.46 ppm (m, 2H). 31P NMR (161 MHz, 
CD2Cl2) δ = -21.24 ppm (J = 1994.8 Hz). 13C NMR (100 MHz, CD2Cl2) δ = 17.5, 18.1, 18.5, 
53.4, 90.6 (d, J = 51.5 Hz), 118.9 (d, J = 70.8 Hz), 126.8 (d, J = 12.9 Hz), 130.9 (d,  
J = 2.3 Hz), 133.5 (d, J = 13.5 Hz), 134.7 ppm (d, J = 8.6 Hz). IR (neat) ν = 679, 1050, 1148, 
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1376, 1557, 1850, 2977 cm-1. HRMS calcd. for C36H61Cl3N4PPt+: 880.333066; found 
880.333903. 
 
Compound 119 
 
 
 
K2PdCl4 (18 mg, 0.053 mmol) was added to a solution of salt 115 (40 mg, 0.053 mmol) in dry 
DCM (2.0 mL). The reaction mixture was stirred overnight, then filtered through the syringe 
filter and the filtrate was concentrated in vacuo affording the desired product as a yelllow 
solid (46 mg, 98%). 1H NMR (400 MHz, CD2Cl2) δ = 1.12 (d, J = 6.7 Hz, 12H), 1.16 (d,  
J = 6.7 Hz, 12H), 1.33 (d, J = 7.0 Hz, 12H), 1.36 (d, J = 7.0 Hz, 12H), 4.05-4.19 (m, 4H), 
4.21-4.38 (m, 4H), 7.62-7.69 (m, 3H), 8.43-8.54 ppm (m, 2H). 31P NMR (161 MHz, CD2Cl2) 
δ = -2.62 ppm. 13C NMR (100 MHz, CD2Cl2) δ = 20.2, 20.2, 20.7, 21.2, 56.4 (br.s), 95.0 (d,  
J = 39.7 Hz), 121.1 (d, J = 59.2 Hz), 129.6 (d, J = 12.5 Hz), 134.0 (d, J = 2.8 Hz), 137.0 (d,  
J = 13.9 Hz), 137.2 ppm (d, J = 8.2 Hz). IR (neat) ν = 694, 1032, 1376, 1556, 1852,  
2978 cm-1. HRMS calcd. for C36H61Cl3N4PPd+: 791.273514; found 791.273504. 
 
Compound 120 
 
 
 
AgNTf2 (9.0 mg, 0.023 mmol) was added to a cooled (0 oC) suspension of complex 117  
(23.0 mg, 0.023 mmol) in dry DCM (2 mL) and the solution stirred at this temperature for 1 h. 
The reaction mixture was then filtered through a Celite plug. After evaporation of the filtrate 
in vacuo the desired product as an off white solid (26 mg, 90%). 1H NMR (400 MHz, CD2Cl2) 
δ = 1.14 (d, J = 6.7 Hz, 12H), 1.23 (d, J = 6.7 Hz, 12H), 1.38 (d, J = 7.0 Hz, 24H), 3.78 (sept, 
J = 7.0 Hz, 4H), 4.15 (sept, J = 6.7 Hz, 4H), 7.70-7.79 (m, 3H), 8.15 ppm (dd, J = 16.4 Hz,  
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J = 6.8 Hz, 2H). 31P NMR (161 MHz, CD2Cl2) δ = -5.53 ppm. 13C NMR (100 MHz, CD2Cl2) 
δ = 21.6, 23.1, 23.1, 55.9, 89.5 (d, J = 56.6 Hz), 120.5 (d, J = 67.9 Hz), 120.1 (q, J = 321.5 
Hz,), 131.7 (d, J = 14.2 Hz), 136.1 (d, J =2.8 Hz), 136.4 (br.s), 139.0 ppm (br.s). IR (neat)  
ν = 693, 1028, 1151, 1360, 1560, 1868, 2966 cm-1. HRMS calcd. for C38H61AuBF10N5O4S2P+: 
1144.351283; found 1144.352705. 
 
Compound 121 
 
 
 
PdCl2(PPh3)2 (0.06 g, 0.08 mmol) and CuI (0.02 g, 0.08 mmol) were added to a stirred 
solution of enyne 103 (1.19 g, 4.1 mmol) and iodobenzene (0.5 mL, 4.5 mmol) in dry Et3N 
(40 mL). The reaction mixture was heated at 50 oC overnight. The mixture was cooled to 
room temperature, then filtered and washed with MTBE (50 mL), and filtrate was 
concentrated in vacuo. The product was purified by bulb-to-bulb distillation followed by 
column chromatography (1:15 MTBE : hexane), affording the desired product as colorless oil 
(1.05 g, 70%). 1H NMR (300 MHz, CDCl3) δ = 1.26 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 7.1 Hz, 
3H), 1.30 (m, 2H), 1.71 (m, 2H), 2.01 (m, 2H), 2.24 (m, 2H), 3.07 (s, 2H), 3.29 (m, 1H), 4.23 
(m, 4H), 5.83 (m, 2H), 7.27 (m, 3H), 7.36 ppm (m, 2H). 13C NMR (75 MHz, CDCl3):  
δ = 14.1, 14.2, 24.1, 26.1, 28.0, 29.8, 31.6, 43.0, 60.7, 61.4, 61.5, 83.2, 85.5, 123.6, 127.8, 
128.2, 131.5, 131.9, 133.0, 170.0, 170.1 ppm. The spectroscopic data were consistent with the 
previously published values.81 
 
Compound 122 
 
 
 
PtCl2 (3.1 mg, 0.012 mmol) and ligand 115 (8.8 mg, 0.012 mmol) were added to a solution of 
enyne 121 (43 mg, 0.12 mmol) in dry toluene (1.5 mL). The reaction mixture was heated at  
80 oC for 3 h. After concentration, the residue was purified by flash column chromatography 
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(1:10 EtOAc : hexane), affording the product as colorless oil (41 mg, 95%). 1H NMR  
(400 MHz, CDCl3) δ = 1.19 (t, J = 7.1 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H), 1.51 (m, 4H), 1.82 
(m, 2H), 2.20 (m, 1H), 2.29 (ddd, J = 13.8 Hz, J = 8.1 Hz, J = 0.9 Hz, 1H), 2.38 (dd,  
J = 13.8 Hz, J = 7.3 Hz, 1H), 3.24 (m, 1H), 2.83 (m, 2H), 3.52 (m, 1H), 4.15 (m, 4H), 7.19 
(m, 1H), 7.30 ppm (m, 4H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 14.2, 27.5, 27.6, 28.6, 
29.6, 32.2, 40.9, 42.5, 49.8, 60.9, 61.3, 71.5, 125.7, 126.7, 128.5, 135.0, 140.3, 145.4, 169.7, 
172.4 ppm. The spectroscopic data were consistent with the previously published values.81 
 
Compound 124 
 
 
 
PtCl2 (2.4 mg, 0.009 mmol) and ligand 115 (6.8 mg, 0.009 mmol) were added to a solution of 
enyne 123 (32 mg, 0.09 mmol) in dry toluene (1.0 mL). The reaction mixture was heated at  
80 oC for 3 h. After concentration, the residue was purified by flash column chromatography 
(1:10 EtOAc : hexane), affording the product as colorless oil (30 mg, 94%). 1H NMR  
(400 MHz, CDCl3) δ = 1.14 (t, J = 7.1 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H), 1.24-1.30 (m, 1H), 
1.48-1.62 (m, 3H), 2.27 (ddd, J = 14.1 Hz, J = 7.8 Hz, J = 0.6 Hz, 1H), 2.47 (dd,  
J = 14.1 Hz, J = 5.0 Hz, 2H), 2.52-2.65 (m, 1H), 2.77-2.87 (m, 1H), 3.17-3.24 (m, 1H),  
3.31-3.39 (m, 1H), 3.99-4.15 (m, 2H), 4.12-4.29 (m, 2H), 7.16-7.38 ppm (m, 5H). 13C NMR 
(100 MHz, CDCl3): δ = 12.9, 13.0, 20.5, 22.5, 24.9, 33.0, 39.7, 41.4, 45.4, 59.9, 64.8, 68.0, 
124.4, 125.7, 127.4, 133.8, 141.0, 141.8, 169.2, 171.8 ppm. The spectroscopic data were 
consistent with the previously published values.81 
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Compound 125 
 
N
N
P
iPr
iPr
iPr
iPr
Ad
AuCl
AuCl
 
 
Compound 114a (0.15 mmol, prepared in situ as described above) was dissolved inTHF at  
-40 oC. Then (Me2S)AuCl (88.4 mg, 0.30 mmol) was added and the reaction mixture was 
stirred at room temperature for 30 min. The solvent was removed in vacuo, the residue 
washed with Et2O (3 × 5 mL) and dried in vacuo. The product was obtained as a white solid 
(129 mg, 99%). 1H NMR (400 MHz, CDCl3) δ = 1.26 (d, J = 6.9 Hz, 12H), 1.41 (d,  
J = 6.6 Hz, 12H), 1.48-1.57 (m, 6H), 1.83-1.90 (m, 9H), 3.90-4.05 (m, 2H), 4.72-4.90 ppm 
(m, 2H). 31P NMR (161 MHz, CDCl3) δ = 10.91 ppm. 13C NMR (100 MHz, CDCl3) δ = 22.2, 
28.8 (d, J = 11.6 Hz), 30.9, 36.2, 42.2(d, J = 26.5 Hz), 43.8 (d, J = 3.8 Hz), 55.3, 124.2 (d,  
J = 763.4 Hz), 148.6 ppm (d, J = 70.8 Hz). IR (neat) ν = 677, 840, 1451, 1530, 1853, 2901 
cm-1. HRMS calcd. for C25H43N2Au2Cl2PNa+: 889.176417; found 889.176486. 
 
Compound 126 
 
 
 
Compound 114a (0.114 mmol, prepared in situ as described above) was dissolved inTHF at  
-30 oC. Then BH3·THF solution (1M, 0.34 mL, 0.432 mmol) was added and the reaction 
mixture was stirred at room temperature for 30 min. The solvent was removed in vacuo, the 
residue washed with Et2O (3 × 8 mL) and dried in vacuo. The product was obtained as a white 
solid (19 mg, 39%). 1H NMR (400 MHz, CD2Cl2) δ = 0.04-0.93 (m, 6H), 1.22-1.41 (m, 24H), 
1.55-1.68 (m, 6H), 1.71-1.80 (m, 6H), 1.83-1.93 (m, 3H), 3.90-4.11 (m, 2H), 4.74-4.94 ppm 
(m, 2H). 31P NMR (161 MHz, CD2Cl2) δ = 8.90 ppm. 11B NMR (128 MHz, CD2Cl2)  
δ = -36.0 (d, J = 47.6 Hz), δ = -35.6 (d, J = 47.6 Hz) ppm. 13C NMR (100 MHz, CD2Cl2)  
δ = 22.0, 23.1, 29.4 (d, J = 8.1 Hz), 34.0 (d, J = 22.2 Hz), 37.5, 39.1, 57.1, 111.6 (d,  
J = 17.2 Hz), 142.2 (d, J = 9.1 Hz) ppm. IR (neat) ν = 670, 1051, 1359, 1524, 1851, 2356, 
2904 cm-1. (ESI) MS calcd. for C25H49B2N2P+: 430.4; found 430.1. 
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Compound 134a 
 
 
 
Tris(trimethylsilyl)phosphine (0.1 mL, 0.34 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 42 (369.0 mg, 1.03 mmol) in freshly distilled fluorobenzene  
(5.0 mL) and the solution was heated at 60 oC overnight. After cooling to room temperature, 
the solvent was removed in vacuo, the residue was washed with THF (5 × 8 mL) and dried in 
vacuo, affording the desired product as a white solid (75 mg, 22%). 1H NMR (400 MHz, 
CD2Cl2) δ = 1.40 (d, J = 6.9 Hz, 36H), 1.46 (d, J = 6.9 Hz, 36H), 3.93-4.04 (m, 6H), 4.29 ppm 
(sept, J = 6.9 Hz, 6H). 31P NMR (161 MHz, CD2Cl2) δ = -76.90 ppm. 13C NMR (100 MHz, 
CD2Cl2) δ = 21.4, 21.9, 22.0, 57.4, 90.5 (d, J = 52.8 Hz), 140.1 ppm (d, J = 3.4 Hz). IR (neat) 
ν = 689, 1032, 1146, 1354, 1568, 1852, 2976 cm-1. HRMS calcd. for C45H84B4F16N6P-: 
1087.666055; found 1087.665515. 
 
Compound 134b 
 
 
 
n-BuLi (0.64 mL, 1.6 M, 1.02 mmol) was added dropwise to a cooled (-78 oC) suspension of 
chlorocyclopropenium salt 133 (430.0 mg, 1.02 mmol) in dry THF (20 mL) and the reaction 
mixture was stirred for 20 min. Then PCl3 (30 µL, 0.34 mmol) was added, the reaction 
mixture slowly allowed to reach room temperature and then stirred overnight. Afterwards, the 
solvent was removed in vacuo and the residue washed with THF (4 × 8 mL) and dried, 
affording the desired product as a white solid (184 mg, 45%). 1H NMR (400 MHz, CD2Cl2)  
δ = 1.40 (d, J = 6.8 Hz, 36H), 1.45 (d, J = 6.8 Hz, 36H), 4.03 (dsept, J = 1.8 Hz, J = 6.8 Hz, 
6H), 4.33 ppm (sept, J = 6.8 Hz, 6H). 31P NMR (161 MHz, CD2Cl2) δ = -76.40 ppm.  
13C NMR (100 MHz, CD2Cl2) δ = 21.8, 22.4, 22.4, 54.1 (br.s), 57.8 (br.s), 90.8 (d,  
J = 52.5 Hz), 121.6 (q, J = 321.6 Hz), 140.4 ppm (d, J = 3.1 Hz). IR (neat) ν = 686, 1029, 
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1142, 1260, 1378, 1568, 1848, 2984 cm-1. HRMS calcd. for C47H84F6N6O6PS2+: 1037.553010; 
found 1037.553102. 
 
Compound 136 
 
 
 
n-BuLi solution in hexane (0.28 mL, 0.45 mmol, 1.6M) was added dropwise to a cooled  
(-78 oC) suspension of chlorocyclopropenium salt 133 (189.0 mg, 0.45 mmol) in dry 
diethylether (3.0 mL) and the mixture was stirred for 20 min. The mixture was allowed to 
warm to room temperature and the solvent was removed in vacuo. The residue was dissolved 
with dry fluorobenzene (1.0 mL) and trimethylsilyl trifluoromethanesulfonate (0.17 mL,  
0.90 mmol) was added, and then the mixture stirred at room temperature for 1h. The solvent 
was removed in vacuo, the residue was washed with dry DCM (3 × 2 mL), the filtrate was 
concentrated yielding the corresponding product as pale yellow air sensitive solid (108 mg,  
52%). 1H NMR (400 MHz, CD2Cl2) δ = 0.45 (s, 9H), 1.37 (d, J = 6.9 Hz, 12H), 1.40 (d,  
J = 6.9 Hz, 12H), 3.99 (sept, J = 6.9 Hz, 2H), 4.12 ppm (sept, J = 6.9 Hz, 2H). 13C NMR  
(100 MHz, CD2Cl2) δ = -0.1, 20.6, 21.5, 54.4, 111.4, 121.4 (quart, J = 321.8 Hz), 141.5 ppm. 
29Si NMR (80 MHz, CD2Cl2) δ = -7.49 ppm. IR (neat) ν = 845, 1030, 1138, 1267, 1532, 1864, 
2983 cm-1. HRMS calcd. for C18H37N2Si: 309.272048; found: 309.271979. 
 
Compound 137 
 
 
 
An excess of dimethylamine (~ 15 mL) was condensed in a cooled (-78 oC) flask, then dry 
DCM (40 mL) was slowly added. The solution of 1,1,2,3-tetrachloropropene (7.0 mL,  
59.8 mmol) in dry DCM (13 mL) was slowly added to a stirred reaction mixture via syringe 
pump over 1 h. The reaction mixture was stirred at -78 oC for 4 h, before it was heated to 0 oC 
and stirred 1 h; then was heated to room temperature and stirred overnight. Then the reaction 
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mixture was refluxed for 3 h. After cooling to room temperature, HBF4 (48% solution in 
water, 15 mL) was added and the reaction mixture stirred for 10 min. The aqueous layer was 
separated, the organic layer was dried over Na2SO4 and concentrated in vacuo to give the 
product as white solid (11.03 g, 72%). 1H NMR (300 MHz, CDCl3) δ = 3.12 ppm (s, 18H). 
13C NMR (75 MHz, CDCl3) δ = 42.7, 118.4 ppm. HRMS calcd. for C9H18N3BF4: 255.152992; 
found: 255.152901. The spectroscopic data were consistent with the previously published 
values.105 
 
Compound 138 
 
 
 
A mixture of cyclopropenium salt 137 (5.50 g, 21.6 mmol) and KOH (12.10 g, 216 mmol) in 
water (68.5 mL) was heated at 65 oC for 2 h. After cooling to room temperature the mixture 
was extracted with DCM (4 × 40 mL), the combined extracts were dried over Na2SO4 and 
concentrated in vacuo to give the desired product (2.99 g, 99%). 1H NMR (300 MHz, CDCl3) 
δ = 2.97 ppm (s, 12H). 13C NMR (75 MHz, CDCl3) δ = 41.7, 121.6, 134.4 ppm. IR (neat)  
ν = 727, 1181, 1392, 1500, 1594, 1888, 2882 cm-1. HRMS calcd. for C7H12N2O: 140.094960; 
found: 140.094853. The spectroscopic data were consistent with the previously published 
values.106 
 
Compound 139 
 
 
 
Oxalyl chloride (6.4 mL, 73.5 mmol) was slowly added to cooled (0 oC) ketone 138 (3.22 g, 
23.0 mmol). The strong gas evolution was observed. The reaction mixture was stirred at room 
temperature for 15 min, then excess of oxalyl chloride was removed in vacuo, getting the 
chlorochyclopropenium salt (4.47 g, 99%). 1H NMR (300 MHz, CDCl3) δ = 3.37 ppm (d,  
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J = 27.9 Hz 12H). 13C NMR (75 MHz, CDCl3) δ = 42.3, 43.3, 92.2, 135.2 ppm. The 
spectroscopic data were consistent with the previously published values.107 
 
Compound 140 
 
 
 
A solution of chlorocyclopropenium salt 139 (5.2 g, 26.6 mmol) in dry acetonitrile (20 mL) 
was added to a solution of magnesium perchlorate (3.00 g, 13.3 mmol) in dry acetonitrile (25 
mL). The formed precipitate was filtered off and washed with acetonitrile (10 mL). After 
evaporation of the filtrate, the desired salt was obtained (6.62 g, 96%). 1H NMR (300 MHz, 
CD2Cl2) δ = 3.18 ppm (d, J = 3.8 Hz, 12H). 13C NMR (100 MHz, CD2Cl2) δ = 42.0, 42.7, 
92.5, 135.0 ppm. The spectroscopic data were consistent with the previously published 
values.108 
 
Compound 141 
 
 
 
Tris(trimethylsilyl)phosphine (0.1 mL, 0.34 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 140 (267.0 mg, 1.03 mmol) in freshly distilled fluorobenzene  
(6.0 mL) and the solution was heated at 60 oC for 3 days. After cooling to room temperature, 
the solvent was removed in vacuo, the residue was washed with CH2Cl2 (3 × 10 mL) and 
dried in vacuo, affording the desired product as a pale orange solid (175 mg, 73%). 1H NMR 
(500 MHz, CD3CN) δ = 3.20 (s, 18H), 3.27 ppm (s, 18H). 31P NMR (202 MHz, CD3CN)  
δ = -93.48 ppm. 13C NMR (125 MHz, CD3CN) δ = 43.7, 43.8, 93.2 (d, J = 51.8 Hz), 142.4 
ppm. IR (neat) ν = 752, 1073, 1217, 1409, 1620, 1902, 2947, 3597 cm-1. HRMS calcd. for 
C21H36N6O8Cl2P+: 601.170382; found 601.171374. 
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Compound 142 
 
 
 
K2PdCl4 (10 mg, 0.03 mmol) was added to a cooled (-20 oC) solution of 141 (21 mg,  
0.03 mmol) in dry acetonitrile (2.5 mL). The reaction mixture was allowed to reach room 
temperature and stirred overnight. The precipitate was filtered off and the filtrate concentrated 
in vacuo to afford the desired product as an orange solid (22 mg, 92%). 1H NMR (400 MHz, 
CD3CN) δ = 3.30 (s, 18H), 3.36 ppm (s, 18H). 31P NMR (161 MHz, CD3CN) δ = -46.10 ppm. 
13C NMR (100 MHz, CD3CN) δ = 44.1, 44.6, 86.7 (d, J = 60.0 Hz), 140.8 ppm (d,  
J = 7.8 Hz). IR (neat) ν = 742, 1075, 1221, 1410, 1615, 1902, 3434 cm-1. HRMS calcd. for 
C21H36Cl14N6O4PPd+: 713.031965; found 713.032286. 
 
Compound 143 
 
 
 
K2PtCl4 (39 mg, 0.094 mmol) was added solution of salt 141 (66 mg, 0.094 mmol) in dry 
acetonitrile (3 mL) and the reaction mixture was stirred overnight. The precipitate was filtered 
off and the filtrate concentrated in vacuo to afford the desired product as an yellow-orange 
solid (74 mg, 87%). 1H NMR (400 MHz, CD3CN) δ = 3.34 (s, 18H), 3.40 ppm (s, 18H).  
31P NMR (161 MHz, CD3CN) δ = -62.43 ppm. 13C NMR (100 MHz, CD3CN) δ = 42.8, 43.2, 
84.4 (d, J = 73.2 Hz), 139.5 ppm (d, J = 7.6 Hz). IR (neat) ν = 755, 1077, 1217, 1407, 1633, 
1897, 2948 cm-1. HRMS calcd. for C21H36Cl14N6O4PPt+: 802.091664; found 802.092584. 
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Compound 144 
 
 
 
Dry acetonitrile (2.0 mL) was added to a cooled (-20 oC) mixture of salt 141 (24 mg,  
0.03 mmol) and (Me2S)AuCl (10 mg, 0.03 mmol). The mixture was stirred for 1 h and 
concentrated in vacuo at 0 oC to give the product as pale yellow solid (30 mg, 94%). 1H NMR 
(400 MHz, CD3CN) δ = 3.27 (s, 18H), 3.28 ppm (s, 18H). 31P NMR (161 MHz, CD3CN)  
δ = -49.67 ppm. 13C NMR (100 MHz, CD3CN) δ = 43.1, 43.7, 102.9 (d, J = 68.2 Hz), 140.2 
ppm (d, J = 5.0 Hz). IR (neat) ν = 749, 1075, 1217, 1408, 1622, 1898, 3429 cm-1. HRMS 
calcd. for C21H36Cl3N6O8PAu+: 833.105788; found 833.106459. 
 
Compound 166a 
 
 
 
Bis(trimethylsilyl)sulfide (77 µL, 0.41 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 42 (294 mg, 0.82 mmol) in dry THF (7.0 mL) and the reaction 
mixture was heated at 60 oC overnight. Then the mixture was cooled to room temperature, the 
precipitate was filtered off and washed with THF (3 × 9 mL), affording the desired compound 
as a white solid (236 mg, 85%). 1H NMR (400 MHz, CD2Cl2) δ = 1.31 (d, J = 6.9 Hz, 24H), 
1.33 (d, J = 6.9 Hz, 24H), 3.86 (sept, J = 6.9 Hz, 4H), 4.06 ppm (sept,  
J = 6.9 Hz, 4H). 13C NMR (100 MHz, CD2Cl2) δ = 21.4, 22.7, 51.7, 57.5, 92.7, 136.9 ppm.  
IR (neat) ν = 893, 1045, 1350, 1562, 1873, 2979 cm-1. HRMS calcd. for C30H56BF4N4S+: 
591.426501; found 591.427218. 
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Compound 166b 
 
 
 
Bis(trimethylsilyl)sulfide (94.8 µL, 0.50 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 133 (425 mg, 1.01 mmol) in dry THF (10.0 mL) and the reaction 
mixture was heated at 60 oC overnight. Then the mixture was cooled to room temperature, the 
precipitate was filtered off and washed with THF (3 × 12 mL), affording the desired 
compound as a white solid (713 mg, 88%). 1H NMR (400 MHz, CD2Cl2) δ = 1.31 (d,  
J = 7.0 Hz, 24H), 1.33 (d, J = 7.0 Hz, 24H), 3.87 (sept, J = 7.0 Hz, 4H), 4.06 ppm (sept,  
J = 7.0 Hz, 4H). 13C NMR (100 MHz, CD2Cl2) δ = 21.1, 22.4, 51.4, 56.9, 92.9, 121.8 (q,  
J = 321.4 Hz), 136.6 ppm. IR (neat) ν = 1029, 1140, 1260, 1558, 1588, 1877, 2975 cm-1. 
HRMS calcd. for C31H56 N4O3F3S2+: 653.374049; found 653.374644. 
 
Compound 167a 
 
 
 
Bis(trimethylsilyl)selenide (50 µL, 0.20 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 42 (143 mg, 0.40 mmol) in dry THF (4.0 mL) and the reaction 
mixture was heated at 60 oC overnight. Then the mixture was cooled to room temperature, the 
solvent was removed in vacuo and the residue was dissolved in DCM (10 mL). The resulting 
solution was filtered through the syringe filter and the filtrate concentrated in vacuo. The 
residue was washed with THF (2 × 8 mL), affording the desired compound as a white solid 
(96 mg, 66%). 1H NMR (300 MHz, CD2Cl2) δ = 1.31 (d, J = 6.9 Hz, 24H), 1.32 (d,  
J = 6.9 Hz, 24H), 3.90 (sept, J = 6.9 Hz, 4H), 4.04 ppm (sept, J = 6.9 Hz, 4H). 13C NMR  
(75 MHz, CD2Cl2) δ = 21.5, 22.6, 51.6, 57.2, 87.1, 139.9 ppm. IR (neat) ν = 680, 890, 1057, 
1354, 1549, 1872, 2974 cm-1. HRMS calcd. for C30H56BF4N4Se+: 639.371658; found 
639.372040. 
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Compound 167b 
 
 
 
Bis(trimethylsilyl)selenide (0.3 mL, 1.20 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 133 (1.00 g, 2.40 mmol) in dry THF (10.0 mL) and the reaction 
mixture was heated at 60 oC overnight. Then the mixture was cooled to room temperature, the 
solvent was removed in vacuo and the residue was dissolved in DCM (25 mL). The resulting 
solution was filtered through the syringe filter and the filtrate concentrated in vacuo. The 
residue was washed with THF (2 × 10 mL), affording the desired compound as a white solid 
(714 mg, 70%). 1H NMR (400 MHz, CD2Cl2) δ = 1.32 (d, J = 6.8 Hz, 48H), 3.91 (sept,  
J = 6.8 Hz, 4H), 4.05 ppm (sept, J = 6.8 Hz, 4H). 13C NMR (100 MHz, CD2Cl2) δ = 21.2, 
22.3, 51.4, 56.4, 87.9, 121.3 (q, J = 320.9 Hz), 139.5 ppm. IR (neat) ν = 800, 1028, 1139, 
1258, 1558, 1872, 2973 cm-1. HRMS calcd. for C31H56F3N4O3SSe+: 701.318486; found 
701.320843. 
 
Compound 169a 
 
 
 
Bis(trimethylsilyl)telluride (50 µL, 0.17 mmol) was added to a stirred suspension of 
chlorocyclopropenium salt 42 (123 mg, 0.34 mmol) in dry THF (3.0 mL) and the reaction 
mixture was heated at 60 oC overnight. Then the mixture was cooled to room temperature, the 
solvent was removed in vacuo and the residue was dissolved in DCM (5 mL). The resulting 
solution was filtered through the syringe filter and the filtrate concentrated in vacuo. The 
residue was washed with THF (2 × 10 mL), affording the desired compound as a white solid 
(43 mg, 32%). 1H NMR (400 MHz, CD2Cl2) δ = 1.30 (d, J = 6.9 Hz, 24H), 1.33 (d,  
J = 6.9 Hz, 24H), 4.02 (sept, J = 6.9 Hz, 4H), 4.03 ppm (sept, J = 6.9 Hz, 4H). 13C NMR  
(100 MHz, CD2Cl2) δ = 21.2, 22.3, 51.3, 56.1, 71.4, 143.6 ppm. IR (neat) ν = 669, 889, 1013, 
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1063, 1141, 1354, 1539, 1575, 1863, 2973 cm-1. HRMS calcd. for C30H56BN4F4Te+: 
689.360549; found 689.360863. 
 
Compound 169b 
 
 
 
Freshly dried THF (6 mL) was added to a mixture of sodium (28.0 mg, 1.22 mmol) and 
naphthalene (156 mg, 1.22 mmol). A dark green solution was formed which was stirred at 
room temperature for 1h. Pulverized tellurium (78 mg, 0.61 mmol) was added to the reaction 
mixture which was stirred overnight. The chlorocyclopropenium salt 133 (512 mg,  
1.22 mmol) was added to a white suspension of sodium telluride and the mixture was stirred 
overnight. The solvent was removed in vacuo, the dark residue was washed with pentane  
(4 × 5 mL) to remove the naphthalene. The remaining residue was washed with DCM  
(4 × 2 mL) to dissolve the product. The filtrate was concentrated in vacuo, then washed with 
hot THF (~ 60 oC, 6 × 7 mL) affording the desired compound as a white solid (289 mg,  
53%). 1H NMR (400 MHz, CD2Cl2) δ = 1.30 (d, J = 6.9 Hz, 24H), 1.33 (d, J = 6.9 Hz, 24H), 
4.03 (sept, J = 6.9 Hz, 4H), 4.04 ppm (sept, J = 6.9 Hz, 4H). 13C NMR (100 MHz, CD2Cl2)  
δ = 21.4, 22.3, 51.4, 55.4, 74.3, 121.1 (q, J = 321.0 Hz), 143.4 ppm. IR (neat) ν = 1027, 1152, 
1263, 1553, 1862, 2984 cm-1. HRMS calcd. for C31H56N4O3F3STe+: 751.308665; found 
751.309581. 
 
Compound 170 
 
 
 
The compound was obtained as a by-product from the reaction between 
chlorocyclopropenium salt 42 (246 mg, 0.68 mmol) and bis(trimethylsilyl)telluride (0.1 mL 
0.34 mmol) upon heating in dry THF (4.0 mL) at 65 oC overnight. The solvent was removed 
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in vacuo, the residue was dissolved in DCM (5.0 mL) and the mixture was filtered through the 
syringe filter. After concentration of the filtrate, the residue was recrystallized from 
DCM/Et2O, obtaining the title compound (139 mg, 67%) 1H NMR (400 MHz, CD2Cl2)  
δ = 1.21 (d, J = 6.7 Hz, 12H), 1.34 (d, J = 6.7 Hz, 12H), 3.70-3.89 ppm (m, 4H). 11B NMR 
(96 MHz, CD2Cl2) δ = -0.54 ppm (q, J = 35.9 Hz). 13C NMR (100 MHz, CD2Cl2) δ = 20.5, 
21.3, 49.2, 55.3, 84.3, 139.0 ppm (q, J = 2.9 Hz). IR (neat) ν = 682, 939, 1028, 1345, 1515, 
1871, 2981 cm-1. HRMS calcd. for C15H28N2BF3Na+: 327.218891; found 327.219088. 
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7 Appendix 
 
7.1 NMR Spectra of Representative Compounds 
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Compound 43a 
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13C NMR 
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Compound 43c 
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31P NMR 
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150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
106 105 104
Chemical Shift (ppm)
145.50 145.25 145.00
Chemical Shift (ppm)
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Compound 44d 
 
1H NMR 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
24.0724.0312.098.128.00 3.883.83
Dichloromethane-d2
4.25 4.00 3.75 3.50
Chemical Shift (ppm)8.00 7.75 7.50Chemical Shift (ppm)
 
 
31P NMR 
120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
2 BF4
N
N
P
iPr
iPr
iPr
iPr
Rh
P
N iPr
iPr
N iPr
iPr
Cl
OC
p-tol
p-tol
p-tol
p-tol
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13C NMR 
 
145.1 145.0 144.9
Chemical Shift (ppm)
136 134 132
Chemical Shift (ppm)
126.0 125.5 125.0
Chemical Shift (ppm)
102.50 102.00
Chemical Shift (ppm)
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
Compound 45d 
 
1H NMR 
 
 
 
 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
12.126.214.09 4.022.032.001.99
Dichloromethane-d2
7.6 7.5 7.4 7.3
Chemical Shift (ppm)
4.094.04
4.2 4.1 4.0 3.9
Chemical Shift (ppm)
2.00 1.91
1.4 1.3 1.2 1.1
Chemical Shift (ppm)
12.12 11.59
 
BF4
N
N
P
iPr
iPr
iPr
iPr
RhCl
p-tol
p-tol
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31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
 
13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
143.85 143.80 143.75
Chemical Shift (ppm)
139.0 138.5
Chemical Shift (ppm)
134 133 132 131
Chemical Shift (ppm)
124.5 124.0 123.5
Chemical Shift (ppm)
108.00 107.75 107.50
Chemical Shift (ppm)
103.25 102.75
Chemical Shift (...
72.50 72.25
Chemical Shift (ppm)
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Compound 46a 
 
1H NMR 
 
 
7.75 7.50
Chemical Shift (ppm)
6.063.97
4.00 3.50
Chemical Shift (ppm)
1.971.95
1.25 1.00
Chemical Shift (ppm)
12.0812.00
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
12.0812.006.063.97 1.971.95
 
 
31P NMR 
140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
BF4
N
N
P
iPr
iPr
iPr
iPr
Au
Cl
Ph
Ph
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13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
97.0 96.5
Chemical Shift (...
136.0 135.5 135.0 134.5
Chemical Shift (ppm)
130.0 127.5 125.0
Chemical Shift (ppm)
 
 
Compound 48a 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
12.196.16 2.00 1.98
7.7 7.6 7.5 7.4
Chemical Shift (ppm)
6.164.12
4.00 3.75 3.50 3.25
Chemical Shift (ppm)
2.00 1.98
1.25 1.00
Chemical Shift (ppm)
12.19 12.13
 
BF4
N
N
P
iPr
iPr
iPr
iPr
Cu
Ph
Ph
Cl
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31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
 
13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
140.2 140.1 140.0
Chemical Shift (ppm)
136 135 134 133 132
Chemical Shift (ppm)
103.25 103.00 102.75
Chemical Shift (ppm)
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Compound 48b 
 
1H NMR 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
12.11 12.096.09 3.252.10 2.04 1.211.00 0.95
Chloroform-d
8.00 7.75 7.50
Chemical Shift (ppm)
6.092.10 2.08
5.5 5.0 4.5 4.0 3.5 3.0
Chemical Shift (ppm)
3.25 2.04 1.211.00 0.960.95
 
 
31P NMR 
140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
BF4N
N
P
iPr
iPr
iPr
iPr
Pd
Cl
Ph
Ph
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13C NMR 
139 138 137 136 135
Chemical Shift (ppm)
132 130 128
Chemical Shift (ppm)
118.25 118.00 117.75
Chemical Shift (ppm)
100.5 100.0
Chemical Shift (ppm)
82.0 81.0
Chemical Shift (...
60 55 50
Chemical Shift (ppm)
21.50 21.00
Chemical Shift (ppm)
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
 
Compound 49 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
15.02 12.196.15 2.112.00
7.9 7.8 7.7 7.6 7.5 7.4
Chemical Shift (ppm)
6.154.04
4.00 3.75 3.50
Chemical Shift (ppm)
2.112.00
 
BF4N
N
P
iPr
iPr
iPr
iPr
Ph
Ph
BH3
Appendix  129 
31P NMR 
 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
 
11B NMR 
60 50 40 30 20 10 0 -10 -20 -30 -40 -50 -60 -70 -80 -90 -100
Chemical Shift (ppm)
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13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
139.00 138.75
Chemical Shift (ppm)
134.50 134.00
Chemical Shift (ppm)
130 128 126
Chemical Shift (ppm)
99.7 99.6 99.5 99.4
Chemical Shift (ppm)
 
 
Compound 50 
 
1H NMR 
 
 
 
10 9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
24.0112.548.29 4.14
8.0 7.5
Chemical Shift (ppm)
12.548.29
4.00 3.75
Chemical Shift (ppm)
4.144.00
 
BF4
N
N
P
iPr
iPr
iPr
iPr
Rh
PhPh
P
N iPr
iPr
N iPr
iPr
Ph Ph
Cl
Cl
Cl
Cl
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31P NMR 
140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
 
13C NMR 
 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
135.75 135.50
Chemical Shift (ppm)
131 130 129
Chemical Shift (ppm)
100.6 100.4
Chemical Shift (ppm)
23.5 23.0 22.5
Chemical Shift ...
141.7 141.6141.5
Chemical Shift (ppm)
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Compound 81 
 
1H NMR 
 
 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
3.121.99 1.171.131.10 1.07 1.051.00
7.50 7.25 7.00
Chemical Shift (ppm)
3.122.991.99 1.05
4.25 4.00 3.75 3.50
Chemical Shift (ppm)
1.10 1.07 1.00
2.5 2.0 1.5
Chemical Shift (ppm)
1.171.13 1.09 1.05
 
 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
Ph
O
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Compound 82 
 
1H NMR 
 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
2.44 2.182.17 2.12
7.3 7.2 7.1 7.0 6.9
Chemical Shift (ppm)
2.442.14 2.10 2.08 1.04
4.4 4.3 4.2 4.1
Chemical Shift (ppm)
2.171.00
2.50 2.25 2.00
Chemical Shift (ppm)
2.18 2.12
 
 
13C NMR 
 
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
Ph
O
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Compound 98 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
3.901.90 1.061.011.011.000.96
7.50 7.25 7.00
Chemical Shift (ppm)
3.903.72 1.951.90 0.960.95
4.0 3.5 3.0
Chemical Shift (ppm)
1.011.011.00
1.9 1.8 1.7 1.6
Chemical Shift (ppm)
1.06 1.05 1.03
 
 
13C NMR 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
Ph
O
Ph
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Compound 99 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
13.90 2.08 2.07 2.07
4.15 4.10
Chemical Shift (ppm)
2.08
2.50 2.25 2.00
Chemical Shift (ppm)
2.07 2.07
7.2 7.1 7.0 6.9
Chemical Shift (ppm)
13.90
 
 
13C NMR 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
Ph
O
Ph
136   Appendix 
Compound 113a 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
18.266.172.00 0.46
Chloroform-d
4.3 4.2 4.1 4.0 3.9 3.8
Chemical Shift (ppm)
2.00 1.97 0.460.45
 
 
31P NMR 
 
100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
N
N
P
iPr
iPr
iPr
iPr
BF4
Ad
H
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13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
102.5 102.0 101.5
Chemical Shift (ppm)
42 40 38
Chemical Shift (ppm)
28.50 28.25
Chemical Shift (ppm)
 
 
Compound 114a 
 
1H NMR 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
12.176.035.892.952.08 2.00
4.00 3.75 3.50
Chemical Shift (ppm)
2.08 2.00
2.5 2.0 1.5 1.0
Chemical Shift (ppm)
12.17 11.606.035.89 2.95
 
N
N
P
iPr
iPr
iPr
iPr
Ad
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31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
 
13C NMR 
140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
126 125 124 123
Chemical Shift (ppm)
49 48 47 46 45
Chemical Shift (ppm)
35 30 25
Chemical Shift (ppm)
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Compound 115 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
24.073.95 3.942.99
7.8 7.7 7.6
Chemical Shift (ppm)
2.992.00
4.00 3.75
Chemical Shift (ppm)
3.95 3.94
 
 
31P NMR 
100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
N(iPr)2
N(iPr)2
Ph
P
(iPr)2N
N(iPr)2
2 BF4
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13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
138 136 134 132
Chemical Shift (ppm)
125.05 125.00
Chemical Shift (ppm)
99.5 99.0 98.5
Chemical Shift (ppm)
55.00 54.75 54.50
Chemical Shift (ppm)
21.50 21.25
Chemical Shift (ppm)
 
 
Compound 117 
 
1H NMR 
 
 
 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
24.054.00 3.952.971.90
Dichloromethane-d2
8.00 7.75
Chemical Shift (ppm)
2.971.90
4.25 4.00 3.75
Chemical Shift (ppm)
4.00 3.95
1.5 1.4 1.3 1.2
Chemical Shift (ppm)
24.05 12.18 12.15
 
N(iPr)2
N(iPr)2
Ph
P
(iPr)2N
N(iPr)2
Au
Cl
2 BF4
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31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
135 130 125
Chemical Shift (ppm)
91.5 91.0 90.5
Chemical Shift (ppm)
56.5 56.0 55.5 55.0
Chemical Shift (ppm)
22.00 21.75 21.50
Chemical Shift (ppm)
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Compound 119 
 
1H NMR 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
12.264.003.222.06
8.50 8.25 8.00 7.75
Chemical Shift (ppm)
3.222.06
4.3 4.2 4.1 4.0
Chemical Shift (ppm)
4.003.93
1.3 1.2 1.1
Chemical Shift (ppm)
12.2612.1412.12 11.96
 
 
31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
N(iPr)2
N(iPr)2
Ph
P
(iPr)2N
N(iPr)2
Pd
Cl
BF4
Cl Cl
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13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
136 134 132 130
Chemical Shift (ppm)
120 112 104 96
Chemical Shift (ppm)
 
 
Compound 125 
 
1H NMR 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
12.009.271.991.90
 
N
N
P
iPr
iPr
iPr
iPr Ad
AuCl
AuCl
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31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
149.0 148.5 148.0
Chemical Shift (ppm)
42.50 42.25 42.00
Chemical Shift (ppm)
43.85 43.80 43.75
Chemical Shift (ppm)
28.9 28.8 28.7 28.6
Chemical Shift (ppm)
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Compound 126 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
24.02 6.005.931.781.77
1.9 1.8 1.7 1.6 1.5 1.4 1.3 1.2
Chemical Shift (ppm)
24.026.365.932.98
 
 
31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
 
N
N
P
iPr
iPr
iPr
iPr Ad
BH3
BH3
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11B NMR 
 
60 50 40 30 20 10 0 -10 -20 -30 -40 -50 -60 -70 -80 -90
Chemical Shift (ppm)
 
 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
142.50 142.00
Chemical Shift (ppm)
111.50
Chemical Shift (ppm)
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Compound 134 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
36.076.045.81
Dichloromethane-d2
4.3 4.2 4.1 4.0 3.9
Chemical Shift (ppm)
6.045.81
1.45 1.40
Chemical Shift (ppm)
36.07 36.00
 
 
31P NMR 
100 80 60 40 20 0 -20 -40 -60 -80 -100
Chemical Shift (ppm)
 
3 BF4
P
(iPr)2N(iPr)2N N(iPr)2
(iPr)2N N(iPr)2
N(iPr)2
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13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
140.2 140.1
Chemical Shift (ppm)
91.0 90.5 90.0
Chemical Shift...
57.75 57.50 57.2557.00
Chemical Shift (ppm)
22.00 21.75 21.50 21.25
Chemical Shift (ppm)
 
 
Compound 136 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
24.39 8.792.04
Dichloromethane-d2
4.1 4.0
Chemical Shift (ppm)
2.042.00
1.45 1.40 1.35 1.30
Chemical Shift (ppm)
24.39
 
Si
N
iPr
iPr
N
iPr
iPr
TfO
Me
Me
Me
Appendix  149 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
136 128 120 112
Chemical Shift (ppm)
 
 
Compound 141 
 
1H NMR 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
18.00
 
3 ClO4
NMe2
NMe2
Me2N
Me2N
P
Me2N
NMe2
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31P NMR 
60 40 20 0 -20 -40 -60 -80 -100 -120 -140 -160
Chemical Shift (ppm)
 
 
13C NMR 
150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
142.5 142.4 142.3
Chemical Shift (ppm)
93.50 93.00
Chemical Shift (ppm)
43.85 43.75
Chemical Shift (ppm)
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Compound 143 
 
1H NMR 
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
18.08
3.45 3.40 3.35 3.30
Chemical Shift (ppm)
18.0818.00
 
 
31P NMR 
160 140 120 100 80 60 40 20 0 -20 -40 -60 -80
Chemical Shift (ppm)
-40 -50 -60 -70 -80
Chemical Shift (ppm)
 
NMe2
NMe2
Me2N
Me2N
P
Me2N
NMe2
PtCl Cl
Cl
2ClO4
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13C NMR 
 
160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
140.00 139.50 139.00
Chemical Shift (ppm)
84.5 84.0
Chemical Shift (ppm)
43.25 43.00 42.75
Chemical Shift (ppm)
 
 
Compound 166b 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
48.044.06
Dichloromethane-d2
4.25 4.00 3.75
Chemical Shift (ppm)
4.064.00
1.450 1.425 1.400 1.375
Chemical Shift (ppm)
48.04
 
N
N
S
iPr
iPr
iPr
iPr
N
N
iPr
iPr
iPr
iPr
2 TfO
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13C NMR 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
135 130 125 120 115
Chemical Shift (ppm)
 
 
Compound 167a 
 
1H NMR 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
24.014.08
4.1 4.0 3.9 3.8
Chemical Shift (ppm)
4.084.05
1.350 1.325 1.300 1.275
Chemical Shift (ppm)
24.0124.00
 
N
N
Se
iPr
iPr
iPr
iPr
N
N
iPr
iPr
iPr
iPr
2 BF4
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13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
 
Compound 169b 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
48.048.00
Edited Region
4.10 4.05 4.00 3.95
Chemical Shift (ppm)
8.00
1.350 1.300
Chemical Shift (ppm)
48.04
 
N
N
Te
iPr
iPr
iPr
iPr
N
N
iPr
iPr
iPr
iPr
2 TfO
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13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
 
 
Compound 170 
 
1H NMR 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
12.144.00
Dichloromethane-d2
4.0 3.9 3.8 3.7
Chemical Shift (ppm)
4.00
1.4 1.3
Chemical Shift (ppm)
12.14 12.09
 
N
N
BF3
iPr
iPr
iPr
iPr
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11B NMR 
 
70 60 50 40 30 20 10 0 -10 -20 -30 -40 -50 -60 -70 -80
Chemical Shift (ppm)
1 0 -1
Chemical Shift (ppm)
 
 
19F NMR 
-10 -20 -30 -40 -50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170
Chemical Shift (ppm)
-137.5 -138.0 -138.5
Chemical Shift (ppm)
 
Appendix  157 
13C NMR 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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7.2 X-ray Structures 
 
7.2.1 Crystal data and structure refinement of compound 43a 
 
C35
C34
F4
C36
F1
F2
B1
C33
C31
C32
F3
P1
C8
C14
C22
C1
C7
C21
C2
C23
C3
N1
C13
C9
C11
N2
C5
C26
C15
C4
C24
C10
C25
C6
C12
 
Empirical formula  C27 H38 B F4 N2 P 
Color  colorless 
Formula weight  508.37  g · mol-1 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/n,  (no. 14) 
Unit cell dimensions a = 10.0045(4) Å α= 90°. 
 b = 17.9768(7) Å β= 100.3280(10)°. 
 c = 15.8577(6) Å γ = 90°. 
Volume 2805.78(19) Å3 
Z 4 
Density (calculated) 1.203  Mg · m-3 
Absorption coefficient 1.242 mm-1 
F(000) 1080 e 
160   Appendix 
Crystal size 0.6 x 0.6 x 0.4 mm3 
θ range for data collection 3.75 to 67.35°. 
Index ranges -10 ≤ h ≤ 11, -21≤ k ≤ 21, -18 ≤ l ≤ 18 
Reflections collected 63399 
Independent reflections 4856 [Rint = 0.0305] 
Reflections with I>2σ(I) 4785 
Completeness to θ = 67.35° 96.4 % 
Absorption correction Empirical 
Max. and min. transmission 0.75 and 0.62 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4856 / 0 / 324 
Goodness-of-fit on F2 1.023 
Final R indices [I>2 σ (I)] R1 = 0.0483 wR2 = 0.1332 
R indices (all data) R1 = 0.0486 wR2 = 0.1334 
Largest diff. peak and hole 0.573 and -0.536 e · Å-3 
 
Appendix  161 
7.2.2 Crystal data and structure refinement of compound 43d 
C37
C33
C34 F4
C32
C35
F1
C5
B1
C31
C36
F3
F2C4
C6
P1 N1
C1 C2
C8
C7
C21C26
C3
C14
C22
C25
C9
N2
C13
C23
C24
C11
C10
C15
C27
C12
 
 
Empirical formula  C29 H42 B F4 N2 P 
Color  colorless 
Formula weight  536.43  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c,  (no. 15) 
Unit cell dimensions a = 22.2571(4) Å α= 90°. 
 b = 19.2743(4) Å β= 105.3470(10)°. 
 c = 14.0616(3) Å γ = 90°. 
Volume 5817.2(2) Å3 
Z 8 
Density (calculated) 1.225  Mg · m-3 
Absorption coefficient 0.140 mm-1 
F(000) 2288 e 
Crystal size 0.50 x 0.40 x 0.4 mm3 
θ range for data collection 2.97 to 33.15°. 
Index ranges -24 ≤ h ≤ 34, -29≤ k ≤ 29, -21 ≤ l ≤ 18 
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Reflections collected 33616 
Independent reflections 11096 [Rint = 0.0492] 
Reflections with I>2σ(I) 6874 
Completeness to θ = 33.15° 99.9 % 
Absorption correction Empirical 
Max. and min. transmission 0.97 and 0.75 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11096 / 0 / 344 
Goodness-of-fit on F2 1.034 
Final R indices [I>2σ(I)] R1 = 0.0553 wR2 = 0.1307 
R indices (all data) R1 = 0.1067 wR2 = 0.1567 
Largest diff. peak and hole 0.491 and -0.801 e · Å-3 
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7.2.3 Crystal data and structure refinement of compound 43e 
C6
C35
C36
C8
C4
F2
C34
P1
C31
N1
C7
C2
C5
C1
C33
C32
C3
C9
C11
C26
C21
N2
C14
C13
C10
C25C22
C12
C15
C24
C23
F5
F4
F1
B1
F6
F3
 
 
Empirical formula  C27 H36 B F6 N2 P 
Color  colorless 
Formula weight  544.36  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n,  (no. 14) 
Unit cell dimensions a = 9.9783(2) Å α= 90°. 
 b = 18.3382(6) Å β= 100.866(2)°. 
 c = 15.6515(4) Å γ = 90°. 
Volume 2812.63(13) Å3 
Z 4 
Density (calculated) 1.286  Mg · m-3 
Absorption coefficient 0.156 mm-1 
F(000) 1144 e 
Crystal size 0.10 x 0.07 x 0.05 mm3 
θ range for data collection 3.04 to 31.59°. 
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Index ranges -14 ≤ h ≤ 14, -26≤ k ≤ 26, -23 ≤ l ≤ 23 
Reflections collected 45554 
Independent reflections 9392 [Rint = 0.0722] 
Reflections with I>2σ(I) 5892 
Completeness to θ = 31.59° 99.6 % 
Absorption correction Empirical 
Max. and min. transmission 0.99 and 0.74 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9392 / 0 / 342 
Goodness-of-fit on F2 1.010 
Final R indices [I>2σ(I)] R1 = 0.0629 wR2 = 0.1299 
R indices (all data) R1 = 0.1161 wR2 = 0.1532 
Largest diff. peak and hole 0.596 and -0.452 e · Å-3 
Appendix  165 
7.2.4 Crystal data and structure refinement of compound 43f 
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Empirical formula  C29 H42 N2 O2 P  · B F4 
Color  colourless 
Formula weight  568.43  g · mol-1 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21,  (no. 4) 
Unit cell dimensions a = 10.3056(4) Å α= 90°. 
 b = 14.3756(5) Å β= 113.206(2)°. 
 c = 11.1033(4) Å γ = 90°. 
Volume 1511.86(10) Å3 
Z 2 
Density (calculated) 1.249  Mg · m-3 
Absorption coefficient 1.257 mm-1 
F(000) 604 e 
Crystal size 0.48 x 0.06 x 0.06 mm3 
θ range for data collection 4.33 to 66.69°. 
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Index ranges -12 ≤ h ≤ 12, -17≤ k ≤ 17, -13≤ l ≤ 13 
Reflections collected 33883 
Independent reflections 5113 [Rint = 0.1041] 
Reflections with I>2σ(I) 4410 
Completeness to θ = 66.69° 98.8 % 
Absorption correction Gaussian 
Max. and min. transmission 0.94 and 0.71 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5113 / 1 / 362 
Goodness-of-fit on F2 1.086 
Final R indices [I>2σ(I)] R1 = 0.0605 wR2 = 0.1461 
R indices (all data) R1 = 0.0732 wR2 = 0.1568 
Absolute structure parameter 0.06(3) 
Largest diff. peak and hole 0.750 and -0.479 e · Å-3 
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7.2.5 Crystal data and structure refinement of compound 44a 
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Empirical formula  C55 H76 Cl N4 O P2 Rh · 2 (B F4-) 
Color  black 
Formula weight  1183.12  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  ORTHORHOMBIC 
Space group  P21 21 21,  (no. 19) 
Unit cell dimensions a = 14.1864(16) Å α= 90°. 
 b = 15.8242(18) Å β= 90°. 
 c = 26.542(3) Å γ = 90°. 
Volume 5958.4(12) Å3 
Z 4 
Density (calculated) 1.327  Mg · m-3 
Absorption coefficient 0.450 mm-1 
F(000) 2476 e 
Crystal size 0.14 x 0.04 x 0.03 mm3 
θ range for data collection 1.50 to 30.46°. 
Index ranges -20 ≤ h ≤ 20, -22≤ k ≤ 22, -37 ≤ l ≤ 37 
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Reflections collected 170338 
Independent reflections 18132 [Rint = 0.0399] 
Reflections with I>2σ(I) 17278 
Completeness to θ = 27.50° 100.0 % 
Absorption correction Gaussian 
Max. and min. transmission 1.00 and 0.91 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 18132 / 0 / 711 
Goodness-of-fit on F2 1.142 
Final R indices [I>2σ(I)] R1 = 0.0282 wR2 = 0.0720 
R indices (all data) R1 = 0.0315 wR2 = 0.0770 
Absolute structure parameter 0.00(12) 
Largest diff. peak and hole 1.026 and -0.556 e · Å-3 
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7.2.6 Crystal data and structure refinement of compound 46a 
 
C34 C33
C35
C32
F2 C36
F3
C25
C31
C26
B1
C24
F1
F4
C21
P1
C12
C23
C22
C5
C1
C10
Au1
C2
C3
N2
C11
C15
C9
C4
N1
Cl1
C13
C7
C6
C14
C8
 
 
Empirical formula  C27 H38 Au B Cl F4 N2 P 
Color  colorless 
Formula weight  740.79  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c,  (no. 14) 
Unit cell dimensions a = 10.6764(2) Å α= 90°. 
 b = 14.4331(2) Å β= 104.3320(10)°. 
 c = 19.9072(4) Å γ = 90°. 
Volume 2972.10(9) Å3 
Z 4 
Density (calculated) 1.656  Mg · m-3 
Absorption coefficient 5.138 mm-1 
F(000) 1464 e 
Crystal size 0.27 x 0.07 x 0.07 mm3 
θ range for data collection 3.01 to 33.19°. 
Index ranges -16 ≤ h ≤ 16, -22≤ k ≤ 22, -30 ≤ l ≤ 30 
Reflections collected 55673 
Independent reflections 11348 [Rint = 0.0409] 
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Reflections with I>2σ(I) 9080 
Completeness to θ = 33.19° 99.6 % 
Absorption correction Empirical 
Max. and min. transmission 0.99 and 0.68 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11348 / 0 / 342 
Goodness-of-fit on F2 1.026 
Final R indices [I>2σ(I)] R1 = 0.0377 wR2 = 0.0857 
R indices (all data) R1 = 0.0537 wR2 = 0.0929 
Largest diff. peak and hole 2.285 and -2.185 e·Å-3 
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7.2.7 Crystal data and structure refinement of compound 46f 
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Empirical formula  C29 H42 Au B Cl F4 N2 O2 P 
Color  colourless 
Formula weight  800.84  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1¯,  (no. 2) 
Unit cell dimensions a = 10.5654(8) Å α= 96.4710(10)°. 
 b = 13.3962(10) Å β= 108.2060(10)°. 
 c = 13.5582(10) Å γ = 111.5600(10)°. 
Volume 1638.2(2) Å3 
Z 2 
Density (calculated) 1.624  Mg · m-3 
Absorption coefficient 4.672 mm-1 
F(000) 796 e 
Crystal size 0.08 x 0.04 x 0.04 mm3 
θ range for data collection 3.55 to 36.68°. 
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Index ranges -17 ≤ h ≤ 17, -22≤ k ≤ 22, -22≤ l ≤ 22 
Reflections collected 61814 
Independent reflections 15258 [Rint = 0.0195] 
Reflections with I>2σ(I) 14610 
Completeness to θ = 36.68° 93.7 % 
Absorption correction Gaussian 
Max. and min. transmission 0.88 and 0.78 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15258 / 0 / 380 
Goodness-of-fit on F2 1.056 
Final R indices [I>2σ(I)] R1 = 0.0182 wR2 = 0.0503 
R indices (all data) R1 = 0.0195 wR2 = 0.0510 
Largest diff. peak and hole 3.629 and -1.464 e · Å-3 
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7.2.8 Crystal data and structure refinement of compound 48b 
C24
C25
C23
C26
C11
C29B
C30
C28
C22
C29A
C27
C10
Pd1
C12
Cl1
P1 N2
C14
C13C2
C15B
C1C16C17
C3
C15AC21
C18
F4
N1
C8
C20
F3
C19
C4
F2
C7
B1
C6
C5
F1
C9
 
 
Empirical formula  C30 H43 B Cl F4 N2 P Pd 
Color  yellow 
Formula weight  691.29  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  TRICLINIC 
Space group  P1¯,  (no. 2) 
Unit cell dimensions a = 10.3679(7) Å α= 80.917(8)°. 
 b = 11.1528(12) Å β= 75.836(7)°. 
 c = 14.9063(12) Å γ = 77.536(7)°. 
Volume 1621.8(2) Å3 
Z 2 
Density (calculated) 1.416  Mg · m-3 
Absorption coefficient 0.749 mm-1 
F(000) 712 e 
Crystal size 0.12 x 0.12 x 0.08 mm3 
θ range for data collection 2.75 to 33.23°. 
Index ranges -15 ≤ h ≤ 15, -17≤ k ≤ 17, -22≤ l ≤ 22 
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Reflections collected 45668 
Independent reflections 12368 [Rint = 0.0542] 
Reflections with I>2σ(I) 8816 
Completeness to θ = 33.23° 99.5 % 
Absorption correction Gaussian 
Max. and min. transmission 0.95 and 0.92 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12368 / 0 / 388 
Goodness-of-fit on F2 1.034 
Final R indices [I>2σ(I)] R1 = 0.0476 wR2 = 0.0980 
R indices (all data) R1 = 0.0830 wR2 = 0.1132 
Largest diff. peak and hole 0.821 and -1.408 e · Å-3 
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7.2.9 Crystal data and structure refinement of compound 48c 
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Empirical formula  C30 H42 B Cl F6 N2 P Pd 
Color  yellow 
Formula weight  728.29  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca,  (no. 61) 
Unit cell dimensions a = 15.8827(7) Å α= 90°. 
 b = 11.0550(5) Å β= 90°. 
 c = 36.5987(16) Å γ = 90°. 
Volume 6426.1(5) Å3 
Z 8 
Density (calculated) 1.506  Mg · m-3 
Absorption coefficient 0.769 mm-1 
F(000) 2984 e 
Crystal size 0.30 x 0.17 x 0.12 mm3 
θ range for data collection 3.16 to 33.19°. 
176   Appendix 
Index ranges -24 ≤ h ≤ 24, -17≤ k ≤ 16, -56 ≤ l ≤ 56 
Reflections collected 80403 
Independent reflections 12270 [Rint = 0.0797] 
Reflections with I>2σ(I) 6885 
Completeness to θ = 33.19° 99.9 % 
Absorption correction Empirical 
Max. and min. transmission 0.99 and 0.68 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12270 / 0 / 388 
Goodness-of-fit on F2 1.031 
Final R indices [I>2σ(I)] R1 = 0.0805 wR2 = 0.2271 
R indices (all data) R1 = 0.1359 wR2 = 0.2741 
Extinction coefficient 0.0024(4) 
Largest diff. peak and hole 2.663 and -2.813 e · Å-3 
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7.2.10 Crystal data and structure refinement of compound 50 
 
 
Empirical formula  C54 H76 B Cl4 F4 N4 P2 Rh 
Color  colourless 
Formula weight  1174.64  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1¯,  (no. 2) 
Unit cell dimensions a = 12.4061(18) Å α= 103.320(3)° 
 b = 15.032(2) Å β= 98.593(3)° 
 c = 19.428(3) Å γ = 104.421(3)° 
Volume 3331.3(8) Å3 
Z 2 
Density (calculated) 1.171  Mg · m-3 
Absorption coefficient 0.509 mm-1 
178   Appendix 
F(000) 1224 e 
Crystal size 0.18 x 0.16 x 0.03 mm3 
θ range for data collection 1.10 to 27.50°. 
Index ranges -16 ≤ h ≤ 16, -19≤ k ≤ 19, -23 ≤ l ≤ 25 
Reflections collected 77788 
Independent reflections 15296 [Rint = 0.0616] 
Reflections with I>2σ(I) 11430 
Completeness to θ = 27.50° 100.0 % 
Absorption correction Gaussian 
Max. and min. transmission 1.00 and 0.98 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15296 / 0 / 648 
Goodness-of-fit on F2 1.106 
Final R indices [I>2σ(I)] R1 = 0.0410 wR2 = 0.1032 
R indices (all data) R1 = 0.0602 wR2 = 0.1094 
Largest diff. peak and hole 1.078 and -0.619 e · Å-3 
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7.2.11 Crystal data and structure refinement of compound 97 
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Empirical formula  C19 H18 O 
Color  colourless 
Formula weight  262.33  g · mol-1 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  Pbca,  (no. 61) 
Unit cell dimensions a = 14.6635(18) Å α= 90°. 
 b = 7.7159(10) Å β= 90°. 
 c = 24.482(3) Å γ = 90°. 
Volume 2770.0(6) Å3 
Z 8 
Density (calculated) 1.258  Mg · m-3 
Absorption coefficient 0.585 mm-1 
F(000) 1120 e 
Crystal size 0.41 x 0.36 x 0.14 mm3 
θ range for data collection 3.61 to 66.97°. 
Index ranges -17 ≤ h ≤ 15, -9≤ k ≤ 8, -26 ≤ l ≤ 28 
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Reflections collected 44701 
Independent reflections 2425 [Rint = 0.0433] 
Reflections with I>2σ(I) 2336 
Completeness to θ = 66.97° 98.1 % 
Absorption correction Gaussian 
Max. and min. transmission 0.92 and 0.79 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2425 / 0 / 182 
Goodness-of-fit on F2 1.051 
Final R indices [I>2σ(I)] R1 = 0.0357 wR2 = 0.0895 
R indices (all data) R1 = 0.0367 wR2 = 0.0902 
Largest diff. peak and hole 0.220 and -0.203 e · Å-3 
 
Appendix  181 
7.2.12 Crystal data and structure refinement of compound 113a 
 
 
Empirical formula  C25 H44 B F4 N2 P 
Color  colourless 
Formula weight  490.40  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21,  (no. 4) 
Unit cell dimensions a = 8.1898(2) Å α= 90.0°. 
 b = 11.3350(3) Å β= 94.9740(10)°. 
 c = 14.5669(3) Å γ = 90.0°. 
Volume 1347.17(6) Å3 
Z 2 
Density (calculated) 1.209  Mg · m-3 
Absorption coefficient 0.145 mm-1 
F(000) 528 e 
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Crystal size 0.42 x 0.12 x 0.06 mm3 
θ range for data collection 2.97 to 33.27°. 
Index ranges -12 ≤ h ≤ 12, -17≤ k ≤ 17, -22≤ l ≤ 22 
Reflections collected 79951 
Independent reflections 10307 [Rint = 0.0972] 
Reflections with I>2σ(I) 6555 
Completeness to θ = 33.27° 99.4 % 
Absorption correction Gaussian 
Max. and min. transmission 0.99131 and 0.95490 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10307 / 1 / 310 
Goodness-of-fit on F2 1.021 
Final R indices [I>2σ(I)] R1 = 0.0560 wR2 = 0.1204 
R indices (all data) R1 = 0.1159 wR2 = 0.1454 
Absolute structure parameter -0.12(9) 
Largest diff. peak and hole 0.412 and -0.430 e · Å-3 
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7.2.13 Crystal data and structure refinement of compound 115 
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Empirical formula  C36 H61 B2 F8 N4 P 
Color  colourless 
Formula weight  754.48  g · mol-1 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  Pbcn,  (no. 60) 
Unit cell dimensions a = 45.8483(14) Å α= 90°. 
 b = 11.6679(3) Å β= 90°. 
 c = 15.3567(5) Å γ = 90°. 
Volume 8215.1(4) Å3 
Z 8 
Density (calculated) 1.220  Mg · m-3 
Absorption coefficient 1.160 mm-1 
F(000) 3216 e 
Crystal size 0.59 x 0.51 x 0.04 mm3 
θ range for data collection 1.93 to 67.48°. 
Index ranges -54 ≤ h ≤ 54, -13≤ k ≤ 13, -18 ≤ l ≤ 18 
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Reflections collected 205006 
Independent reflections 7325 [Rint = 0.1118] 
Reflections with I>2σ(I) 6324 
Completeness to θ = 67.48° 99.0 % 
Absorption correction Gaussian 
Max. and min. transmission 0.96 and 0.51 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7325 / 0 / 495 
Goodness-of-fit on F2 2.065 
Final R indices [I>2σ(I)] R1 = 0.0794 wR2 = 0.1689 
R indices (all data) R1 = 0.0895 wR2 = 0.1718 
Extinction coefficient 0.00099(8) 
Largest diff. peak and hole 0.608 and -0.429 e · Å-3 
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7.2.14 Crystal data and structure refinement of compound 117 
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Empirical formula  C23 H38 Au Cl N2 O P+ · B F4- 
Color  yellow 
Formula weight  708.75  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/n,  (no. 14) 
Unit cell dimensions a = 10.6782(11) Å α= 90° 
 b = 13.9102(9) Å β= 104.871(6)° 
 c = 19.8627(18) Å γ = 90° 
Volume 2851.5(4) Å3 
Z 4 
Density (calculated) 1.651  Mg · m-3 
Absorption coefficient 5.353 mm-1 
F(000) 1400 e 
Crystal size 0.20 x 0.14 x 0.10 mm3 
θ range for data collection 2.87 to 27.50°. 
Index ranges -13 ≤ h ≤ 13, -17≤ k ≤ 18, -25 ≤ l ≤ 25 
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Reflections collected 43582 
Independent reflections 6536 [Rint = 0.0529] 
Reflections with I>2σ(I) 5652 
Completeness to θ = 27.50° 99.9 % 
Absorption correction Gaussian 
Max. and min. transmission 0.61 and 0.40 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6536 / 0 / 325 
Goodness-of-fit on F2 1.088 
Final R indices [I>2σ(I)] R1 = 0.0407 wR2 = 0.0930 
R indices (all data) R1 = 0.0500 wR2 = 0.0980 
Largest diff. peak and hole 3.314 and -1.230 e · Å-3 
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7.2.15 Crystal data and structure refinement of compound 118 
 
 
Empirical formula  C37 H61.50 B Cl6 F4 N4 P Pt 
Color  yellow 
Formula weight  1087.97  g · mol-1 
Temperature  200 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14) 
Unit cell dimensions a = 25.819(3) Å α= 90°. 
 b = 15.859(2) Å β= 113.707(6)°. 
 c = 25.450(2) Å γ = 90°. 
Volume 9541.1(19) Å3 
Z 8 
Density (calculated) 1.515  Mg · m-3 
Absorption coefficient 3.357 mm-1 
F(000) 4380 e 
Crystal size 0.153 x 0.152 x 0.050 mm3 
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θ range for data collection 2.71 to 27.50°. 
Index ranges -33 ≤ h ≤ 33, -20≤ k ≤ 20, -33 ≤ l ≤ 32 
Reflections collected 129550 
Independent reflections 21869 [Rint = 0.0612] 
Reflections with I>2σ(I) 18230 
Completeness to θ = 27.50° 99.8 % 
Absorption correction Gaussian 
Max. and min. transmission 0.85 and 0.35 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 21869 / 0 / 998 
Goodness-of-fit on F2 1.208 
Final R indices [I>2σ(I)] R1 = 0.0822 wR2 = 0.2045 
R indices (all data) R1 = 0.0969 wR2 = 0.2135 
Largest diff. peak and hole 4.066 and -2.870 e · Å-3 
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7.2.16 Crystal data and structure refinement of compound 126 
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Empirical formula  C25 H48 B2 N2 P 
Color  colorless 
Formula weight  429.24  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pnma,  (no. 62) 
Unit cell dimensions a = 14.3239(2) Å α= 90°. 
 b = 16.1313(2) Å β= 90°. 
 c = 11.9731(2) Å γ = 90°. 
Volume 2766.54(7) Å3 
Z 4 
Density (calculated) 1.031  Mg · m-3 
Absorption coefficient 0.113 mm-1 
F(000) 948 e 
Crystal size 0.16 x 0.10 x 0.05 mm3 
θ range for data collection 3.11 to 27.49°. 
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Index ranges -18 ≤ h ≤ 18, -20≤ k ≤ 20, -15 ≤ l ≤ 15 
Reflections collected 41754 
Independent reflections 3291 [Rint = 0.0555] 
Reflections with I>2σ(I) 2417 
Completeness to θ = 27.49° 99.8 % 
Absorption correction Gaussian 
Max. and min. transmission 0.99 and 0.54 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3291 / 1 / 180 
Goodness-of-fit on F2 1.042 
Final R indices [I>2σ(I)] R1 = 0.0720 wR2 = 0.1816 
R indices (all data) R1 = 0.0968 wR2 = 0.2067 
Extinction coefficient 0.018(3) 
Largest diff. peak and hole 0.401 and -0.298 e · Å-3 
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7.2.17 Crystal data and structure refinement of compound 134a 
C42
C44
C40
C9
C41
F7
C45
C43
N6
C26
C7
F5A
C5
F5B
B2
C8
C27
C25
C32
N1
F6
F12
C4
P1
F8
C3
C31
C1
C6
C12
C33
N4
C35
C2
C29
B3
C16
F10
C17
C14
F9
N2
C28
C10
N5
C30
F11
C34
C36
C13
C18
C11
C20
C37
C38
N3
C15
F2
C19C21
C22
C39
F4
C23
B1 F3
C24
F1
O1
 
 
Empirical formula  C45 H86 B3 F12 N6 O P 
Color  colourless 
Formula weight  1018.60  g · mol-1 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  MONOCLINIC 
Space group  P21/c,  (no. 14) 
Unit cell dimensions a = 13.2410(6) Å α= 90°. 
 b = 20.3202(9) Å β= 101.408(2)°. 
 c = 21.5275(10) Å γ = 90°. 
Volume 5677.8(4) Å3 
Z 4 
Density (calculated) 1.192  Mg · m-3 
Absorption coefficient 1.087 mm-1 
F(000) 2176 e 
Crystal size 0.3 x 0.24 x 0.14 mm3 
θ range for data collection 3.02 to 67.21°. 
Index ranges -15 ≤ h ≤ 15, -24≤ k ≤ 24, -25 ≤ l ≤ 24 
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Reflections collected 246109 
Independent reflections 10120 [Rint = 0.0552] 
Reflections with I>2σ(I) 9467 
Completeness to θ = 67.21° 99.7 % 
Absorption correction Gaussian 
Max. and min. transmission 0.88 and 0.71 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10120 / 0 / 655 
Goodness-of-fit on F2 1.050 
Final R indices [I>2σ(I)] R1 = 0.0500 wR2 = 0.1255 
R indices (all data) R1 = 0.0527 wR2 = 0.1279 
Largest diff. peak and hole 0.826 and -0.615 e · Å-3 
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7.2.18 Crystal data and structure refinement of compound 166a 
C5
F3
F5
C4
C8
F7
F2
C6
F6
B1 B2
Cl1
F1
N1
S1
C7
C31
F4
C9
C27
C2
C1
F8
C21
C16
C3
Cl2
C25C26
C17
C18
N4
C19
N2
C11
C20
C30
N3
C13
C10
C14 C28
C12
C24
C22
C15
C29
C23
 
 
Empirical formula  C31 H58 B2 Cl2 F8 N4 S 
Color  colourless 
Formula weight  763.39  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pbca,  (no. 61) 
Unit cell dimensions a = 15.9281(17) Å α= 90°. 
 b = 16.791(3) Å β= 90°. 
 c = 29.680(2) Å γ = 90°. 
Volume 7937.7(18) Å3 
Z 8 
Density (calculated) 1.278  Mg · m-3 
Absorption coefficient 0.281 mm-1 
F(000) 3232 e 
Crystal size 0.32 x 0.16 x 0.16 mm3 
θ range for data collection 2.71 to 33.10°. 
Index ranges -24 ≤ h ≤ 24, -25≤ k ≤ 24, -44 ≤ l ≤ 45 
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Reflections collected 186573 
Independent reflections 15030 [Rint = 0.0649] 
Reflections with I>2σ(I) 9521 
Completeness to θ = 30.00° 99.8 % 
Absorption correction Gaussian 
Max. and min. transmission 0.98 and 0.97 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15030 / 0 / 449 
Goodness-of-fit on F2 1.039 
Final R indices [I>2σ(I)] R1 = 0.0464 wR2 = 0.1007 
R indices (all data) R1 = 0.0959 wR2 = 0.1178 
Largest diff. peak and hole 1.036 and -1.045 e · Å-3 
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7.2.19 Crystal data and structure refinement of compound 167a 
F3
F2
B1
F4
Cl2
F1
C25
C14
Cl1 C99
C29
C24
C13
C15
C26
C12
F8
N3
C27
C11
N2
C28
C10
F7
B2
C22
C2
Se1
F5
C21
C35
C1
F6
C23
C3
N4
C33
C9
N1
C31
C7
C34
C30
C6
C4
C8 C32
C5
 
 
Empirical formula  C31 H58 B2 Cl2 F8 N4 Se 
Color  colorless 
Formula weight  810.29  g · mol-1 
Temperature  130 K 
Wavelength  1.54184 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pbca,  (no. 61) 
Unit cell dimensions a = 16.0030(6) Å α= 90°. 
 b = 16.9693(7) Å β= 90°. 
 c = 29.6752(12) Å γ = 90°. 
Volume 8058.6(6) Å3 
Z 8 
Density (calculated) 1.336  Mg · m-3 
Absorption coefficient 3.034 mm-1 
F(000) 3376 e 
Crystal size 0.24 x 0.23 x 0.21 mm3 
θ range for data collection 2.98 to 67.28°. 
Index ranges -18 ≤ h ≤ 18, -20≤ k ≤ 20, -35 ≤ l ≤ 33 
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Reflections collected 175830 
Independent reflections 7176 [Rint = 0.0501] 
Reflections with I>2σ(I) 6719 
Completeness to θ = 67.28° 99.3 % 
Absorption correction Gaussian 
Max. and min. transmission 0.74 and 0.63 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7176 / 0 / 449 
Goodness-of-fit on F2 1.025 
Final R indices [I>2σ(I)] R1 = 0.0301 wR2 = 0.0747 
R indices (all data) R1 = 0.0318 wR2 = 0.0756 
Largest diff. peak and hole 0.711 and -0.765 e · Å-3 
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7.2.20 Crystal data and structure refinement of compound 169b 
O5B
C27
F6A
C29
O4A S2B
C25
O4B
F5B
C32A
F5A
O6B
S2A
O6A
O1
C26
N4
F4A
C28
C32B
F4B
C30
O2
C17
Te1
S1
O5A
F6B
C16
O3
F2 C18
C31
F1
C9
C1
C24
N3
C22
C14
C21
F3
C13
C2
C8
C7
C3
C19
C15
Cl2B
N2
C23
N1
Cl2A
C20
C6
C33B
Cl1B
C12
C10
C4
C33A
Cl1A
C11
C5
 
 
Empirical formula  C33 H58 Cl2 F6 N4 O6 S2 Te 
Color  colorless 
Formula weight  983.45  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pbca,  (no. 61) 
Unit cell dimensions a = 15.536(2) Å α= 90°. 
 b = 18.1269(15) Å β= 90°. 
 c = 32.831(4) Å γ = 90°. 
Volume 9246.1(18) Å3 
Z 8 
Density (calculated) 1.413  Mg · m-3 
Absorption coefficient 0.915 mm-1 
F(000) 4032 e 
Crystal size 0.29 x 0.19 x 0.06 mm3 
θ range for data collection 2.62 to 33.11°. 
Index ranges -23 ≤ h ≤ 23, -27≤ k ≤ 27, -50 ≤ l ≤ 50 
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Reflections collected 164134 
Independent reflections 17563 [Rint = 0.0530] 
Reflections with I>2σ(I) 13988 
Completeness to θ = 27.50° 99.9 % 
Absorption correction Gaussian 
Max. and min. transmission 0.95 and 0.88 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 17563 / 0 / 572 
Goodness-of-fit on F2 1.151 
Final R indices [I>2σ(I)] R1 = 0.0559 wR2 = 0.1227 
R indices (all data) R1 = 0.0741 wR2 = 0.1299 
Largest diff. peak and hole 2.381 and -2.058 e · Å-3 
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7.2.21 Crystal data and structure refinement of compound 170 
C11
C10
C14
C12
C13
N2
C8
C3
C7
C2
C15
N1
C1
F2
C9
C6
C4
B1
F3
F1
C5
 
Empirical formula  C15 H28 B F3 N2 
Color  colourless 
Formula weight  304.20  g · mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pna21,  (no. 33) 
Unit cell dimensions a = 12.512(3) Å α= 90°. 
 b = 13.905(3) Å β= 90°. 
 c = 9.644(3) Å γ = 90°. 
Volume 1677.9(8) Å3 
Z 4 
Density (calculated) 1.204  Mg · m-3 
Absorption coefficient 0.093 mm-1 
F(000) 656 e 
Crystal size 0.20 x 0.19 x 0.05 mm3 
θ range for data collection 2.93 to 29.89°. 
Index ranges -17 ≤ h ≤ 17, -19≤ k ≤ 19, -13 ≤ l ≤ 13 
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Reflections collected 35900 
Independent reflections 4846 [Rint = 0.0757] 
Reflections with I>2σ(I) 3995 
Completeness to θ = 27.50° 99.9 % 
Absorption correction Gaussian 
Max. and min. transmission 0.91 and 0.71 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4846 / 1 / 198 
Goodness-of-fit on F2 1.084 
Final R indices [I>2σ(I)] R1 = 0.0441 wR2 = 0.0855 
R indices (all data) R1 = 0.0638 wR2 = 0.0934 
Absolute structure parameter -0.7(5) 
Largest diff. peak and hole 0.476 and -0.225 e · Å-3 
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